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Sickle Cell Disease Erythrocyte Stiffness and Cytoadhesion Investigated 
via Atomic Force Microscopy 
 
Jamie Lynn Maciaszek, PhD 
University of Connecticut, 2013 
 
The biomechanical properties of red blood cells (RBCs), including increased stiffness and 
abnormal cytoadherence, are integral components in the cascade of events resulting to 
vasoocclusive episodes (VOEs) in sickle cell disease (SCD). VOEs are the main cause of 
morbidity in SCD and sickle cell trait (SCT). Using experimental techniques based on atomic 
force microscopy (AFM), we studied the stiffness and adhesion of RBCs from SCD patients and 
from subjects with SCT. We found that SCD and SCT RBCs are three-fold stiffer than normal 
RBCs. Further, a ten-fold increase in the stiffness of sickled RBCs was measured upon 
deoxygenation. In an effort to rectify the increased stiffness of sickle RBCs, mice were fed a diet 
supplemented with docosahexanoic acid (DHA), an omega-3 fatty acid. A decrease in RBC 
stiffness was measured suggesting therapeutic benefits of DHA. Cytoadherence of RBCs to 
subendothelial laminin via the basal cell adhesion molecule/Lutheran (BCAM/Lu) is implicated in 
vasculopathy, a common condition in SCD patients. We established the in vitro technique of 
single-molecule force spectroscopy (SMFS) which enables detection of single BCAM/Lu 
proteins on the RBC surface via measurement of the unbinding force with laminin. It was shown 
that epinephrine, acting through the cyclic adenosine monophosphate (cAMP) signaling 
pathway, increases the population of active BCAM/Lu receptors on SCT RBCs, suggesting a 
role in exercise-induced VOEs. The sensitivity of the SMFS system was validated in a neuronal 
system to quantitatively map SK channels and then employed to investigate the effects of cAMP 
pathway targeting on BCAM/Lu receptor expression on normal and SCD RBCs. We illustrated  
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that A-kinase anchoring proteins are crucial for BCAM/Lu receptor activation. To examine the 
relevance of results based on SMFS in the cytoadhesion of entire RBCs, single-cell force 
spectroscopy (SCFS) was established to measure the adhesion of whole cells with a 
functionalized substrate. We established a correspondence between the SMFS and SCFS 
results. Both techniques were able to detect significant changes in the adhesive response of 
RBCs to cAMP pathway modulation and variability was measured amongst human subjects, 
suggesting that RBCs maintain diverse intracellular levels of tonic protein kinase A.  
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Chapter 1. Introduction 
1.1. Sickle cell disease 
Sickle cell disease (SCD) is a multisystem disease characterized by extreme pain and episodes 
of acute illness resulting from microvascular infarction [1-3]. The genotype for homozygous SCD 
results in early mortality and high morbidity, while the heterozygous sickle cell trait (SCT) 
occasionally can be associated with collapse and sudden death during physical exertion [1-4]. 
SCD occurs in over 100,000 individuals in the United States [4] and over 3 million individuals 
worldwide [5-6]. Over 70% of sufferers live in Africa, where little is known about the disease [1, 
4, 7-8]. The number of SCD cases is expected to increase about 30% by 2050, making it a 
significant global health issue [5]. SCT occurs in approximately 300 million people worldwide, 
with the highest prevalence of approximately 30% to 40% in sub-Saharan Africa where it offers 
protection against severe malaria [9]. Recurrent vasoocclusive episodes (VOEs) and 
inflammation result in progressive damage to most organs, including the brain, kidneys, lungs, 
bones, and cardiovascular system, which becomes apparent with increasing age [1]. One of the 
main problems of SCD in children is the increased occurrence of stroke [10-12], with overt 
stroke estimated to occur in 11% of individuals under the age of 20, often resulting in permanent 
neurological and cognitive impairment [11-19]. Silent cerebral infarcts, a relatively newly 
recognized complication of SCD, occur in 22% of neurologically asymptomatic children and 
correlate with neurophysiologic dysfunction and predisposition of overt stroke [12, 19-27]. 
 
SCD is an inherited blood disorder caused by a single point mutation in one of the genes 
encoding hemoglobin [28-34]. Hemoglobin (Hb) is formed by four polypeptide chains, two of 
type α and two of type β. In abnormal sickle hemoglobin (HbS), the normal sequence of Val-His-
Leu-Thr-Pro-Glu-Glu-Lys is changed to Val-His-Leu-Thr-Pro-Val-Glu-Lys, with the amino acid 
valine substituting for glutamic acid at the β6 site. The replacement of two charged groups with 
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two hydrophobic groups leads to polymerization of deoxygenated Hb and to the formation of 
long stiff rodlike fibers [33, 35-36], which force RBCs to assume a wide variety of irregular 
shapes [37]. Other factors such as lowered pH, RBC dehydration and hyperthermia are also 
known to prompt sickling [38]. The genetics and underlying biophysics of the disease related to 
HbS have been extensively studied [1, 33, 35, 37, 39-42], however little remains known about 
the onset and progression of VOEs, specifically cell-cell interactions and blood cell adhesion 
events which are thought to be an integral component of VOEs. Therefore, clinical management 
of SCD is still basic and, although some evidence lends support to the use of blood transfusion 
and hydroxyurea in some circumstances, no drugs have been developed that specifically target 
the pathophysiology of the disease. 
 
SCT is marked by the presence of both HbS and HbA [43]. HbS comprises approximately 20-
46% of the total hemoglobin content in RBCs from persons with SCT [44], with most individuals 
having 40-42% [45]. SCT has a very significant social impact because approximately it occurs in 
approximately 300 million people worldwide and three million people in the United States, 
making it 40 to 50 times more prevalent than SCD [46]. In comparison to the homozygous SCD, 
the heterozygous SCT is traditionally regarded as a benign condition [28, 47-48]. During 
strenuous exercise, individuals can develop a syndrome resembling SCD with VOEs resulting 
from changes in the RBC morphology, viscoelasticity, and adhesion [38, 49-54]. These VOEs 
can lead to organ damage and ischemic pain, and are occasionally associated with significant 
morbidity and mortality, specifically in the case of physical training [55]. VOEs can also develop 
in other extreme conditions such as hypoxia, acidosis, dehydration, hyperosmolarity, or elevated 
erythrocyte 2,3-diphosphoglycerate (DPG) [46, 49-50, 56]. SCT is exclusively associated with 
rare but often fatal renal medullary cancer. Other complications associated with SCT include 
increased urinary tract infections in women, gross hematuria, complications of hyphema, splenic 
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infarction with altitude hypoxia or exercise, and life-threatening complications of exercise, 
exertional heat illness (exertional rhabdomyolysis, heat stroke, or renal failure) or idiopathic 
sudden death [46, 53, 57]. 
 
 
Figure 1.1.1. Human red blood cell surface adhesion receptors. These receptors mediate 
adhesion on healthy and pathological RBCs. 
 
Healthy RBCs have a diameter of approximately 8-10 µm and a height of 2.5 µm. They are very 
deformable and have the ability to deform to diameters as small as 1-3 μm to traverse narrow 
capillaries and blood vessels during their approximately three-month life cycle [58]. Healthy 
erythrocytes contain only soluble adult hemoglobin (HbA), a globular protein totaling 25-30% of 
the cell, which transports oxygen from the lungs to tissues [33, 59]. These cells have a 
characteristic biconcave shape which increases the surface area to facilitate the diffusion of O2 
and CO2 into and out of the cell [59-60]. This biconcave morphology is also associated with the 
high compliance of the erythrocytes [61]. Although RBCs are generally considered to be 
relatively inactive due to their lack of a nucleus and organelles, they express several surface 
adhesion receptors (Figure 1.1.1) which modulate cellular physiology and function [62]. Many of 
these receptors mediate cell-cell interactions, or adhesion, on both healthy and pathological 
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RBCs. Membrane proteins known to be involved in mediating the interaction between RBCs and 
the endothelium include: basal cell adhesion molecule and its isoform Lutheran (BCAM/Lu), a 
high-affinity laminin receptor; ICAM-4 (LW glycoprotein), a receptor for a number of integrins; 
CD47, a thrombospondin (TSP) receptor, as shown in Figure 1.1.2 [63]. 
 
 
Figure 1.1.2. Red blood cell surface adhesion receptors for endothelial ligands. 
 
A cascade of events results in the onset and progression of painful VOEs, the hallmark of SCD, 
which result from the blockage of small vessels in many different organs [31, 64-67]. The 
development of vascular obstruction in SCD is complicated and likely involves many different 
abnormalities of both circulating blood and the blood vessel wall (Figure 1.1.3). Endothelial cell 
activation, cytoadherence, inflammation, and coagulation activation contribute to blood flow 
obstruction and play a critical role in the pathophysiology of VOEs [64, 66, 68]. The 
pathogenesis of complications in SCD begins with loss of RBC deformability and increased 
cytoadherence of the RBCs. Loss of deformability and increased RBC rigidity occurs because 
Hb fibers form noncovalent cross-links and create a gel. This gives RBCs their irregular shapes 
and also alters their viscoelastic behavior and increases their cytoadherence [36, 69-70]. The 
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abnormal morphologic, adhesive, and elastic properties of sickle RBCs then causes obstruction 
of the microvasculature which ultimately results in stroke, VOEs, and organ damage. 
Importantly, cytoadherence of RBCs to the vascular endothelium and subendothelial matrix is 
thought to be a major contributor to and possibly the primary cause of vasculopathy in SCD [12, 
64, 71]. 
 
 
Figure 1.1.3. Vasculopathy of sickle cell disease. The combination of abnormal cytoadherence 
of the sickle RBC, the over-activity of the blood clotting system, and vessel wall damage 
contribute importantly to blood vessel occlusion and crises in SCD. There are many other 
factors involved in SCD vasculopathy including: sickle RBC adhesion, abnormal shear, 
increased inflammation, oxidative endothelial cell damage (ROS), an increase in serum free Hb, 
dysregulation of the nitric oxide pathway (NO/NOS), increases in cell adhesion molecule (CAM) 
and tissue factor (TF) expression, loss of vasoregulation, intimal hyperplasia, platelet and 
leukocyte adhesion, propagation of fibrin clot, and entrapment of rigid sickle RBCs. 
 
On healthy and pathological RBCs, the activation of adhesion receptors can be modulated by 
hormones such as epinephrine [30, 72], pharmaceutical drugs such as hydroxyurea [73], and 
other biochemical stimuli. Hydroxyurea (HU) is currently the only pharmacologic treatment to 
reduce the frequency of VOEs, yet only two-thirds of patients respond favorably to the drug [74]. 
Hydroxyurea stimulates an increase in fetal hemoglobin (HbF) [75-76], however clinical 
improvement following HU treatment has been observed prior to measureable increases in HbF, 
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suggesting the critical role of other mechanisms such as altered RBC signaling [73, 77-78].  
 
Quantitative understanding of RBC cytoadherence mediated by the second messenger cyclic 
adenosine monophosphate (cAMP) is necessary to fully elucidate the mechanism of RBC 
adhesion and signaling, and to guide advances in SCD pharmacotherapy. The current work will 
focus in part on subcellular targeting of the cAMP-dependent protein kinase A (PKA), a 
tetrameric holoenzyme consisting of two catalytic and two regulatory subunits [79]. Because 
SCD patients have extensive endothelial damage [80] and elevated plasma levels of laminin 
[81], RBC adhesion studies have focused on the specific interaction between BCAM/Lu and the 
α5 chain of laminin (LAMA5), a component of the subendothelial matrix [82-83]. Importantly, by 
using a flow adhesion assay, Hines et al [72] previously demonstrated that the interaction 
between BCAM/Lu and laminin is mediated by cAMP, an upstream effector of the PKA pathway 
[84]. In RBCs, stimulation of the β2-adrenergic receptor (β2-AR) [85-86] activates the G-protein 
coupled receptor Gαs, which stimulates adenylyl cyclase (AC) [87]. AC then catalyzes the 
conversion of adenosine triphosphate (ATP) to cAMP, which results in PKA activation and 
resultant BCAM/Lu-laminin adhesion (Figure 1.1.4). It was previously reported that levels of 
cAMP are significantly higher in sickle RBCs than RBCs from healthy subjects [72-73]. Contrary 
to the established mechanism of the PKA pathway, studies have also shown that healthy RBCs 
have little response to stimulation by epinephrine or forskolin [72]. Further, it is currently 
unknown if scaffold or anchoring proteins, such as A-kinase anchoring proteins (AKAPs), which 
compartmentalize PKA [88], play a role in BCAM/Lu receptor activation. Subsequent chapters of 
this work will investigated these subcellular targets and their specific effects on the population of 
active BCAM/Lu receptors. In addition, we will investigate the effect of epinephrine on the 
population of active BCAM/Lu and ICAM-4 receptors on normal and SCT erythrocytes. 
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Figure 1.1.4. Beta adrenergic pathway. The beta adrenergic pathway is a cAMP-dependent 
signaling pathway which modulates the activation of adhesion receptors on human RBCs.  
 
1.2. Objectives 
The objectives for subsequent chapters are outlined below. 
  
Chapter 2. Atomic Force Microscopy 
Atomic force microscopy (AFM) is appropriate for measuring the biomechanical and adhesive 
properties of living cells due to its high force sensitivity and its ability to measure local and 
overall properties of individual cells under physiological conditions. This chapter aims to 
describe the principles of AFM with respect to biological applications.  
 
Chapter 3. Microelasticity of Red Blood Cells in Sickle Cell Disease 
A systematic force-displacement curve analysis is reported on the quantification of material 
stiffness via AFM using two theoretical models derived from the Hertz model. We determined 
the model for a four-sided pyramidal indenter to be the best fit for our application as compared 
to the model for a parabolic indenter. This analysis was applied to red blood cells from patients 
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with sickle cell disease to determine the Young’s modulus of these cells in the oxygenated and 
deoxygenated state. Our findings conclude that deoxygenation and therapeutic treatment have 
a significant impact on the stiffness. This analysis presents a new approach to addressing 
medical disorders. 
 
Chapter 4. Sickle Cell Trait Human Erythrocytes Show a Significant Increase in their Stiffness 
Compared to Erythrocytes from Healthy Individuals 
The force-displacement curve analysis established in Chapter 3 was employed to measure the 
stiffness of abnormal human RBCs from patients with the genotype for SCT. The determined 
Young’s modulus was compared with measurements of erythrocytes from healthy subjects. The 
results showed that the Young’s modulus of SCT erythrocytes was approximately three times 
higher than in normal cells. Observed differences indicate the effect of the polymerization of 
hemoglobin S as well as possible changes in the organization of the cell cytoskeleton 
associated with the sickle cell trait. 
 
Chapter 5. Dietary Supplementation with Docosohexanoic Acid (DHA) Increases Red Blood Cell 
Membrane Flexibility in Mice with Sickle Cell Disease 
In an effort to rectify the increased stiffness of sickle RBCs determined in Chapter 3, mice were 
fed a diet supplemented with docosahexanoic acid (DHA), an omega-3 fatty acid, and 
measurements were recorded via AFM. Murine RBCs were examined for: 1) stiffness, as 
measured by AFM using the force-displacement curve analysis established in Chapter 3; 2) 
deformability, as measured by ektacytometry; and 3) percent irreversibly sickled RBCs on 
peripheral blood smears. Using AFM, stiffness is increased and deformability decreased in 
RBCs from SS mice fed CTRL diet compared to wild-type mice. In contrast, RBCs from SS mice 
fed DHA diet had markedly decreased stiffness and increased deformability compared to RBCs 
from SS mice fed CTRL diet. Furthermore, examination of peripheral blood smears revealed 
9 
 
less irreversibly sickled RBCs in SS mice fed DHA diet as compared to CTRL diet. In summary, 
our findings indicate that DHA supplementation improves RBC flexibility and reduces irreversibly 
sickled cells in SS mice. These results point to potential therapeutic benefits of dietary omega-3 
fatty acids in SCD. changes 
 
Chapter 6. Epinephrine Modulates BCAM/Lu and ICAM-4 Expression on the Sickle Cell Trait 
Red Blood Cell Membrane 
The in vitro technique of single-molecule force spectroscopy was established using RBCs from 
subjects with SCT. We report that epinephrine, a hormone secreted under stress and strenuous 
exercise, increases both the frequency and strength of adhesion events between BCAM/Lu and 
subendothelial laminin, and between ICAM-4 and endothelial integrin αvβ3, compared to non-
stimulated SCT erythrocytes. Increases in adhesion frequency present significant evidence of 
the role of epinephrine in BCAM/Lu-laminin and ICAM-4-αvβ3 bonding, and suggest 
mechanisms of vaso-occlusion during physical exertion in SCT. 
 
Chapter 7. Topography of Native SK Channels Revealed by Force Nanoscopy in Living 
Neurons 
As a proof of principle, we demonstrate that integration of pharmacology with single molecule 
AFM allows for the high-resolution mapping of native potassium channels in living neurons. By 
linking apamin, a toxin that specifically binds to SK channels, to the tip of an AFM cantilever, we 
are able to detect binding events between the apamin and SK channels. We find that native SK 
channels from rat hippocampal neurons reside primarily in dendrites as single entities and in 
pairs. To establish the sensitivity of the assay, we also show that SK channel dendritic 
distribution is dynamic and under the control of protein kinase A. 
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Chapter 8. AKAP-Dependent Modulation of BCAM/Lu Adhesion on Normal and Sickle Cell 
Disease RBCs Revealed by Force Nanoscopy 
SMFS was employed to investigate the effects of subcellular cAMP pathway targeting on 
BCAM/Lu receptor expression on normal and SCD RBCs. Human normal and sickle RBCs 
adhere with high affinity to laminin via the BCAM/Lu receptor which is implicated in VOEs in 
SCD and activated through the cAMP signaling pathway. We measured the unbinding force 
between BCAM/Lu on the RBC and laminin attached to the AFM probe. We showed that the 
expression of active BCAM/Lu receptors is higher in homozygous sickle RBCs (SS-RBCs) than 
normal RBCs and that it is critically dependent on the cAMP signaling pathway on both normal 
and SS-RBCs. Importantly, we illustrated that A-kinase anchoring proteins (AKAPs) are crucial 
for BCAM/Lu receptor activation. Furthermore, we found that SS-RBCs from hydroxyurea-
treated patients show a lower expression of active BCAM/Lu receptors, a lower unbinding force 
to laminin, and insignificant stimulation by epinephrine as compared to SS-RBCs from untreated 
patients. These findings may lead to novel anti-adhesive targets for VOEs in SCD. 
 
Chapter 9. Single-Cell Force Spectroscopy as a Technique to Quantify Human Red Blood Cell 
Adhesion to Subendothelial Laminin 
To examine the relevance of results based on SMFS in the cytoadhesion of entire RBCs, single-
cell force spectroscopy (SCFS) was established to measure the adhesion of whole cells with a 
functionalized substrate. Adhesion forces were recorded as RBCs attached to AFM cantilevers 
were pulled-off of substrates coated with laminin protein. We established a correspondence 
between the SMFS and SCFS results. In particular, it was found that elevated overall cell 
adhesion measured via SCFS coincided with a rise in the resultant total force measured on 1 
µm2 areas of the RBC membrane at baseline via SMFS. Both techniques were able to detect 
significant changes in the adhesive response of RBCs to cAMP pathway modulation and 
variability was measured amongst human subjects, suggesting that RBCs maintain diverse 
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intracellular levels of tonic protein kinase A. By using single-cell measurements, we established 
a powerful new method for the quantitative measurement of the adhesion of single RBCs with 
specific receptor-mediated binding. 
 
1.3. Rationale 
Multiple biological processes contribute to the pathogenesis of vasculopathy in SCD including 
red cell sickling, inflammation and adhesion biology, coagulation activation, stasis, deficient 
bioavailability and excessive consumption of NO, excessive oxidation, and reperfusion injury 
physiology. The biomechanical properties of RBCs, including increased stiffness and abnormal 
cytoadherence, are integral components in the cascade of events resulting to vasculopathy in 
SCD and SCT [1, 9, 28]. The hemoglobin biophysics and genetics underlying the disease have 
been extensively studied, however despite substantial evidence underlining the importance of 
RBC stiffness and hetero-cellular interactions in the onset and progression of VOEs, the exact 
mechanism is not known. Thus, clinical management of SCD is still basic and although some 
evidence supports the use of blood transfusion therapy and hydroxyurea to reduce the 
frequency of VOEs, no drugs have been developed that specifically target the pathophysiology 
of the disease. Therefore, substantial work must be performed to better understand RBC 
biophysics in SCD, namely stiffness and adhesion, in an effort to develop better 
therapeutic methods for the prevention and treatment of VOEs.  
 
Human normal and sickle RBCs adhere with high affinity to laminin via the BCAM/Lu receptor 
which is activated through the cAMP signaling pathway. The adhesion of single RBCs and the 
effect of cAMP signaling at the single-molecule and single-cell level are central to disease 
pathology and anti-adhesive drug development. We established two in vitro techniques, based 
on AFM, to study human RBC adhesion in physiological conditions. The first, SMFS enables 
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detection of single BCAM/Lu proteins on the RBC surface and measures the exact unbinding 
force between BCAM/Lu and laminin. The second, SCFS enables quantitative study of RBC 
adhesion while maintaining the native state of surface receptors. By studying RBC adhesion 
using SMFS in conjunction with SCFS, we expect a significant impact on identifying potential 
targets for anti-adhesive drug therapies to prevent and treat VOEs in SCD. 
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Chapter 2. Atomic Force Microscopy 
 
Atomic force microscopy (AFM; Figure 2.1) [89] has opened a wide range of novel possibilities 
for imaging and manipulating biological systems in their native environment [90-91].  It allows for 
measurements of native biological samples in physiological conditions [30, 92-93] while 
avoiding complex sample preparation procedures and the artifacts connected with such 
procedures. The mild experimental conditions used in AFM allow for dynamic studies of cellular 
morphology, elasticity, and molecular interactions at the single-molecule and single-cell level 
[30, 90, 94]. In particular, functionalization of the AFM cantilever tip with ligands has allowed for 
mapping the distribution of complementary receptors on model or cellular surfaces [90-91, 94-
98] with high resolution.  
 
Figure 2.1. Atomic force microscope. Labeled components of the Asylum Research MFP-3D-
BIO AFM atop a Zeiss optical inverted microscope. Image edited from Asylum Research MFP-
3D-BIO brochure [99]. 
 
The AFM works by scanning, in a raster fashion, a very tiny tip mounted at the end of a flexible 
cantilever in gentle touch with the sample. This relative motion is performed with sub-Angstrom 
accuracy by a piezoelectric actuator. Interacting with the sample, the cantilever deflects and the 
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tip-sample interaction can be monitored with high resolution exploiting a laser beam impinging 
on the back of the cantilever [89, 92]. The beam is reflected towards a split photodetector 
configuring an optical lever which amplifies cantilever deflections. Connected to the cantilever 
deflection sensor is a feedback circuit that keeps interactions between the cantilever tip and the 
sample at a fixed value by controlling the distance between the cantilever tip and the sample. 
AFM cantilever probes utilized in biological applications are generally composed of thin silicon 
nitride with a tiny pyramid tip at the end of the probe. Typical spring constants for these AFM 
cantilevers range from 0.01 N/m to 100 N/m, enabling a minimum force sensitivity of 
approximately 10-11 N. 
 
A typical force-distance curve (Figure 2.2) can be divided into several regions. Starting from the 
right (region I) the AFM tip is far from the sample and no interaction is detected. Moving towards 
the left side of the plot (dotted curve), the tip is approaching the sample and no interaction is 
detected until the cantilever deflects downwards towards the sample as a result of van der 
Waals forces (region II). At this point, these van der Waals forces cause the cantilever tip to 
snap into contact with the sample. The ‘jump to contact’ point corresponds to the position where 
the gradient of the interaction force exceeds the cantilever spring constant. At each position in 
the force curve, the cantilever is deflected until the restoring force is equal to the interaction 
force with the sample, thus causing the system to be always at equilibrium. After the contact, as 
the tip continues its approach cycle and moves closer to the surface, a positive deflection of the 
cantilever arises (region III) due to repulsive forces. This is the contact region of the force curve 
where elastic properties of the sample can be measured [93, 100-103]. The cantilever moves 
toward the sample until a preset force threshold is reached. At this time, the movement direction 
is inverted and the cantilever starts moving away from the sample (solid curve). Initially, the 
behavior of the cantilever during withdrawal equals that described for the approach, but due to 
adhesion between the functionalized cantilever tip and the sample, the cantilever starts to 
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deflect negatively (region IV) until the adhesion force is overcome by the cantilever restoring 
force and the contact breaks. The resulting breakage of contact is referred to as the rupture 
force and is used to determine the bond magnitude of a protein-protein interaction, or any 
interaction between a molecule functionalized on the cantilever tip and a receptor on the 
sample. 
 
 In a force-curve cycle the cantilever deflection is measured and can be converted to force using 
Hooke’s law: 
 
       
 
where   is the force,   is the spring constant of the cantilever and   is the cantilever deflection. 
By using a cantilever with a very small spring constant, a resolution of 10 pN can be obtained in 
the measurement of forces [92]. 
 
The retraction component of the force curve quantifies the exact detachment force, denoting the 
adhesive force, of the cell-cell or cell-protein interaction [30, 91]. If on the sample surface there 
is a molecule or a cell and the tip is functionalized in order to expose a partner suitable to 
specific interaction with it off its surface, the ligand-receptor interaction can be measured by 
exploiting the detachment force in the retraction portion of the force-distance curve. When the 
tip and sample are brought into contact, the molecules/cells present on the tip and surface 
interact and form bonds. Upon cantilever retraction, the bonds previously formed are disrupted 
and the typical detachment force is measured. To analyze the collected data, usually a 
distribution of the number of detachment events as a function of the detachment force is 
obtained. In SMFS, the presence of a detachment force is the indication that a single-molecule 
interaction is measured, the multiples of the unbinding force being the result of coincident 
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breakage of several bonds. Moreover, when a retraction curve presents several detachment 
events, the last one most likely represents a single bond breakage [92, 104]. In SCFS, the 
detachment forces are characteristic of the breakage of many receptor-ligand bond formations 
and are typically higher than those recorded in SMFS.  
 
 
Figure 2.2. Force curve regions. Force curve illustration with the different regions of the 
approach and withdrawal portions highlighted. Region I demonstrates no interaction between 
the tip and the sample, region II shows the cantilever deflecting downward towards the sample 
as a result of van der Waals forces, region III shows the positive deflection of the cantilever due 
to repulsive forces, and region IV demonstrates the negative deflection of the cantilever tip as a 
result of adhesion forces between the tip and the sample. The different regions are discussed 
thoroughly in the text. 
 
Contact problems 
The general theory of elasticity has been applied to AFM measurements based on the contact 
theory of Hertz and Sneddon [105-107]. AFM stiffness measurement is modeled as indentation 
of an elastic half-space,   < 0, by a frictionless rigid punch [108], as shown in Figure 2.3. The 
profile of the punch is described by the function       , and         is the normal deformation 
of the indented elastic half-space surface. In this case, the half-space represents the indented 
RBC.  
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Figure 2.3. The general indentation problem for a smooth, rigid, frictionless punch. 
 
The gap        between the punch and the half-space is defined as 
 
                          .        (1) 
 
When the shape of the employed indenter exhibits a two-fold symmetry (e.g. pyramidal or 
parabolic) then the contact area   preserves the same symmetry as the base of the indenter, 
with the center of   at the coordinate origin (  = 0,   = 0,   = 0). The contact tractions act 
normal to the surface and are compressive inside   and zero exactly at the contact perimeter, 
as well as outside  . 
 
The gap is zero within the contact region   and positive in the separation region   , since 
interpenetration of material is prohibited. Therefore, we have two conditions 
 
                ; in           (2) 
                ; in   .         (3) 
 
The definition of the frictionless contact problem is completed by assuming that the tangential 
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traction is zero throughout the surface of the half-space, 
 
         ; all                   (4) 
 
and that the contact pressure                    is zero in the separation region    and 
positive in the contact region  , that is 
 
         in             (5) 
 
         in  .          (6) 
 
If the contact region A is specified, the equality conditions (2), (4), (5) define a well-posed 
boundary value problem for the half-plane which has a unique solution. Then the total contact 
force is obtained by 
 
                         (7) 
 
The inequalities (3) and (6) serve to determine the extent of the contact area for the contact 
problem, but it has been shown [109] that the value of  , which satisfies (3) and (6), maximizes 
the total force    given by equation (7). 
 
In the case of a spherical indenter, by solving the boundary contact problem as performed by 
Hertz [106], the following result is obtained, 
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           (8) 
 
where               
             
  
 
   is the distance between source          and 
observation point         ;   is the angular distance and             
  , where   is the 
Young’s modulus. The contact radius,  , is given in terms of the applied force,  , and the 
Poisson’s ration,  , of the sample 
 
   
 
 
    
 
   
 
  
          (9) 
 
Sneddon extended the Hertz model from a spherical indenter to an indenter of arbitrary profile 
deforming elastic half space [107, 110]. Solutions of the boundary contact problem for other tip 
geometries with two-fold symmetry generated models for parabolic [111-113] and pyramidal 
[102, 110, 114-115] indenters. The general solution for force as a function of indentation for a 
parabolic indenter can be approximated as 
 
            
 
 
     
 
           (10) 
 
where    is the reduced Young’s modulus of the tip-sample system defined as 
 
 
  
 
    
 
            (11) 
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The general solution for force as a function of indentation for a pyramidal indenter [102, 114-
115] can be approximated as 
 
         
      
       
  
           (12) 
 
Atomic force microscopy contact problems 
In a force curve on a sample indented via AFM, the indentation,   , is equal to  
 
                 (13) 
 
where   is the deflection of the cantilever on the rigid substrate and   is the deflection of the 
cantilever on the indented half-space. In this particular study,   is the deflection of the cantilever 
on the poly-l-lysine coated mica substrate and   is the deflection of the cantilever on the 
indented erythrocyte surface. 
 
Three important assumptions of the Hertz-Sneddon model are the following: (i) the indenter 
must have a parabolic shape, (ii) the indented sample is assumed to be extremely thick in 
comparison to the indentation depth, and (iii) there is no adhesive interaction between the 
sample and the indenter. The first assumption remains a valid one for the case when a spherical 
tip radius is much larger than the indentation depth (   < 0.3 ) [116]. The second assumption 
states that elastic models based on Hertz-Sneddon contact mechanics are accurate when the 
indentation depth is small compared to the thickness of the cell. This corresponds with the well 
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known fact that the effect of the substrate over which the cells are placed is negligible if the 
indentation depth is less than 10% of the total thickness of the specimen [117]. In cases where 
the third assumption is not satisfied, the Johnson-Kendall-Roberts (JKR) model should be 
employed to incorporate the effect of adhesion [118]. The JKR model considers the effect of 
contact pressure and adhesion within the area of contact. In the current study, we did not 
observe a pull-off force, or rupture force, in the experimental force-distance curves. This can be 
attributed to the fact that our AFM indenter was not functionalized. Therefore, the Hertz-
Sneddon model appropriately describes the measurements in the present study. 
 
While in the current work only the elastic behavior of RBCs is studied, RBCs have been found to 
exhibit viscoelastic behavior under repetitive deformations [119]. The viscoelastic properties of 
normal RBCs have been studied via magnetic twisting cytometry. Results indicate that   , the 
storage modulus which represents the Young’s modulus, is nearly constant for different 
frequencies, while   , the loss modulus, increases with frequency [119]. This result suggests 
that the measurement of the effective Young’s modulus presented in this work remains valid 
when repetitive loading is applied, at least for normal RBCs. Finally, it should be noted that AFM 
has been used to measure the viscoelastic behavior of epithelial cells [102, 115]. In principle, 
the employed methods can be used to perform viscoelasticity measurements on normal and 
pathological RBCs. 
 
Parabolic tip 
When the shape of the AFM tip is approximated by a paraboloid with a radius of curvature   at 
the apex, the force            as a function of indentation    is described by the following 
equation [111-113]: 
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             (14) 
 
where    is the reduced Young’s modulus of the tip-sample system defined as 
 
 
  
 
         
 
    
 
         
 
       
          (15) 
 
in which     ,      and        ,         are the Young’s moduli and the Poisson ratios for the 
materials of the tip and the sample, respectively. If              (in the case of Si3N4 tips, the 
Young’s modulus is 150 GPa [103]),    can be simplified as: 
 
   
       
         
            (16) 
 
Poisson’s ratio,  ,  is defined as the ratio of the transverse, or orthongonal, strain to the strain 
along the direction of elongation. It is useful for determining how much the material extends 
orthogonally to the direction in which the force is applied. The value of   is always between 0 
and 0.5 [120-121]. 
 
Pyramidal tip 
When the shape of the AFM tip is a four-sided pyramidal indenter, the force          as a 
function of indentation    is described by the following equation [102, 110, 114-115]: 
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            (17) 
 
with an effective radius of contact            
    with   defined as nominal angle of the 
pyramidal geometry [102, 114-115].  
 
Adhesion measurements 
In the past, RBC adhesion was traditionally investigated via large-scale flow adhesion assays 
[122-125], which measure the average adherence of a large number of RBCs to a 
functionalized-substrate under flow-induced shear stress [126-127]. These measurements 
provide only estimates of the adhesion force to which cells are subjected because the shear 
force exerted on cells in these assays depends on parameters such as cell size, cell shape, how 
the cell attaches to the substrate, as well as the viscoelastic and elastic properties of the cells 
[128-130]. For example, it is known that RBCs from SCD patients show variability in their 
viscoelastic and elastic properties [100, 119], and these properties can change after 
biochemical or pharmacologic treatment [87]. Specifically, RBCs from patients taking the drug 
hydroxyurea are more compliant than RBCs from patients who are not taking the drug [77]. 
Further, given the nature of flow adhesion assays, they are unable to provide information 
regarding receptor activity, including detachment forces, receptor localization, and changes in 
the number of active receptors upon biochemical stimulation. To obtain more controlled and 
quantitative measurements of RBC adhesion, single-cell methods must be employed. 
 
AFM studies of RBC adhesion have been employed to provide quantitative evidence of changes 
in surface receptor distribution, and unbinding forces with specific ligands [30]. A technique 
known as SMFS utilizes cantilever tips functionalized with specific ligands to probe the cell 
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surface. SMFS measures the unbinding, or detachment force, between a specific ligand on the 
AFM tip and its corresponding receptor on a single cell with piconewton sensitivity [30, 90-92, 
131-132]. Because SMFS is broadly used in conjunction with optical microscopy, the user has 
the ability to choose a RBC of interest for measurements. SMFS operates by collecting a set of 
force-distance curves of the approach-retract cycle of the functionalized tip from the cell surface. 
Specifically, the retraction curve, obtained when the functionalized probe pulls away from the 
RBC surface gives the detachment force. Individual approach/retract curves can be obtained at 
many points on a sample to create a two-dimensional map of detected surface adhesion 
receptors [30]. Forces probed by SMFS reflect interactions within or between molecules [133]. 
Specifically, this technique allows for (i) quantifying the detachment force of specific receptor-
ligand bonds, (ii) mapping the distribution of active receptors on cellular surfaces with high 
resolution, (iii) calculating the density of active receptors on the cell surface [90-91, 94-98]. 
While SMFS presents a very powerful tool to study RBC adhesion at the single-molecule level, it 
cannot measure the overall adhesion of a living cell to a substrate or another living cell. Further, 
it is currently unknown how SMFS measurements compare to whole cell measurements. 
 
To overcome these limitations, SCFS assays, that are using a living cell as a probe, were 
developed [130, 134-138]. This AFM-based method is highly versatile because of its ability to 
measure a wide range of forces, from ~5 pN to ~100 nN [130]. In SCFS, a RBC attached to an 
AFM cantilever is positioned above a functionalized substrate or another living cell. Similar to 
SMFS measurements, SCFS also records force-distance curves of an approach/retract cycle 
between the RBC probe and the functionalized substrate or cell. The RBC is lowered onto the 
substrate until a preset contact force is reached, and then held stationary for a defined time. 
Subsequently, the cell is withdrawn from the substrate at a constant speed and bonds between 
the cell and substrate break sequentially until the two entities are completely separated. In this 
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case, the maximum detachment force is characterized as the force required to fully remove the 
RBC from the functionalized substrate. 
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Chapter 3. Microelasticity of Red Blood Cells in Sickle Cell Disease 
 
3.1. Abstract 
Translation of cellular mechanics findings is crucial in many diseases, including Alzheimer’s 
disease, Parkinson’s disease, type II diabetes, malaria, sickle cell disease, and cancer. Atomic 
force microscopy (AFM) is appropriate for measuring mechanical properties of living and fixed 
cells due to its high force sensitivity and its ability to measure local and overall properties of 
individual cells under physiological conditions. A systematic force-displacement curve analysis 
is reported on the quantification of material stiffness via AFM using two theoretical models 
derived from the Hertz model. This analysis was applied to red blood cells from patients with 
sickle cell disease to determine the Young’s modulus of these cells in the oxygenated and 
deoxygenated state. Sickle cell disease pathophysiology is a consequence of the polymerization 
of sickle hemoglobin in red blood cells upon partial deoxygenation and the impaired flow of 
these cells in the microcirculation. We determined the model for a four-sided pyramidal indenter 
to be a better fit for our application as compared to the model for a parabolic indenter. Our 
findings conclude that deoxygenation and therapeutic treatment have a significant impact on the 
stiffness. This analysis presents a new approach to addressing medical disorders. 
 
3.2. Introduction 
A detailed knowledge of the mechanical properties of the cell  is required in understanding how 
mechanical stresses and deformations regulate cellular functions including fundamental cell 
processes including mechanotransduction, growth, differentiation, protein and DNA synthesis, 
motility, and apoptosis [139-140]. The most common approach reported to study cell mechanics 
is to determine the stiffness or an apparent elastic modulus of the cell, assuming that it is an 
elastic body. Atomic force microscopy (AFM) [89] is appropriate for measuring the mechanical 
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properties of living and fixed cells due to its high force sensitivity and its ability to measure local 
and overall properties of individual cells under physiological conditions [101, 141-146]. AFM 
allows simultaneous evaluation of the local mechanical properties and the morphology of the 
living cells at a high spatial resolution and force sensitivity. The basic technique for quantitative 
study of mechanical characteristics of cells and tissues via AFM is the force-displacement curve 
analysis. By recording the force-displacement curves on the sample surface, vertical deflection 
of the cantilever represents a basis for estimation of sample Young’s modulus. In the current 
study, we apply the force-displacement curve analysis to explore the pathophysiology of sickle 
cell disease. Understanding the relationship between proteins and cellular material properties 
will allow for detection of diseases and new approaches to addressing medical disorders [147]. 
 
3.3. Sickle Cell Disease 
In the current study, we measure the Young’s modulus of red blood cells (RBCs, erythrocytes) 
from patients with sickle cell disease (SCD), a severe disease caused by polymerization of 
abnormal hemoglobin [148], a globular protein which transports oxygen from the lungs to 
tissues [59] . Hemoglobin (Hb) is formed by four polypeptide chains, two of type α and two of 
type β. In sickle cell hemoglobin (HbS), the normal sequence of Val-His-Leu-Thr-Pro-Glu-Glu-
Lys is changed to Val-His-Leu-Thr-Pro-Val-Glu-Lys, with the amino acid valine substituting for 
the glutamic acid in the β6 site. The replacement of two charged groups by two hydrophobic 
ones leads to polymerization of deoxygenated Hb and to formation of long stiff rodlike fibers [33, 
35-36], which force RBCs to assume a wide variety of irregular shapes [37]. The fibers form 
noncovalent cross-links and create a gel that gives RBCs their irregular shapes and alters their 
viscoelastic behavior, increases their rigidity, fragility, and cytoadherence [36, 69-70]. Other 
factors such as lowered pH, RBC dehydration and hyperthermia are also known to prompt 
sickling [38]. Pathology in SCD begins with loss of deformability and increased cell adherence of 
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the sickle cells resulting in serious and often life threatening complications such as chronic 
hemolytic anemia and vaso-occlusion [31, 64, 67, 69]. Persons with sickle cell trait (SCT) have 
only one abnormal hemoglobin β gene producing thus both normal hemoglobin (HbA) and sickle 
hemoglobin HbS with a prevalence of HbA [44-45]. 
 
In the case of SCD, it has been hypothesized that increased association of HbS with the 
membrane proteins contributes to the change of the mechanical behavior of sickle erythrocytes 
[149].  HbS could alter the mechanical properties of RBCs not only by extending the spectrin 
filaments, and by the interaction between HbS filaments and the lipid bilayer but also by altering 
the functionality of the membrane proteins [150]. It is known that Hb interacts with the spectrin 
network via the protein band 3 [40, 151-152] and the introduction of HbS has recently been 
found to have an effect on the mechanical properties of SCT erythrocytes [93]. In the present 
study, we employ AFM techniques to measure the Young’s modulus of RBCs from patients with 
SCD under both oxygenated and fully deoxygenated conditions.  
 
3.4. Atomic Force Microscopy Probing of Cell Elasticity 
In the current work, we perform nanoindentation of RBCs to measure the local cell stiffness. The 
measurements are performed via AFM by pushing a tip onto the surface of the sample at the 
position of interest. From the resulting force-displacement curves the local Young’s modulus is 
determined.  
 
Introduction to contact problems 
The general theory of elasticity has been applied to AFM measurements based on the contact 
theory of Hertz and Sneddon [105-107]. AFM stiffness measurement is modeled as indentation 
of an elastic half-space,   < 0, by a frictionless rigid punch [108], as shown in Figure 3.4.1. The 
29 
 
profile of the punch is described by the function       , and         is the normal deformation 
of the indented elastic half-space surface. In this case, the half-space represents the indented 
RBC. The gap        between the punch and the half-space is defined as 
 
                          .        (1) 
 
 
Figure 3.4.1. The general indentation problem for a smooth, rigid, frictionless punch. 
 
When the shape of the employed indenter exhibits a two-fold symmetry (e.g. pyramidal or 
parabolic) then the contact area   preserves the same symmetry as the base of the indenter, 
with the center of   at the coordinate origin (  = 0,   = 0,   = 0). The contact tractions act 
normal to the surface and are compressive inside   and zero exactly at the contact perimeter, 
as well as outside  . 
 
The gap is zero within the contact region   and positive in the separation region   , since 
interpenetration of material is prohibited. Therefore, we have two conditions 
 
                ; in           (2) 
                ; in   .         (3) 
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The definition of the frictionless contact problem is completed by assuming that the tangential 
traction is zero throughout the surface of the half-space, 
 
         ; all                   (4) 
 
and that the contact pressure                    is zero in the separation region    and 
positive in the contact region  , that is 
 
         in             (5) 
         in  .          (6) 
 
If the contact region A is specified, the equality conditions (2), (4), (5) define a well-posed 
boundary value problem for the half-plane which has a unique solution. Then the total contact 
force is obtained by 
 
                         (7) 
 
The inequalities (3) and (6) serve to determine the extent of the contact area for the contact 
problem, but it has been shown [109] that the value of  , which satisfies (3) and (6), maximizes 
the total force    given by equation (7). 
 
In the case of a spherical indenter, by solving the boundary contact problem as performed by 
Hertz [106], the following result is obtained, 
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           (8) 
 
where               
             
  
 
   is the distance between source          and 
observation point         ;   is the angular distance and             
  , where   is the 
Young’s modulus. The contact radius,  , is given in terms of the applied force,  , and the 
Poisson’s ration,  , of the sample 
 
   
 
 
    
 
   
 
  
          (9) 
 
Sneddon extended the Hertz model from a spherical indenter to an indenter of arbitrary profile 
deforming elastic half space [107, 110]. Solutions of the boundary contact problem for other tip 
geometries with two-fold symmetry generated models for parabolic [111-113] and pyramidal 
[102, 110, 114-115] indenters. The general solution for force as a function of indentation for a 
parabolic indenter can be approximated as 
 
            
 
 
     
 
           (10) 
 
where    is the reduced Young’s modulus of the tip-sample system defined as 
 
 
  
 
    
 
            (11) 
The general solution for force as a function of indentation for a pyramidal indenter [102, 114-
115] can be approximated as 
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Atomic force microscopy contact problems 
In a force curve on a sample indented via AFM, the indentation,   , is equal to  
 
                 (13) 
 
where   is the deflection of the cantilever on the rigid substrate and   is the deflection of the 
cantilever on the indented half-space. In this particular study,   is the deflection of the cantilever 
on the poly-l-lysine coated mica substrate and   is the deflection of the cantilever on the 
indented erythrocyte surface. 
 
Three important assumptions of the Hertz-Sneddon model are the following: (i) the indenter 
must have a parabolic shape, (ii) the indented sample is assumed to be extremely thick in 
comparison to the indentation depth, and (iii) there is no adhesive interaction between the 
sample and the indenter. The first assumption remains a valid one for the case when a spherical 
tip radius is much larger than the indentation depth (   < 0.3 ) [116]. The second assumption 
states that elastic models based on Hertz-Sneddon contact mechanics are accurate when the 
indentation depth is small compared to the thickness of the cell. This corresponds with the well 
known fact that the effect of the substrate over which the cells are placed is negligible if the 
indentation depth is less than 10% of the total thickness of the specimen [117]. In cases where 
the third assumption is not satisfied, the Johnson-Kendall-Roberts (JKR) model should be 
employed to incorporate the effect of adhesion [118]. The JKR model considers the effect of 
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contact pressure and adhesion within the area of contact. In the current study, we did not 
observe a pull-off force, or rupture force, in the experimental force-distance curves as shown in 
Figure 3.4.2. This can be attributed to the fact that our AFM indenter was not functionalized. 
Therefore, the Hertz-Sneddon model appropriately describes the measurements in the present 
study. 
 
Figure 3.4.2. Force-distance curves obtained during the retraction cycle of the indention. The 
absence of a pull-off force, or rupture force, indicates that there is no adhesion present between 
the sample and the indenter during experimentation. 
 
While in the current work only the elastic behavior of RBCs is studied, RBCs have been found to 
exhibit viscoelastic behavior under repetitive deformations [119]. The viscoelastic properties of 
normal RBCs have been studied via magnetic twisting cytometry. Results indicate that   , the 
storage modulus which represents the Young’s modulus, is nearly constant for different 
frequencies, while   , the loss modulus, increases with frequency [119]. This result suggests 
that the measurement of the effective Young’s modulus presented in this work remains valid 
when repetitive loading is applied, at least for normal RBCs. Finally, it should be noted that AFM 
has been used to measure the viscoelastic behavior of epithelial cells [102, 115]. In principle, 
the employed methods can be used to perform viscoelasticity measurements on normal and 
pathological RBCs. 
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Parabolic tip 
When the shape of the AFM tip is approximated by a paraboloid with a radius of curvature   at 
the apex, the force            as a function of indentation    is described by the following 
equation [111-113]: 
 
            
 
 
      
 
             (14) 
 
where    is the reduced Young’s modulus of the tip-sample system defined as 
 
 
  
 
         
 
    
 
         
 
       
          (15) 
 
in which     ,      and        ,         are the Young’s moduli and the Poisson ratios for the 
materials of the tip and the sample, respectively. If              (in the case of Si3N4 tips, the 
Young’s modulus is 150 GPa [103]),    can be simplified as: 
   
       
         
            (16) 
 
Poisson’s ratio,  ,  is defined as the ratio of the transverse, or orthongonal, strain to the strain 
along the direction of elongation. It is useful for determining how much the material extends 
orthogonally to the direction in which the force is applied. The value of   is always between 0 
and 0.5 [120-121]. 
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Pyramidal tip 
When the shape of the AFM tip is a four-sided pyramidal indenter, the force          as a 
function of indentation    is described by the following equation [102, 110, 114-115]: 
 
         
      
       
  
            (17) 
 
with an effective radius of contact            
    with   defined as nominal angle of the 
pyramidal geometry [102, 114-115].  
 
3.5. Methods 
Experiments were carried out using an Asylum MFP 3D-BIO (Asylum Research, Santa Barbara, 
CA) AFM equipped with a “liquid cell” setup.  
 
Red blood cell preparation 
Whole blood was drawn from patients with sickle cell disease during clinical visits to the Lea 
Center for Hematologic Disorders at the University of Connecticut Health Center (UCHC) 
following the guidelines of the Human Subjects Protection Office at UCHC. Blood was drawn by 
venipuncture into 5 IU/ml heparin and centrifuged at 400 g for 15 min at 25°C to isolate the 
RBCs. The yellowish supernatant containing plasma and the white fluffy coat on the pellet was 
discarded. All buffers were pre-warmed to 37°C prior to use. RBCs were washed three times 
with phosphate-buffered saline (PBS) and finally re-suspended in PBS at a concentration 5%. 
Deoxygenated red blood cells were obtained by bubbling N2 through a suspension of RBCs in a 
sealed flask for 1 hr. The state of deoxygenation of the erythrocytes was expected to be 
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maintained for 1-1.5h [153] and experiments were performed during this time. 
 
Erythrocyte immobilization 
Cells were immobilized on AFM grade mica (Novascan Technologies, Inc., Ames, IA) coated 
with poly-L-lysine (PLL) (Sigma-Aldrich, St. Louis, MO) to increase cell adherence. 150 μl of 1 
mg/ml PLL solution was allowed to adsorb for 5 min to an unmodified mica surface, and excess 
solution was drained away. RBCs of 0.5% concentration in PBS were allowed to adhere to each 
PLL-coated mica surface for 10 min in the incubator. Unattached cells were removed by gentle 
rinsing of the slide with PBS solution at 25°C. For imaging, fixation was performed by a 1-min 
treatment of the cells with 0.5% glutaraldehyde (Sigma-Aldrich, St. Louis, MO) in PBS buffer. 
The sample was again rinsed several times with PBS and a volume of PBS was added for 
experiments. Glutaraldehyde was not employed for stiffness measurements. 
 
Imaging 
Erythrocytes were imaged in tapping mode with a scan rate of 0.2 Hz, and the minimal force 
necessary to obtain good image contrast was determined by gradually increasing the force 
applied to the sample from zero force (noncontact) to the necessary minimal force. Silicon 
nitride probes with a nominal spring constant of 0.01 N/m (Veeco Probes, Camarillo, CA) were 
employed for imaging.  
 
Measurements 
Erythrocyte’s stiffness measurements were carried out in contact mode using silicon nitride 
cantilevers with a nominal spring constant of 0.03 N/m (Veeco Probes, Camarillo, CA). Exact 
values for the cantilever spring constants were obtained via a thermal noise based method 
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implemented by the manufacturer and were used in all calculations. Probes had nominal tip radii 
  of 20 nm and nominal angle   of 20°, as provided by the manufacturer. Tip height was 2.5 
µm, as provided by the manufacturer. All measurements were performed in PBS at 25°C. Local 
elastic properties of erythrocytes were quantitatively determined from the force-distance curves. 
The force curves were generated at a loading rate of 15,000 pN/s, and for both states, 
oxygenation and deoxygenation, more than 500 measurements were collected. 
 
Data processing 
Data was imported into MATLAB (The MathWorks, Natick, MA) and the value of E  was 
obtained by fitting the theoretical curves generated by Eq. (2) and Eq. (5) to the experimental 
data up to a minimum depth of 250 nm, which is approximately 10% of the total thickness of the 
cell. The method is in agreement with the well known fact that the effect of the substrate over 
which the cells are placed is negligible if the indentation depth is less than 10% of the total 
thickness of the specimen [117].  
 
3.6. Results 
Morphology of SCD erythrocytes via AFM imaging 
Under both oxygenated and deoxygenated states, highly irregular morphologies were observed 
in the RBC samples. Normal RBCs are characterized by a biconcave shape which not only 
increases the surface area and facilitates O2 and CO2 diffusion into and out of the cell [59-60] 
but also increases the compliance of the erythrocytes [61]. Polymerization of Hb fibers forces 
RBCs to assume a wide variety of irregular shapes [37]. Two representative examples are 
shown in Figure 3.6.1. Repeated cycles of oxygenation and deoxygenation lead to irreversible 
sickling, a phenomenon we suspect has occurred to the erythrocyte in Figure 2.6.1A, imaged 
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under oxygenated conditions. This cell is characterized by protrusions likely resulting from 
polymerized Hb fibers and also an enlarged morphology. Upon deoxygenation, as in Figure 
2.6.1B, HbS fibers are expected to polymerize and aggregate, thus forming the highly elongated 
and irregular structure shown. In addition, this cell also contains bumps and surface 
irregularities which are possibly associated with protruding polymerized HbS fibers and changes 
in the RBC membrane cortex. 
 
 
Figure 3.6.1. Three-dimensional topographical images of SCD erythrocytes obtained via AFM  
(A) in an oxygenated environment and (B) in a fully deoxygenated state. Both RBCs have a 
highly irregular morphology as compared to the characteristic biconcave shape of a normal 
erythrocytes. It is evident that polymerized Hb results in highly irregular RBC morphologies 
characterized by protrusions, elongation, bumps, and enlargement associated with aggregation 
of HbS fibers. 
 
Determination of the indentation depth 
The quantitative determination of the elastic properties of a particular material can be obtained 
from the relationship between the applied force   and the indentation depth   using Eq. (14) 
and Eq. (17). When force is measured on a hard substrate, the cantilever deflection is 
proportional to the relative sample position resulting in a linear slope for the portion of the curve 
where the tip and the sample are in contact. When soft samples like erythrocytes are 
investigated, the recorded cantilever deflection as a function of the relative sample position is 
not linear due to the deformable structure of the RBC. Prior to taking force measurements on 
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the RBC surface, the force is measured on the PLL-coated mica substrate. This curve is used 
for calibration since no permanent sample deformation is observed. The indentation produced 
by the AFM tip was determined by subtracting the calibration curve from the curve recorded for 
the erythrocyte using the Igor Pro 6.04 (Wavemetrics, Portland, OR) software program.  
 
Force-displacement curve analysis 
The MATLAB output of both the pyramidal indenter model obtained from Eq. (17) and the 
parabolic indenter model obtained from Eq. (14) fit to the force v. indentation curve obtained via 
experimentation is shown in Figure 3.6.2. The model of the pyramid indenter appears to provide 
a better fit, as shown by the representative curves shown in Figure 3.6.2. At small Young’s 
modulus values (  < 3 kPa), as in Figure 3.6.2A and Figure 3.6.2B, we observed that both the 
pyramid model and the parabolic model appeared to fit the experimental force-displacement 
curves to a minimum depth of 250 nm, which is approximately 10% of the thickness of the cell 
[112].  
 
However, as indentation continues, the pyramid model continues to follow the trend of the 
experimental force-displacement curves while the paraboloid model greatly diverges. As the 
stiffness of the erythrocyte’s increased, the pyramid model continued to provide a more 
accurate fit to the experimental data as shown in Figure 3.6.2C and Figure 3.6.2D. Although the 
paraboloid model appears to fit the data up to 50 nm indentations, the pyramid model continues 
to fit the data up to approximately 250 nm, representative of 10% of the total thickness of the 
cell. Based on our theoretical model analysis, we opted to continue our cell stiffness analysis via 
the model for the four-sided pyramidal indenter. 
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Figure 3.6.2.  Theoretical models for a pyramid indenter and a parabolic indenter fitted to the 
experimental data for clinical SCD erythrocytes obtained via AFM. In these curves, the Young’s 
modulus values are (A) 0.65 kPa, (B) 1.20 kPa, (C) 8.50 kPa, and (D) 13.0 kPa. The curves 
shown above are representative of force curves obtained for all SCD clinical samples of varying 
stiffness values. From the given data at a broad range of Young’s modulus values, it appears 
that the pyramid indenter model provides a better fit. Legend in (A) applies for all. 
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Figure 3.6.3. Experimental data for Young’s modulus. (A) The data above show the theoretical 
pyramid model (Eq. 4) fitted to the experimental data for normal, SCT, and SCD erythrocytes. In 
these curves, the Young’s modulus values for the normal, SCT, and both oxygenated and 
deoxygenated SCD RBCs are 1.30, 3.30 kPa, and 7.0 kPa, respectively. Curves shown are 
representative of the 500-600 force curves obtained for each normal and SCT RBCs, and 
1000+ curves for SCD clinical samples. (B) Histograms of the Young’s modulus values 
determined for RBCs from normal, SCT, and both oxygenated and deoxygenated SCD 
erythrocytes. Values for normal RBCs are         = 1.10 kPa ± 0.40 kPa and SCT RBCs are 
     = 3.05 kPa ± 1.09 kPa. SCD clinical samples reveal a bimodal distribution with     = 1.0 
kPa ± 1.1 kPa, and    = 3.0 ± 2.7 kPa, as well as higher (  > 7.0 kPa) values. 
 
Cell stiffness determination 
A representative curve showing experimental data for erythrocytes from patients with SCD is 
shown in Figure 3.6.3A. This data was fitted to the theoretical pyramid model and theoretical 
pyramid model curves representative of normal and SCT erythrocytes also shown for 
comparison. The average values of Young’s modulus for oxygenated and deoxygenated SCD 
erythrocytes were obtained by fitting the Gaussian distribution to the generated histograms of 
the measured Young’s modulus values (Figure 3.6.3B). It appears that both oxygenated and 
deoxygenated sickle cell disease RBCs maintain a bimodal distribution with peaks at     = 1.0 
kPa ± 1.1 kPa, and    = 3.0 ± 2.7 kPa. A similar value has been found via optical tweezers 
[154]. By overlaying the histogram of the distribution of oxygenated SCD erythrocyte elasticity 
values atop the normal and SCT distribution, it is evident that each peak in the focused sickle 
cell disease erythrocyte distribution corresponds to the same Young’s modulus value as the 
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SCT and normal RBCs, 3.0 kPa and 1.0 kPa, respectively [93]. As seen in Figure 3.6.4, 
oxygenated RBCs have an additional peak at approximately 15 kPa, while deoxygenated RBCs 
have an additional peak at approximately 40 kPa.  
 
 
Figure 3.6.4. Histograms of the Young’s modulus determined for sickle cell disease RBCs 
maintained in oxygenated and deoxygenated environments. The Young’s modulus values 
obtained from fitting the theoretical pyramid indenter model to the experimental data were fitted 
with the Gaussian distribution. The full distribution shows evidence of an additional peak 
appearing around 15 kPa for the oxygenated RBCs and 40 kPa for the deoxygenated RBCs. 
 
3.7. Discussion 
The Young’s modulus is the basic material coefficient of elasticity. It can range from ~100 GPa 
for high-strength materials (steel, titanium) [155-156] to 100s MPa for typical polymers 
(polystyrene), and 1 MPa for soft gel-like materials (gelatin in its gel-phase) [156]. Typical 
values for cells range from 1 kPa to 100 kPa [143-144, 157-163]. In the present study, we 
determined that sickle erythrocytes possess Young’s modulus values between 1-60 kPa 
depending on their degree of oxygenation and the percentage of HbS present in the 
erythrocytes. Both oxygenated and deoxygenated samples of RBCs from patients with SCD 
maintain a bimodal distribution with peaks representative of normal RBCs (   = 1.0 kPa ± 1.1 
kPa) and SCT RBCs (   = 3.0 ± 2.7 kPa) [93]. Evidence of an additional peak is also present for 
both oxygenated and deoxygenated samples at   = 15 kPa and   = 40 kPa, respectively. The 
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large variation and presence of multiple peaks within the distribution can likely be attributed to 
patient treatment with hydroxyurea. 
 
Significantly higher Young’s modulus values resulting in peaks at   = 15 kPa for oxygenated 
cells and   = 40 kPa for deoxygenated cells are a result of the presence of polymerized HbS in 
the RBC samples from SCD patients. At high concentrations, deoxy sickle hemoglobin results in 
the formation of a seven stranded polymer structure which increases RBC rigidity [164]. 
Polymerization of deoxygenated HbS is dependent on intraerythrocytic HbS concentration, 
degree of cell oxygenation, pH, and the intracellular concentration of HbF. Polymerized HbS 
fibers form noncovalent cross-links and create a gel that results in increased rigidity of RBCs 
[36, 69-70]. In addition, spectrin, which is the main protein responsible for the mechanical 
strength of the erythrocyte, has been found to bind to hemoglobin via the Band 3 protein that 
binds almost exclusively to hemoglobin fibers [152, 165]. Thus, in the deoxygenated state, 
interaction between the HbS fibers that are connected to the membrane and the HbS fibers in 
the cytoplasm could also contribute to the measured increase in stiffness [166]. Our data 
present evidence of a minimal doubling of the Young’s modulus upon full deoxygenation of SCD 
erythrocytes. This can present major problems in SCD patients because rigid sickle RBC can 
cause microcirculatory obstruction, resulting in vaso-occlusive crisis.  
 
Small Young’s modulus values found in the present study for both oxygenated and 
deoxygenated SCD erythrocytes are likely due to hydroxyurea treatment, a variable in the 
obtained clinical samples. Hydroxyurea is the only approved medication for the treatment of 
sickle cell disease in adults; there are no approved drugs for children [7, 77]. Hydroxyurea 
stimulates the production of fetal hemoglobin (HbF) in patients with SCD, which inhibits sickling 
[167] by preventing effective contact between adjacent HbS molecules and also by forming 
44 
 
mixed hybrids with HbS that have greater solubility than HbS polymers [77]. Increases in HbF 
contribute to an increase in total Hb and a decrease in hemolysis with the release of free 
hemoglobin [7]. It has been proposed that hydroxyurea increases HbF indirectly by killing rapidly 
dividing late erythroid cells, causing recruitment of more primitive erythroid precursors which in 
turn produce high levels of HbF, or by acting directly on the primitive precursors thereby 
stimulating HbF production, the exact mechanism by which hydroxyurea induces HbF is unclear 
[77]. 
 
In summary, the present study suggests a significant impact of deoxy sickle hemoglobin in 
significantly increasing the rigidity of SCD erythrocytes, thus resulting in vaso-occlusive crisis. 
Our data conclude that Young’s moduli and standard deviations were    = 1.0 kPa ± 1.1 kPa 
and    = 3.0 ± 2.7 kPa for both oxygenated and deoxygenated SCD erythrocytes. 
Deoxygenated SCD erythrocytes also possessed an additional peak at   = 40 kPa, while 
oxygenated SCD erythrocytes possessed an additional peak at the significantly lower value of   
= 15 kPa. However, in contrast to normal RBCs and sickle trait RBCs, SCD erythrocytes 
substantially deviate from the characteristic biconcave shape and possess highly irregular 
morphologies characterized by protrusions, elongation, bumps, and enlargement associated 
with aggregation of HbS fibers. 
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Chapter 4. Sickle Cell Trait Human Erythrocytes Show a Significant Increase in 
their Stiffness Compared to Erythrocytes from Healthy Individuals 
 
4.1. Abstract 
Atomic force microscopy (AFM) allows for high-resolution topography studies of biological cells 
and measurement of their mechanical properties in physiological conditions. In this work, AFM 
was employed to measure the stiffness of abnormal human red blood cells (RBCs) from patients 
with the genotype for sickle cell trait. The determined Young’s modulus was compared with that 
obtained from measurements of erythrocytes from healthy subjects. The results showed that the 
Young’s modulus of pathological erythrocytes was approximately three times higher than in 
normal cells. Observed differences indicate the effect of the polymerization of hemoglobin S as 
well as possible changes in the organization of the cell cytoskeleton associated with the sickle 
cell trait. 
 
4.2. Introduction 
Sickle cell disease (SCD) is an inherited blood disorder caused by a single point mutation in one 
of the genes encoding hemoglobin. Four polypeptide chains, two of type α and two of type β, 
form the globular protein Hb. In sickle cell hemoglobin (HbS), the normal sequence of Val-His-
Leu-Thr-Pro-Glu-Glu-Lys is changed to Val-His-Leu-Thr-Pro-Val-Glu-Lys, with the amino acid 
valine substituting for the glutamic acid in the β6 site. The replacement of two charged groups 
by two hydrophobic ones leads to polymerization of deoxygenated Hb and to formation of long 
stiff rodlike fibers [33, 35-36] which force RBCs to assume a sickle shape. Other factors such as 
lowered pH, RBC dehydration and hyperthermia are also known to prompt sickling [52]. Healthy 
RBCs are very deformable and easily pass through narrow capillaries during their approximately 
three-month life span.  The characteristic biconcave shape of RBCs does not only increase the 
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surface area and facilitate O2 and CO2 diffusion into and out of the cell [59-60] but it has been 
shown that it is compatible with the increased compliance of the erythrocytes [61]. The 
abnormal morphology and rheology of the sickle cells triggers the obstruction of the 
microvasculature which results to the development of hypoxia, vaso-occlusive crisis and organ 
damage.  
 
SCT has a very significant social impact because approximately three million people in the 
United States have this genotype, making it 40 to 50 times more prevalent than SCD [46]. 
People with sickle cell trait do not have the symptoms of SCD [168] and thus SCT is not usually 
regarded as a disease state because it has complications that are either uncommon or mild 
[46]. Although SCT is considered to be benign, in extreme conditions including hypoxia, 
acidosis, dehydration, hyperosmolarity, or elevated erythrocyte 2,3-diphosphoglycerate (DPG), 
individuals with SCT can develop a syndrome resembling SCD with vaso-occlusive sequelae 
resulting from rigid erythrocytes [46, 49-50, 56]. Other complications associated with SCT 
include increased urinary tract infection in women, gross hematuria, complications of hyphema, 
splenic infarction with altitude hypoxia or exercise, and life-threatening complications of 
exercise, exertional heat illness (exertional rhabdomyolysis, heat stroke, or renal failure) or 
idiopathic sudden death [46, 53, 57]. 
 
The red cell membrane derives its resilience and resistance to mechanical stresses from the 
membrane skeleton, a hexagonal lattice network composed of spectrin tetramers. These are 
formed by the side-by-side alignment of pairs of heterodimers attached at their ends to 
complexes consisted mainly of actin and of several other proteins [59-60, 169]. Horizontal 
connections between the spectrin filaments are formed at the actin junctions with proteins such 
as protein 4.1R, tropomyosin, tropomodulin, and adducing. Vertical connections between the 
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spectrin network and the lipid bilayer are formed at the ankyrin linkers which connect the β-
spectrin filaments to the band 3 protein along with protein 4.2 (pallidin). A second type of vertical 
connection is formed at the actin junctions where, protein 4.1 binds the spectrin network to the 
lipid bilayer via the integral protein, glycophorin C [60, 170-171]. Mutations in membrane 
proteins related to vertical connections cause hereditary spherocytosis related to membrane 
loss because of reduced support to lipid bilayer. Mutations in proteins associated to horizontal 
connections cause hereditary elliptocytosis [172].  
 
Normal erythrocytes in adults contain approximately 250 million adult hemoglobin (HbA) 
molecules, totaling 25-30% of the cell [33]. Sickle cell trait (SCT, sicklemia), in contrast, is 
marked by the presence of both HbS and HbA. Sickle hemoglobin comprises approximately 20-
46% of the total hemoglobin content in persons with sickle cell trait [44], with most individuals 
having 40-42% HbS [45]. In the case of SCD, it has been hypothesized that increased 
association of HbS with the membrane proteins contributes in the change of the mechanical 
behavior of Sickle cells [149].  HbS could alter the mechanical properties of RBCs not only by 
extending the spectrin filaments, and by the interaction between HbS filaments and the lipid 
bilayer but also by altering the functionality of the membrane proteins [150]. There is 
considerable evidence that HbS is associated with the inner membrane of RBCs and in 
particular with the cytoplasmic tail of the band 3 protein [33]. 
 
Many case studies have shown that translation of cellular mechanics findings is crucial in many 
diseases, including Alzheimer’s disease, Parkinson’s disease, type II diabetes, malaria, sickle 
cell disease, and most recently cancer [144, 147]. Understanding the relationship between 
proteins and cellular material properties will allow for detection of diseases and new approaches 
to addressing medical disorders [147]. Recently, atomic force microscopy methods have shown 
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that the stiffness of metastatic cancer cells is more than 70% softer than their benign 
counterparts [144]. Because these findings correlate well with the commonly employed 
immunohistochemical testing, it is reasonable to argue that AFM methods can enhance cancer 
detection methods. SCD is a characteristic case where molecular changes in a protein alter 
their structural properties causing the initiation of a disease state. Additional reason for the SCD 
is the increased adherence of sickle cells on the endothelial cells and on leucocytes which can 
generate an inflammation and chronic vasculopathy [34]. AFM can return information not only 
on the stiffness of the cells but also on the specific interaction between proteins expressed on 
the cellular erythrocyte membrane and proteins expressed on leucocytes, on endothelial cells 
and/or the extracellular matrix [34]. Because of this characteristic, AFM could decisively 
enhance our knowledge on the biology and consequently on the therapy of SCD. 
 
Characterization of erythrocyte mechanical properties has been conducted via micropipette 
aspiration [173-174], cell poking [175], atomic force microscopy [111-112, 117], optical tweezers 
[176-177], optical stretching [177-178], and magnetic tweezers [119], and magnetic twisting 
cytometry [179]. However, values of mechanical moduli derived from experimental data tend to 
vary largely based on which of the aforementioned techniques is used [180]. In the present 
student, we quantified the stiffness of erythrocytes from patients with the genotype for sickle cell 
trait using atomic force microscopy, a tool for imaging and characterization of materials at the 
nanometer scale [89]. The high force sensitivity of AFM and its ability to measure local and 
overall properties of individual cells under physiological conditions make this technique 
particularly appropriate for measuring the mechanical properties of living and fixed cells [101, 
112, 117, 181-182]. We established that the stiffness of cells from patients with the genotype for 
SCT was approximately three times greater than normal RBCs. 
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4.3. Methods 
AFM allows for high-resolution topography studies of biological cells and measurement of their 
mechanical properties in physiological conditions [183]. Experiments were carried out using an 
Asylum MFP 3D-BIO (Asylum Research, Santa Barbara, CA) AFM equipped with a “liquid cell” 
setup. Normal RBCs and RBCs from patients with the sickle cell trait were purchased from 
Research Blood Components, LLC (Brighton, MA). RBCs were maintained in PBS at room 
temperature during experiments. 
 
Erythrocyte immobilization 
Cells were immobilized on AFM grade mica (Novascan Technologies, Inc., Ames, IA) coated 
with poly-L-lysine (PLL) (Sigma-Aldrich, St. Louis, MO) to increase cell adherence. 150 μl of 1 
mg/ml PLL solution was allowed to adsorb for 5 min to an unmodified mica surface, and excess 
solution was drained away. RBCs of 0.5% concentration in PBS were allowed to adhere to each 
PLL-coated mica surface for 10 min in the incubator. Unattached cells were removed by gentle 
rinsing of the slide with PBS solution at 25°C. For imaging, fixation was performed by a 1-min 
treatment of the cells with 0.5% glutaraldehyde (Sigma-Aldrich, St. Louis, MO) in PBS buffer. 
The sample was again rinsed several times with PBS and a volume of PBS was added for 
experiments. Glutaraldehyde was not employed for stiffness measurements. 
 
Erythrocyte imaging 
Erythrocytes were imaged in tapping mode with a scan rate of 0.2 Hz, and the minimal force 
necessary to obtain good image contrast was determined by gradually increasing the force 
applied to the sample from zero force (noncontact) to the necessary minimal force. Silicon 
nitride probes with a nominal spring constant of 0.01 N/m (Veeco Probes, Camarillo, CA) were 
employed for imaging. While the characteristic biconcave shape was observed for the fixed 
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normal erythrocyte (Figure 4.3.1A) the SCT erythrocyte  appeared to have an irregular 
biconcave shape accompanied by a decrease in size which is most likely due to dehydration 
associated with the polymerization of HbS (Figure 4.3.1B).  
 
 
Figure 4.3.1. Three-dimensional topographical images of RBCs from a (A) normal subject and 
(B) a patient with the SCT genotype measured by AFM. While the normal RBC has the 
characteristic biconcave shape, the SCT erythrocyte has an irregular biconcave morphology. In 
addition, the SCT erythrocyte is smaller than the normal erythrocyte, most likely due to 
dehydration associated with HbS polymerization. 
 
Cell stiffness determination 
Stiffness measurements were carried out in contact mode using silicon nitride cantilevers with a 
nominal spring constant of 0.03 N/m (Veeco Probes, Camarillo, CA). Exact values for the 
cantilever spring constants were obtained via a thermal noise based method implemented by 
the manufacturer and were used in all calculations. Probes had nominal tip radii of 20 nm and 
nominal angle of 20°, as provided by the manufacturer. The force curves were generated at a 
loading rate of 10,000 pN/s, and for each cell type between 500-600 measurements were 
collected. 
 
The Young’s modulus was calculated using the Hertz model describing the elastic deformation 
of the two bodies in contact under load. This theory was extended by Sneddon assuming an 
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appropriate shape of indenter deforming elastic half space [107, 110]. It characterizes the 
relationship between the applied force and the indentation depth [142, 184]. When the shape of 
the AFM tip is a four-sided pyramidal indenter, the force as a function of indentation is described 
by the following equation: 
 
2
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F           (1) 
 
where E  and   are the Young’s modulus and the Poisson’s ratio of the cell, respectively [102, 
114-115]. The Poisson ratio used in the present study was assumed to be 0.5 [111].  
 
Figure 4.4.1. Theoretical model for a pyramidal shaped indenter fitted to the experimental data 
for normal and SCT erythrocytes obtained via AFM. In these curves, the Young’s modulus 
values for the normal and SCT cell are 1.30 and 3.30 kPa, respectively. The curves shown 
above are representative of the 500-600 force curves obtained for each normal and SCT 
erythrocytes. Minor variations can be seen in other curves obtained during experimentation, 
representative of the standard deviation we observe in the calculation of the Young’s modulus. 
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4.4. Results 
Determination of the indentation depth 
The quantitative determination of the elastic properties of a particular material can be obtained 
from the relationship between the applied force F and the indentation depth   using Eq. (1). 
When force is measured on a hard substrate, the cantilever deflection is proportional to the 
relative sample position resulting in a linear slope for the portion of the curve where the tip and 
the sample are in contact. When soft samples like erythrocytes are investigated, the recorded 
cantilever deflection as a function of the relative sample position is not linear due to the 
deformable structure of the RBC. Prior to taking force measurements on the RBC surface, the 
force is measured on the PLL-coated mica substrate. This curve is used as calibration curve 
since no permanent sample deformation is observed. 
 
The indentation produced by the AFM tip was determined by subtracting the calibration curve 
from the curve recorded for the erythrocyte using the Igor Pro 6.04 (Wavemetrics, Portland, OR) 
software program. The force vs. indentation curves obtained for normal erythrocytes indicate a 
greater compliance than that of the sickle trait RBCs. 
 
Data processing 
Data was imported into MATLAB (The MathWorks, Natick, MA) and the value of E  was 
obtained by fitting the theoretical curve generated by Eq. (1) to the experimental data up to a 
minimum depth of 250 nm, which is approximately 10% of the total thickness of the cell. The 
method is in agreement with the well known fact that the effect of the substrate over which the 
cells are placed is negligible if the indentation depth is less than 10% of the total thickness of 
the specimen [117].  Figure 4.4.1 shows the MATLAB output of the pyramidal indenter model fit 
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to the force v. indentation curve obtained via experimentation. It appears that the theoretical 
model for a pyramidal indenter fits the SCT data up to a greater indentation depth (700 nm) than 
that of the normal RBC (400 nm), indicating that SCT follow the elastic model for larger 
indentation depth.  
 
The average values of Young’s modulus for normal erythrocytes and SCT erythrocytes were 
obtained by fitting the Gaussian distribution to the generated histograms of the measured 
Young’s modulus values (Figure 4.4.2A-B, respectively). The measured Young’s moduli and 
standard deviations were: E1 = 1.10 kPa, σ1 = 0.40 kPa, and E2 = 3.05 kPa, σ2 = 1.09 kPa, for 
normal and sickle cell trait, respectively. 
 
 
Figure 4.4.2. Histograms of the Young’s modulus determined for RBCs from (A) normal and (B) 
sickle cell trait blood samples. The Young’s modulus values obtained from fitting the theoretical 
model to the experimental data were fitted with the Gaussian distribution. Normal RBCs are 
more elastic and their Young’s modulus values have a lesser standard deviation (E1 = 1.10 kPa, 
σ1 = 0.40 kPa) while SCT erythrocytes have a stiffness approximately three times greater as 
well as a larger standard deviation (E2 = 3.05 kPa, σ2 = 1.09 kPa). The observed increase in 
stiffness for the pathological erythrocytes is likely due to changes in the affinity of spectrin and 
actin filaments resulting from the presence of abnormal hemoglobin, HbS. 
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4.5. Discussion 
The main goal of this work was the determination of the erythrocyte’s stiffness in blood samples 
taken from patients with the sickle cell trait genotype. The obtained Young’s modulus of 
erythrocytes from patients with SCT was approximately three times larger than that of normal 
erythrocytes. 
 
Hemoglobin S is responsible for converting normal RBCs into “sickled” cells in patients with SS-
SCD. At high concentrations, deoxy sickle hemoglobin results in the formation of a seven 
stranded polymer structure which increases RBC rigidity [164]. As expected, we observe the 
characteristic biconcave shape for normal erythrocytes (Figure 4.3.1a) when imaging on a PLL-
coated mica substrate. In contrast, due to an increased membrane stiffness and dehydration, 
the sickle trait RBC digresses from its characteristic biconcave shape (as shown in Figure 
4.3.1b) and also experiences a decrease in size.  
 
Our findings show that the Young’s modulus of normal erythrocytes is 1.10 kPa with a standard 
deviation of 0.40 kPa, while erythrocytes from patients with the genotype for sickle cell trait have 
a Young’s modulus of 3.05 kPa with a standard deviation of 1.09 kPa. Other techniques, such 
as micropipette aspiration and optical tweezers, result to RBC moduli values in similar range 
[154, 174, 185]. AFM has previously been used in the measurement of the Young’s modulus of 
various types of cells e.g., platelets (1-50 kPa), lymphocytes (1.24 kPa), fibroblasts (1-5 kPa), 
mesenchymal stem cells (1-2.5 kPa) and osteoblasts (1-200 kPa) [143, 157-163]. 
 
The threefold increase in the stiffness of SCT erythrocytes is probably due to changes in the 
affinity of the spectrin and actin filaments that comprise the membrane skeleton. It has been 
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proposed that SCT erythrocytes show an increased concentration in Ca+2 which results in a 
higher cytoskeleton rigidity via an increased binding of Band 3 to the spectrin bound ankyrin 
[186-187]. Another possible source of the measured increased stiffness is the dehydration of the 
SCT erythrocytes that promotes polymerization of deoxygenated HbS [188-189]. It has been 
shown that activation of the Gardos channel by an increase of the intracellular free Ca+2 
concentrations results to expulsion of potassium and H2O. In addition, spectrin which is the main 
protein responsible for the mechanical strength of the erythrocyte has been found to bind to 
hemoglobin via the Band 3 protein that binds almost exclusively to hemoglobin fibers [152, 165]. 
Thus, interaction between the HbS fibers that are connected to the membrane and the HbS 
fibers in the cytoplasm could also contribute to the measured increase in stiffness [166]. 
 
In summary, the present study suggests that sickle hemoglobin promotes a threefold increase in 
the stiffness of sickle trait erythrocytes. Our data conclude that Young’s moduli and standard 
deviations were E1 = 1.10 kPa, σ1 = 0.40 kPa, and E2 = 3.05 kPa, σ2 = 1.09 kPa, for normal and 
sickle trait erythrocytes, respectively. In contrast to normal RBCs with a characteristic biconcave 
shape, SCT erythrocytes deviate from this configuration with irregularities in the expected 
morphology and a decrease in both diameter and height. 
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Chapter 5. Dietary Supplementation with Docosohexanoic Acid (DHA) Increases 
Red Blood Cell Membrane Flexibility in Mice with Sickle Cell Disease 
 
5.1. Abstract 
Humans and mice with sickle cell disease (SCD) have stiff red blood cells (RBCs). Omega-3 
fatty acids, such as docosahexanoic acid (DHA), may influence RBC deformability via 
incorporation into the RBC membrane during dietary supplementation. In this study, sickle cell 
(SS) mice were fed natural ingredient rodent diets supplemented with 3% DHA (DHA diet) or a 
control diet matched in total fat (CTRL diet). After 8 weeks of feeding, we examined the RBCs 
for: 1) stiffness, as measured by atomic force microscopy; 2) deformability, as measured by 
ektacytometry; and 3) percent irreversibly sickled RBCs on peripheral blood smears. Using 
atomic force microscopy, stiffness is increased and deformability decreased in RBCs from SS 
mice fed CTRL diet compared to wild-type mice. In contrast, RBCs from SS mice fed DHA diet 
had markedly decreased stiffness and increased deformability compared to RBCs from SS mice 
fed CTRL diet. Furthermore, examination of peripheral blood smears revealed less irreversibly 
sickled RBCs in SS mice fed DHA diet as compared to CTRL diet. In summary, our findings 
indicate that DHA supplementation improves RBC flexibility and reduces irreversibly sickled 
cells in SS mice. These results point to potential therapeutic benefits of dietary omega-3 fatty 
acids in SCD. 
 
5.2. Introduction 
Individuals with sickle cell disease (SCD) exhibit increased red blood cell (RBC) stiffness and 
adhesion, multiorgan and vascular pathology, and complex pain syndromes [12, 122, 190-198]. 
In addition, there is evidence of activation of the inflammatory and coagulation pathways [80, 
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199-204]. Berkeley sickle cell (SS) mice exclusively express human sickle hemoglobin and have 
a phenotype that mimics many features of severe SCD in humans [205-207].  
 
Omega-3 fatty acids, such as docosahexanoic acid (DHA), are essential fatty acids that have 
anti-inflammatory and anti-thrombotic activities [208-210]. As dietary supplements, omega-3 
fatty acids are beneficial in many cardiovascular diseases [208-209, 211-213]. In addition, Ren 
et al [214-216] demonstrated that humans with SCD have decreased omega-3 fatty acids and 
increased arachidonic acid (AA, an omega-6 fatty acid) in the RBC membrane. To date, trials in 
humans with SCD have indicated that dietary supplementation with omega-3 fatty acids may 
reduce severe anemia, vaso-occlusive pain episodes, white blood cell count, and prothrombotic 
activity [217-219].  
 
Several studies have demonstrated that dietary supplementation with omega-3 fatty acids 
results in increased incorporation of these fatty acids into the RBC membrane, which can 
influence RBC deformability [220-221]. In the present study, we sought to determine whether 
dietary supplementation with the omega-3 fatty acid DHA would improve RBC stiffness and 
other hematologic and disease parameters in SS mice. Our results indicate that 8-week dietary 
supplementation with DHA increases RBC flexibility and decreases irreversibly sickled RBCs in 
SS mice.  
 
5.3. Methods 
Mice 
C57BL/6J mice (hereafter, WT mice) were purchased from The Jackson Laboratory (Bar 
Harbor, ME; stock number 000664). Berkeley SCD mice (Tg(Hu-miniLCR1G AS) 
Hba0//Hba0 Hbb0//Hbb0; hereafter, SS mice) on the Berkeley mixed genetic background have 
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been previously described [205-206]. Mice were cared for according to AAALAC specifications. 
Animal experiments were approved by the Institutional Animal Care and Use Committee of the 
Medical College of Wisconsin. Experimental groups contained comparable numbers of male 
and female mice; the average age of mice when placed on diets was 27 wks (range 14 - 36 
wks). 
Table 5.3.1. Fatty Acid Composition 
Fatty Acid CTRL Diet DHA Diet 
Saturated, % of total fatty acids 32 29 
Monounsaturated, % of total fatty acids 19 22 
Polyunsaturated, % of total fatty acids 48 49 
Fatty acid profile, % of total fatty acids   
  C8:0 Caprylic 1.0 0.0 
C10:0 Capric 1.1 0.9 
C12:0 Lauric 5.4 3.6 
C14:0 Myristic 4.4 9.9 
C16:0 Palmitic 13.8 12.8 
C16:1 Palmitoleic 0.4 1.1 
C18:0 Stearic 4.7 1.2 
C18:1 Oleic 18.1 20.1 
C18:2 Linoleic 47.0 18.0 
C18:3 Linolenic 1.3 1.2 
C22:6 DHA 0.0 30.1 
Predominant fatty acid 18:2 linoleic acid 22:6 DHA 
Energy Density, kcal/g 3.5 3.5 
 
Dietary Feeding 
Mice were fed natural ingredient 2016 Teklad Global 16% Protein Rodent Diet supplemented 
with 3% DHA, an omega-3 fatty acid (DHA diet), or a control diet supplemented with safflower 
oil, which predominantly contains the omega-6 fatty acid linoleic acid (CTRL diet) (Table 5.3.1). 
The macronutrient composition of the CTRL and DHA diets is shown in Table 5.3.1. Diets were 
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matched in total fat and had a similar distribution of saturated/monounsaturated versus 
polyunsaturated fatty acids (Table 5.3.1). Detailed information on the base 2016 Teklad Global 
16% Protein Rodent Diet can be found at 
http://www.harlan.com/products_and_services/research_models_and_services/laboratory_anim
al_diets/teklad_natural_ingredient_diets/teklad_global_diets/global_rodent_diets/teklad_global_r
odent_diet_16_protein_2016.hl#Macronutrient_Information. DHA oil was a kind gift from Martek 
Biosciences (a division of DSM Nutritional Products, Columbia, MD). DHA and CTRL diets were 
designed in consultation with nutritionists at Harlan-Teklad Laboratories and diets were 
compounded at Harlan-Teklad Laboratories (Madison, WI). Mice were weighed prior to being 
placed on CTRL or DHA diet, fed their respective diets for 8 weeks, and then weighed again 
prior to harvest. No significant differences in weight gain were observed between CTRL and 
DHA diet groups (data not shown). 
 
CBC and reticulocyte measurements 
Blood was obtained from deeply anesthetized mice by cardiac puncture and drawn into heparin 
anticoagulant. Complete blood count (CBC) and reticulocyte analyses were performed as 
previously described [222]. 
 
Flow adhesion assay  
RBCs were separated from whole blood and washed twice in citrate/glucose/saline buffer as 
previously described [122, 223]. Washed RBCs were resuspended at a 2% hematocrit in M199 
serum free medium (Sigma, St. Louis, MO) containing 0.2% bovine serum albumin (Sigma, St. 
Louis, MO). RBC adhesion to immobilized thrombospondin (TSP, 1 g/75 l) was carried out 
using Vena8 Fluoro Biochips on the VenaFlux Platform (Cellix, Dublin, Ireland). RBCs were 
perfused through the channel at a wall shear stress of 0.4 dyne/cm2, and adherent RBCs 
manually quantified by analyzing five different images captured from the middle of the channel. 
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Atomic Force Microscopy 
Whole blood was collected as described above and stored overnight at 4oC. RBCs were 
sedimented by centrifugation at 500 x g at 4°C for 10 minutes and the plasma, buffy coat, and 
uppermost erythrocytes removed by aspiration and discarded. The remaining erythrocytes were 
washed three times in Cell Wash Buffer (21.0 mM tris (hydroxymethyl)aminomethane, 4.7 mM 
KCl, 2.0 mM CaCl2, 140.5 mM NaCl, 1.2 mM MgSO4, 5.5 mM glucose, 0.5% bovine serum 
albumin (BSA) fraction V; pH 7.4) [224]. Cells were immobilized on a glass surface coated with 
1 mg/ml poly-L-lysine solution for 10 min in the incubator (37°C, 5% CO2). Unattached cells 
were removed by gentle rinsing of the surface with Cell Wash Buffer. Cells were prepared on 
the day of use and experiments were performed in Cell Wash Buffer maintained at 37°C. 
 
Stiffness measurements were carried out as previously described [93] on non-fixed adhered 
erythrocytes. All force measurements were recorded with a loading rate of 24000 pN/s for small 
indentation depths up to 150 nm and small indentation forces up to 300 pN [101, 112, 117]. The 
Young’s modulus was calculated using the Hertz model which describes the elastic deformation 
of two bodies in contact under load, in this case the contact between the erythrocyte and the 
AFM probe. Further detail regarding AFM measurements and calculations is found in 
Supplemental Methods. Five mature RBCs were evaluated for stiffness measurements from 
each mouse; reticulocytes were excluded based on their larger size [225]. 
 
Ektacytometry  
Red cell membrane deformability was assessed by ektacytometry as described previously [226], 
using a Technicon model 152 Ektacytometer (Spectra Physics, France) at Purdue University.  
Whole blood was collected as described above and stored overnight at 4oC, followed by 
centrifugation at 1000 x g for 3 min to pellet RBCs. Packed RBCs were washed twice with Cell 
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Wash Buffer lacking BSA, then resuspended at 0.3% hematocrit in isoosmotic sample buffer 
(136mM NaCl, 6.3mM Na2HPO4, 1.2mM NaH2PO4) containing ~4% polyvinylpyrrolidone (PVP).  
Samples were loaded into the ektacytometer and subjected to increasing shear stresses (0-250 
dynes/cm2, increased linearly over 125s) at constant osmolarity. The deformation of the cells 
was quantified by laser diffraction as elongation index (EI) which was recorded as a function of 
time.  RBCs from each mouse were analyzed in duplicate ektacytometer runs, and the overall 
RBC deformability for each mouse was determined from the average maximum EI of the 
duplicate trials. 
 
Quantification of Irreversibly Sickled RBCs  
Blood smears were prepared on glass slides using anticoagulated whole blood. Unstained 
smears were examined using a Nikon Eclipse 80i microscope and fields of well-separated RBCs 
selected for photography using a Nikon Digital DS-Fi1 camera. The total number of RBCs in 
each field and the number of irreversibly sickled RBCs, defined as having a length greater than 
2-fold its width [227], were enumerated by manual counting. Five representative fields were 
examined and the average percent of irreversibly sickled RBCs was determined for each 
mouse. 
 
Statistics  
GraphPad Instat or GraphPad Prism were used for all statistical analyses. For data that passed 
tests for normality, unpaired t-tests were used, with Welch’s correction applied when comparing 
populations with unequal SDs. For data that were not normally distributed, nonparametric Mann-
Whitney U-tests were used for comparisons of two groups. Kruskal-Wallis nonparametric 
ANOVA with Dunn’s Multiple Comparisons Post-Hoc Test was used for comparisons of more 
than two groups. P<0.05, with corrections for multiple comparisons when appropriate, was 
considered significant.  
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5.4. Results  
DHA supplementation decreases RBC stiffness in SCD mice  
Atomic force microscopy (AFM) was used to assess RBC stiffness of mature RBCs in wild-type 
(WT) and SS mice after 8-week dietary feeding on CTRL or DHA diets. RBC stiffness is 
comparable in WT mice fed either CTRL or DHA diets (Figure 5.4.1A, left panel, representative 
WT-CTRL and WT-DHA mice; Figure 5.4.1C, group data). RBC stiffness in WT-CTRL and WT-
DHA mice is similar to that seen in WT mice fed a standard fat diet (Figure 5.4.1A, right panel, 
representative WT mouse on standard Teklad Global 2016 diet; Figure 5.4.1C, group data), 
indicating that the increased fat composition of the diets used in this study does not alter normal 
RBC stiffness.  
 
In comparison to WT RBCs, RBC stiffness is increased in SS mice fed CTRL diet (Figure 
5.4.1B, left panel, filled bars, representative SS-CTRL mouse; Figure 5.4.1C, group data, 
P<0.001 vs. WT-2016, WT-CTRL, or WT-DHA). RBC stiffness in SS-CTRL mice is comparable 
to that obtained from SS mice fed a standard fat diet (Figure 5.4.1A, right panel, representative 
SS mouse on standard Teklad Global 2016 diet; Figure 5.4.1C, group data), indicating that the 
increased fat composition of the CTRL diet is not the cause of increased RBC stiffness in CTRL 
diet-fed SS mice. In addition, since only mature RBCs were assessed for RBC stiffness 
measurements, the observed difference in RBC stiffness between SS and WT mice is not 
influenced by the higher presence of reticulocytes in SS as compared to WT blood samples. In 
marked contrast, RBCs from DHA diet-fed SS mice had decreased stiffness compared to RBCs 
from CTRL diet-fed SS mice (Figure 5.4.1B, open bars, representative SS-DHA mouse; Figure 
5.4.1C, group data, P<0.001 vs. SS-CTRL or SS-2016). In fact, RBC stiffness in SS-DHA mice 
was decreased to nearly WT levels (Figure 5.4.1C, P value is not significant for SS-DHA vs. 
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Figure 5.4.1. Dietary supplementation with DHA decreases RBC stiffness in SS mice. (A, B): 
Representative results from individual wild-type (WT) (A) and sickle (SS) (B) mice fed either: left 
panels: CTRL (filled bars) or DHA (open bars) diet; right panel: Teklad Global Diet 2016 
standard fat diet (grey bars; “2016”). Data are presented as Gaussian histograms of the 
frequency of measurements versus the Young’s modulus in Pascals (Pa). (C): Box-Whisker plot 
of Young’s modulus from the groups indicated on the X axis. Data are presented as median with 
max and min whiskers. The ‘n’ indicated on X-axis indicates the total number of mature RBCs 
analyzed in each group, obtained from the following numbers of mice: WT-2016: 2 mice; WT-
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CTRL and WT-DHA: 4 mice; SS-2016: 2 mice; SS-CTRL: 12 mice; SS-DHA: 11 mice. Statistical 
comparisons by Kruskal-Wallis nonparametric ANOVA with Dunn’s Multiple Comparisons Post-
Hoc Test: **, P<0.001 SS-2016 vs. WT-2016, WT-CTRL, or WT-DHA; ***, P<0.01 SS-CTRL vs. 
WT-2016, and P<0.001 SS-CTRL vs WT-CTRL or WT-DHA; #, P<0.001 SS-DHA vs. SS-2016 
or SS-DHA. All other differences (including SS-DHA vs. WT-2016, WT-CTRL, or WT-DHA) are 
not significant. 
 
Table 5.4.1. Red blood cell and reticulocyte measures 
Group Diet Hgb, g/dL Hct, % MCV, fl MCHC, g/dL Retic, % 
WT 
CTRL  13.3+0.6 41.2+2.5 45+1 32.2+1.6 ND 
DHA  12.6+0.6 40.5+2.5 45+1 31.1+1.0 ND 
SS 
CTRL  5.0+1.1 15.0+3.3 45+4 33.8+4.4 60+16 
DHA 5.0+1.1 16.1+3.7 48+6 31.4+2.9 41+18† 
All values mean+SD. ND, not determined; retic (reticulocytes) is given as % of total RBCs. WT-
CTRL, n=10; WT-DHA, n=11. SS-CTRL, n=18 for Hgb/Hct/MCV/MCHC and n=7 for Retic; SS-
DHA, n=22 for Hgb/Hct/MCV/MCHC and n=9 for Retic. No significant differences between WT-
CTRL and WT-DHA or between SS-CTRL and SS-DHA groups for Hgb, Hct, MCV or MCHC 
after correcting for multiple comparisons. †Difference in retic % between SS-CTRL and SS-DHA 
groups is not significant but trending towards a decrease in SS-DHA mice (P=0.051). 
 
WT-2016, WT-CTRL, or WT-DHA). Analysis of hematologic parameters revealed no statistically 
significant differences in red blood cell or reticulocyte parameters in CTRL versus DHA diet 
groups, although there was a trend (P=0.051) towards decreased reticulocytes in SS-DHA as 
compared to SS-CTRL mice in the small sample subset analyzed (Table 5.4.1).  
 
DHA supplementation improves RBC deformability in SCD mice 
To verify the decrease in RBC stiffness seen by AFM, deformability of RBCs from a subset of 
SS mice fed CTRL or DHA diets was examined using ektacytometry. Consistent with other 
studies [228-233], RBCs from SS mice fed CTRL diet exhibit low deformability by ektacytometry 
as compared to RBCs from WT mice (Figure 5.4.2; WT data for comparison only). Similar to the 
AFM results, RBCs from SS mice fed DHA diet had improved deformability compared to RBCs 
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from SS mice fed CTRL diet (Figure 5.4.2, P<0.02).  
 
 
 
Figure 5.4.2. Dietary supplementation with DHA increases RBC deformability in SS mice. 
Scatter plot of average maximum Elongation Index (EI) for SS mice fed CTRL (SS-CTRL, n=5) 
or DHA (SS-DHA, n=9) diets. Each symbol represents the maximum EI (average of two 
replicates) for an individual mouse; horizontal line represents mean for each SS diet group. WT 
data average of two samples from normal mice fed standard diet, and is shown for comparison 
only. *, P<0.05, SS-CTRL vs. SS-DHA, unpaired t-test with Welch correction. 
 
 
DHA supplementation decreases irreversibly sickled RBCs in SCD mice  
Both AFM and ektacytometry indicated increased RBC flexibility in SS mice fed DHA diet, 
suggesting a change in RBC membrane properties. RBC adhesion is known to be elevated in 
human and murine SCD, and has been attributed to multiple factors including altered membrane 
properties [122, 124, 197, 234-235]. In addition, repeated cycles of sickling of RBCs results in 
cytoskeletal damage and membrane changes that eventually become permanent, leading to the 
appearance of “irreversibly sickled RBCs” with altered shape even in the presence of 
oxygenated sickle hemoglobin [227, 236].  
 
Therefore, we next examined whether there was a decrease in: 1) in vitro RBC adhesion; or 2) 
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numbers of irreversibly sickled RBCs in SS-DHA as compared to SS-CTRL mice. While the 
mean RBC adhesion to thrombospondin in vitro was reduced in DHA as compared to CTRL diet 
fed SS mice, this difference was not significant in the small number of samples examined 
(Figure 5.4.3A). In contrast, enumeration of irreversibly sickled RBCs from blood smears 
revealed a notable decrease in irreversibly sickled RBCs in SS-DHA as compared to SS-CTRL 
mice (Figure 5.4.3B, P<0.04). These data suggest that the improvement in RBC membrane 
flexibility after 8 weeks of dietary DHA supplementation decreases the cytoskeletal and 
membrane damage that leads to irreversibly sickled RBCs. 
 
5.5. Discussion 
The results of our studies indicate that 8-week dietary supplementation with DHA improves RBC 
flexibility and decreases irreversibly sickled RBCs in sickle cell mice. The complete 
normalization of RBC stiffness (Figure 5.4.1) as compared to only partial improvement in RBC 
deformability (Figure 5.4.2) is not completely surprising. Since deformability reflects not only cell 
stiffness but also hydration status [226, 237], the lack of complete normalization of RBC 
deformability in SS-DHA mice may reflect the improvement in RBC stiffness without a 
concomitant improvement in RBC hydration. In addition, only individual mature RBCs were 
evaluated for stiffness by AFM, while deformability measurements involve the assessment of a 
population of erythroid cells, which in SS mice includes ~40% reticulocytes. Therefore, it is also 
possible that the difference in the AFM versus ektacytometry results reflects incorporation of 
DHA into erythroid membranes with effects that are more pronounced in mature RBCs than in 
reticulocytes.    
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Figure 5.4.3. Dietary supplementation with DHA does not affect in vitro adhesion to TSP but 
decreases irreversibly sickled RBCs in SS mice. (A) Scatter plot of adhesion of washed RBCs 
from SS-CTRL (n=7) or SS-DHA (n=7) mice to human thrombospondin (TSP, 1 g/75 l) at a 
wall shear stress of 0.4 dyne/cm2. Adherent RBCs per unit area were quantified as described in 
Methods. Each symbol represents an individual mouse; horizontal line represents mean for 
each group. (B) Scatter plot of percent irreversibly sickle RBCs in SS-CTRL (n=6) and SS-DHA 
(n=8) mouse groups. Each symbol represents an individual mouse; horizontal line represents 
mean for each group. ns, not significant SS-CTRL vs. SS-DHA, unpaired t-test; *, P<0.05, SS-
CTRL vs. SS-DHA, unpaired t-test.  
 
There are several potential avenues through which DHA supplementation could improve RBC 
flexibility in SS-DHA mice. Ren et al have demonstrated that humans with SCD have decreased 
omega-3 fatty acids and increased arachidonic acid (AA, an omega-6 fatty acid) in the RBC 
membrane [214-215]. It is known that omega-3 and omega-6 fatty acids compete for 
incorporation into the phospholipids of the erythrocyte membrane [238], suggesting that DHA is 
replacing AA in the RBC membrane in SS mice. Increasing the degree of unsaturation for a 
given phospholipid influences membrane fluidity less than increasing phospholipid content itself 
[239], indicating that the improvement in RBC membrane flexibility in SS-DHA mice is not 
primarily the result of the increased degree of unsaturation of DHA (22:6, n-3) compared to AA 
(20:4, n-6) or linoleic acid (18:2, n-6; the major fatty acid in the CTRL diet). However, DHA in 
phospholipid bilayers possesses higher stability toward non-enzymatic lipid peroxidation than 
AA or linoleic acid, which may also contribute to membrane stability [240]. 
In addition, omega-3 and omega-6 fatty acids can interact and react with the same receptors 
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and enzymes with divergent physiologic effects [239]. For instance, 15-lipoxygenase-1 (15-LOX-
1) is activated after erythroblast enucleation and is instrumental in initiating the degradation of 
mitochondria in maturing reticulocytes [241]. Using AA as substrate, 15-LOX-1 produces the 
pro-inflammatory, pro-oxidant molecules 15-hydroxyeicosatetranoic acid (15-HETE) and lipoxins 
A4 and B4 [239]. In contrast, if DHA is the substrate, 15-LOX produces docosatrienes and 
protectins, which are anti-inflammatory and protect from oxidative stress [239]. Furthermore, 
dietary supplementation with omega-3 versus omega-6 fatty acids leads to enhanced 
transcription of antioxidant enzymes and suppressed transcription of enzymes that produce 
reactive oxygen species [239]. There is also increased activity of RBC catalase and lowered 
malondialdehyde levels in rat RBCs after dietary supplementation with omega-3 fatty acids 
[242]. Taken together, this suggests greater protection from RBC lipid peroxidation and 
oxidative injury. Finally, supplementation with omega-3 fatty acids influences the acylation of 
proteins and functions of ion channels, which can alter intracellular calcium, membrane 
flexibility, protein-protein interactions, and catalytic activity of enzymes [239].  
 
To date, studies of omega-3 fatty acids in human SCD showed a decrease in acute 
painful/vaso-occlusive episodes [217-219], but have not carefully assessed the effect of DHA on 
sickle RBC structural and functional characteristics. Although individuals with SCD are known to 
have increased daily pain and allodynia [194], effects of omega-3 fatty acid supplementation on 
chronic or neuropathic pain in SCD have not been reported. SS mice are also known to exhibit 
nociceptive sensitivities at steady state that are exacerbated by acute sickling [207].  
 
In summary, our findings indicate that DHA supplementation improves RBC membrane flexibility 
and reduces irreversibly sickled cells in SS mice. The current studies evaluated RBCs in SS 
mice at steady-state. The increased RBC flexibility and decrease in irreversibly sickled RBCs 
found in our studies at steady state suggest that the RBCs in SS-DHA mice may be more 
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resistant to an acute sickling event and resultant tissue injury, such as can be induced using 
hypoxia-reoxygenation in SS mice [243-244]. A recent study has shown that dietary 
supplementation with omega-3 fatty acids does not exacerbate oxidative stress in human SCD, 
a complication that has been suggested in studies of omega-3 supplementation in non-SCD 
individuals [245]. Therefore, dietary supplementation with omega-3 fatty acids may provide a 
safe and effective way to ameliorate pathologies associated with vaso-occlusive crises in 
human and murine SCD. 
 
  
70 
 
Chapter 6. Epinephrine Modulates BCAM/Lu and ICAM-4 Expression on the Sickle 
Cell Trait Red Blood Cell Membrane 
 
6.1. Abstract 
Collapse and sudden death in physical training are the most serious complications of sickle cell 
trait (SCT). During strenuous exercise, there is evidence that erythrocytes from SCT patients 
aggregate likely because of adhesive interactions with the extracellular matrix (ECM) and 
endothelial cells, and because of their irregular viscoelastic properties. This results in 
inflammation, blood flow impairment, and vaso-occlusive events. However, the exact role of 
stress conditions and how they lead to these complications is virtually unknown. Using single-
molecule atomic force microscopy experiments, we report that epinephrine, a hormone secreted 
under stressful conditions, increases both the frequency and strength of adhesion events 
between BCAM/Lu (basal cell adhesion molecule) and ECM laminin, and between intercellular 
adhesion molecule-4 (ICAM-4) and endothelial αvβ3, compared to non-stimulated SCT 
erythrocytes. Increases in adhesion frequency present significant evidence of the role of 
epinephrine in BCAM/Lu-laminin and ICAM-4-αvβ3 bonding, and suggest mechanisms of vaso-
occlusion during physical exertion in SCT.  
 
6.2. Introduction 
Sickle cell trait (SCT) is a risk factor for collapse and sudden death in physical training [9, 49-50, 
53, 57, 246-247]. SCT is characterized by the presence of both normal adult hemoglobin (HbA) 
and abnormal sickle hemoglobin (HbS) in the red blood cell (RBC, erythrocyte). SCT affects 
over three million people in the United States, about 40 to 50 times more than sickle cell 
disease (SCD) [46]. In HbS, the normal sequence Val-His-Leu-Thr-Pro-Glu-Glu-Lys is changed 
to Val-His-Leu-Thr-Pro-Val-Glu-Lys, with the amino acid valine substituted for glutamic acid in 
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the β6 site. The replacement of two charged groups by two hydrophobic ones leads to 
polymerization of deoxygenated Hb and to the formation of stiff HbS fibers comprising a fibrous 
gel [33, 35, 42]. Between 40-42% of the hemoglobin content of most individuals with SCT is 
HbS [45]. In comparison to the homozygous SCD, the heterozygous SCT is traditionally 
regarded as a benign condition [28, 47-48]. However, during strenuous exercise, individuals can 
develop a syndrome resembling SCD with vaso-occlusive events resulting from changes in the 
RBC morphology, viscoelasticity, and adhesion [38, 49-54]. Vaso-occlusion occurs in crises in 
which the arterial circulation is blocked at one or many sites, leading to organ damage and 
ischemic pain [55]. Endothelial cell activation, cytoadherence, inflammation, and coagulation 
activation contribute to blood flow obstruction and play a critical role in the pathophysiology of 
vaso-occlusion [64, 66, 68].  
 
It is known that SCD RBCs adhere abnormally to extracellular matrix (ECM) components as well 
as to endothelial cells (ECs) via changes in their adhesive interactions. Immature (reticulocytes) 
and mature erythrocytes express several adhesion receptors. One of them is the Lutheran (Lu) 
blood group RBC antigen and basal cell adhesion molecule (BCAM), known as BCAM/Lu which 
is a high-affinity laminin receptor. Another one is the intercellular adhesion molecule-4 (ICAM-4, 
LW glycoprotein), a receptor for a number of integrins [248].  
 
While it is known that epinephrine enhances SCD erythrocyte adhesion, the mechanism has not 
yet been quantitatively explored in SCT or in SCD [72, 249]. Epinephrine is a hormone secreted 
from the adrenal medulla during periods of stress and strenuous exercise [250]. Increased 
circulating levels of epinephrine act on the RBC β2-adrenergic receptor, thereby activating Gαs 
proteins which stimulate adenylyl cyclase (AC). This enzyme catalyzes the conversion of 
adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP), leading to protein 
kinase A (PKA) activation, an intermediate step in the up-regulation of BCAM/Lu- and ICAM-4-
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mediated adhesion [72, 249, 251]. The interaction of BCAM/Lu with the α5 chain of laminin 
(LAMA5) on the ECM, as well as  the interaction of ICAM-4 with the αvβ3 integrin on ECs, may 
contribute to vaso-occlusive events in SCD due to over-expression of BCAM/Lu and ICAM-4 on 
SCD RBCs in the presence and absence of epinephrine [72, 248-249].  
 
6.3. Design and Methods 
Preparation of BCAM/Lu and ICAM-4 substrate 
To attach purified CD239 (Sigma Aldrich, St. Louis, MO), commonly known as BCAM/Lu, onto a 
gold-coated mica substrate (Novascan Technologies, Inc., Ames, IA), the substrate was first 
incubated for 2 hours in 50 mM mercaptoethanesulfonate. Mercaptoethanesulfonate was 
prepared by adding sodium 2-mercaptoethanesulfonate to equal parts ethanol and 18 MΩ 
water. The gold surface was allowed to dry, then a drop of 1 µg/mL protein in PBS was added to 
the surface. After 20 min, the prepared gold surface was rinsed with PBS and a volume of PBS 
is added for experiments. The same method was employed in the attachment of ICAM-4-1 
(Sigma Aldrich, St. Louis, MO) onto a gold-coated mica substrate. 
 
Preparation of laminin and αvβ3 probes 
Silicon nitride cantilevers were gently rinsed with ethanol and 18 MΩ water before being placed 
in a clean, dry petri dish with 30 μL APTES (3-aminopropy-triethoxysilane) and 10 µL 
triethylamine for 1h. N3-dPEG-NH2 linker was prepared by adding dry methylene chloride (0.5 
mL), triethylamine (7 µL), and 7.5 mg (7.5 µL) of N3-dPEG-NH2 linker (Quanta Biodesign, 
Powell, OH) to a small, dry glass vial. The vial was sealed and inverted several times until all of 
the solid substances dissolved. After the atomic force microscopy (AFM) probes were tightly 
sealed with APTES for 1h, they were removed and immediately added to the N3-dPEG-NH2 
linker at 4°C. After 1 h, the probes were rinsed with methylene chloride, ethanol, and then 18 
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MΩ water. The probes were placed in a parafilm-coated dish with their tips pointed upwards and 
inwards in a circular manner. 50 μL of 250 μg/mL purified Laminin α5, clone 4C7 (Millipore, 
Temecula, CA) or 50 μL of 210 μg/mL purified human integrin αvβ3 (Millipore, Temecula, CA) is 
added to the center of the cantilevers, in contact with the probes. After 2 hours, AFM probes 
were rinsed with PBS buffer. 
 
Erythrocyte preparation 
The study included RBCs from a SCT adult subject (n = 1) and RBCs from a healthy adult 
subject (n = 1) purchased from Research Blood Components, LLC (Brighton, MA). An IRB 
approved consent form was obtained by the company for each donor giving permission to use 
the acquired sample for research purposes. Sodium citrate anticoagulant is used, RBCs were 
utilized for experiments within 14 days of blood draw, and maintained at 4ºC prior to use. Cell 
age did not appear to have an effect on the data. Erythrocytes were diluted to a concentration of 
50% in Alsever’s solution (Sigma Aldrich, St. Louis, MO) and maintained in 5% CO2 at 37ºC 
prior to immobilization and experiments. 
 
Erythrocyte immobilization 
Cells were immobilized on glass-bottom petri dishes (MatTek Corporation, Ashland, MA) coated 
with poly-L-lysine (PLL) to increase cell adherence. 150 μl of 1 mg/ml PLL solution (Sigma 
Aldrich, St. Louis, MO) was allowed to adsorb for 5 min to a sterile glass surface, and excess 
solution was drained away. RBCs of 50% concentration in Alsever’s solution were allowed to 
adhere to each PLL-coated glass surface for 10 min in the incubator (37ºC and 5% CO2). 
Unattached cells were removed by gentle rinsing of the surface with Alsever’s solution at 25°C 
and a volume of 3.0 mL Alsever’s solution was added for experiments. In epinephrine-mediated 
adhesion experiments, a volume of 3.0 mL of 10 nM epinephrine (Sigma Aldrich, St. Louis, MO) 
was added for experiments.  
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Atomic force microscopy measurements 
Adhesion maps and force-distance curves were obtained using an Asylum MFP 3D-BIO 
(Asylum Research, Santa Barbara, CA) AFM equipped with a “liquid cell” setup. A petri dish 
heater was employed to maintain the RBCs at physiological body temperature (37ºC) during 
experiments. The temperature inside the sample was controlled (±0.1ºC) via closed loop 
temperature control using an environmental controller (Asylum Research, Santa Barbara, CA). 
Baseline measurements were performed in Alsever’s solution at 37ºC. Epinephrine-mediated 
experiments were performed in a 10 nM epinephrine solution, using Alsever’s as the base, at 
37ºC. Unless otherwise specified, all force measurements were recorded with a loading rate of 
24000 pN/s, calculated by multiplying the tip retraction velocity (nm/s) by the spring constant of 
the cantilever (pN/nm). 
 
The nominal spring constant kc of the employed cantilever was 30 pN/nm, as provided by the 
manufacturer (Bruker Probes, Camarillo, CA). Exact values for the cantilever spring constants 
were obtained via a thermal noise based method implemented by the manufacturer and were 
used in all calculations. We chose this cantilever stiffness because it is known that when kc > 10 
pN/nm, the soft linkage of the protein-protein interaction dominates the behavior of the 
cantilever-protein effective spring system [104]. The approach and retraction velocities were 
held constant at 800 nm/s. Probes had nominal tip radii of 20 nm and nominal angle of 20°, as 
provided by the manufacturer. 
 
Statistical analysis 
Reported adhesion interaction forces for the BCAM/Lu-laminin complex and ICAM-4-αvβ3 
complex in the text are average values obtained via the Gaussian distribution. The differences 
among the groups are assessed using the two-tailed t-test for independent samples to evaluate 
respectively the effect of the SCT genotype and that of the epinephrine stimulation. The 
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significance level is defined as p < 0.05. The statistical analyses are conducted with the Data 
Analysis Toolpack in Microsoft Excel (Microsoft, Redmond, WA). 
 
 
 
Figure 6.4.1.  Strategy for measuring the BCAM/Lu-laminin binding force at the single-molecule 
level using AFM. (A) Schematic of the surface chemistry used to functionalize the AFM tip and 
substrate with LAMA5 and BCAM/Lu. A PEG-linker was attached to an AFM tip terminated with 
NH2 groups, and BCAM/Lu was bound to a gold substrate via mercaptoethanesulfonate. (B) 
Force-distance curves are three representative examples obtained using independent tips and 
substrates. The blue curve demonstrates zero adhesive interaction, while the red and black 
curves show rupture forces associated with adhesion events. (C) Dynamics of the BCAM/Lu-
laminin interaction. Dependence of the adhesion force on the loading rate applied during 
retraction, measured between a LAMA5 tip and a BCAM/Lu substrate, while keeping the 
interaction time (0 s) and loading rate during approach (24000 pN/s) constant. The mean 
adhesion force does not notably change with the loading rate, indicating the measurements 
were performed close to thermodynamic equilibrium 
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6.4. Results 
Dynamics of the BCAM/Lu-laminin and ICAM-4-αvβ3 interaction 
Direct measurements of the BCAM/Lu-laminin and ICAM-4-αvβ3 adhesive interactions are 
obtained via single molecule force spectroscopy [90, 94, 96]. Adhesive forces, defined as the 
maximum rupture force (Figure 6.4.1B) associated with the force-distance curves, are extracted 
from each of the 1024 force curves acquired to determine the rupture force. Upon investigation 
of the dynamics of the BCAM/Lu-laminin interaction, force curves between the LAMA5 tip and 
the BCAM/Lu-coated substrate are recorded at various retraction rates. The mean adhesion 
force does not substantially depend on the loading rate applied during retraction, over the 
experimentally tested range (Figure 6.4.1C). Dynamics of the ICAM-4-αvβ3 interaction shows a 
similar trend. This observation, in contrast to the behavior of several other receptor-ligand 
complexes that usually have an increase in adhesion force with the logarithm of loading rate, 
indicates that the force measurements are performed close to thermodynamic equilibrium [252]. 
 
Interaction force of the BCAM/Lu-laminin and ICAM-4-αvβ3 pairs 
For the BCAM/Lu-laminin pair, force-distance curves are recorded between the LAMA5 probe 
and the BCAM/Lu-coated substrate. Adhesive forces are extracted from each of the 1024 force 
curves acquired and an average rupture force of 50 ± 11 pN (Figure 6.4.2A). In atomic force 
microscopy, the specificity of ligand-receptor binding is demonstrated by performing blocking 
experiments with free ligands, which are injected into the solution to block the receptor sites on 
the cell surface. Consequently, almost all specific recognition signals completely disappear and 
only occasional adhesion events are observed [56, 90]. The specificity of the interaction is 
demonstrated by performing experiments in 250 μg/mL laminin solution, thus blocking the 
BCAM/Lu receptors. By recording force-distance curves between the LAMA5 tip and the 
BCAM/Lu-coated substrate in the laminin solution, the number of curves showing adhesion 
events dramatically reduces from 26% to 6% (p < 10-6, Figure 6.4.2A). For the ICAM-4-αvβ3 pair,  
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Figure 6.4.2. Measurement of the binding force of the BCAM/Lu-laminin and ICAM-4-αvβ3 
complexes. (A) Adhesion force histogram obtained from 1024 force curves (n = 1024) measured 
in PBS between a LAMA5 tip and a BCAM/Lu substrate. The distribution of adhesion forces 
reveals a maximum value at 50 ± 11 pN as determined by a Gaussian fit. The frequency of 
adhesion events was 26%, as determined by the percentage of curves showing rupture forces. 
Overlay shows the adhesion force histogram (n = 1024) obtained after injection of free laminin 
(250 µg/mL) into the solution. The dramatic reduction of adhesion frequency and broadening of 
the distribution reflect the blocking of the BCAM/Lu receptors. (B) Adhesion force histogram 
obtained from 1024 force curves (n = 1024) measured in PBS between an integrin αvβ3 tip and a 
ICAM-4 substrate. The distribution of adhesion forces reveals a maximum value at 47 ± 15 pN 
as determined by a Gaussian fit. The frequency of adhesion events was 18%. Overlay shows 
the adhesion force histogram (n = 1024) obtained after injection of free integrin αvβ3 (210 
µg/mL) into the solution. The dramatic reduction of adhesion frequency reflects the blocking of 
the ICAM-4 receptors. 
 
force-distance curves are recorded between the αvβ3 probe and the ICAM-4-coated substrate, 
resulting in an average rupture force of 47 ± 15 pN (Figure 6.4.2B). The specificity of the 
interaction is demonstrated by performing experiments in 210 μg/mL integrin αvβ3 solution, thus 
blocking the ICAM-4 receptors. The number of curves showing adhesion events dramatically 
reduces from 18% to 3% (p < 10-6, Figure 6.4.2B). 
 
Non-stimulated SCT RBC adhesion to laminin and integrin αvβ3 
In this paper, we measure, on single erythrocytes, the effects of epinephrine on the bond 
strength and on the frequency of binding events between (1) the BCAM/Lu antigen, expressed 
on the surface of SCT RBCs, and the laminin complex, expressed on the ECM, and (2) the 
ICAM-4 antigen expressed on the surface of SCT RBCs, and the αvβ3 integrin, expressed on 
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ECs. We also measure the adhesion of non-stimulated SCT RBCs compared to non-stimulated 
wild-type RBCs. The methodology followed requires functionalization of the AFM probe [90, 94-
96] with LAMA5 or integrin αvβ3 to measure the interaction between the α5 chain of laminin and 
BCAM/Lu receptor expressed on the tested RBC (Figure 6.4.3), or the interaction between 
integrin αvβ3 and ICAM-4 receptor expressed on the tested RBC. From these measurements, 
the distribution of the BCAM/Lu and ICAM-4 receptor on the RBC surface is also obtained. The 
RBCs are placed in an environment with a physiologically relevant level of epinephrine to 
explore the effect of the stress-induced epinephrine environment on the frequency and 
distribution of adhesive interactions. 
 
 
Figure 6.4.3. AFM topographic image of a SCT erythrocyte displaying the characteristic 
biconcave shape associated with healthy, wild-type RBCs. This erythrocyte is a representative 
example of those scanned during experiments to map the distribution of BCAM/Lu and ICAM-4 
receptors on human erythrocytes.  
 
To detect the distribution of the receptors on the cell surface, as well as to measure the 
physiologic BCAM/Lu-laminin bond strength, spatially-resolved adhesion maps are recorded 
using a LAMA5 tip over 1 µm x 1 µm areas. Adhesive forces are extracted from each of the 
1024 force curves acquired from tests on n=6 wild-type and n=6 SCT erythrocytes. The average 
magnitude of the BCAM/Lu-laminin bond is the same for wild-type and SCT (Figure 6.4.4A) 
erythrocytes, 46 ± 6 pN and 46 ± 10 pN, respectively. This bond strength is also the same as 
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the average rupture force of 50 ± 11 pN (Figure 6.4.2A) measured between a BCAM/Lu-coated 
gold substrate and a functionalized LAMA5 probe. The number of observed binding events, 
however, shows an increase from 10.42% to 16.89% (p < 0.05). 
 
 
Figure 6.4.4. Measurement of the binding force of the BCAM/Lu-laminin and ICAM-4-αvβ3 
complexes on erythrocytes. (A) Foreground: Adhesion force histogram obtained from 6,144 
force curves (n = 6 cells x 1024 force curves) measured in Alsever’s solution between a LAMA5 
tip and a wild-type (WT) RBC. The distribution of adhesion forces reveals a maximum value at 
46 ± 6 pN, as determined by a Gaussian fit. Background: Adhesion force histogram obtained 
from 6,144 force curves (n = 6 cells x 1024 force curves) obtained between a LAMA5 tip and a 
sickle cell trait RBC reveals a distribution of adhesion forces with a maximum value at 46 ± 10 
pN. The frequency of adhesion events increased significantly from 10.42% on the wild-type 
RBC to 16.89% on the SCT RBC (p < 0.05). (B) Foreground: Adhesion force histogram 
obtained from 6,144 force curves (n = 6 cells x 1024 force curves) measured in Alsever’s 
solution between a αvβ3 tip and a wild-type RBC. The distribution of adhesion forces reveals a 
maximum value at 46 ± 10 pN, as determined by a Gaussian fit. Background: Adhesion force 
histogram (n = 6 cells x 1024 force curves) obtained between a αvβ3 tip and a sickle cell trait 
RBC reveals a distribution of adhesion forces with a maximum value at 47 ± 10 pN. There is a 
non-significant increase from 5.91% to 7.56% (p > 0.05) in the number of adhesion events. 
 
For the measurements of the ICAM-4-αvβ3 pair bond strength and local distribution, adhesive 
forces are extracted from each of the 1024 force curves acquired from tests on n=6 wild-type 
and n=6 SCT erythrocytes. The average magnitude of the ICAM-4-αvβ3 bond is the same for 
wild-type and SCT (Figure 6.4.4B) erythrocytes, 46 ± 10 pN and 47 ± 10 pN, respectively. This 
bond strength is also nearly the same as the average rupture force of 47 ± 15 pN (Figure. 
6.4.2B) measured between an ICAM-4-coated gold substrate and a functionalized integrin αvβ3 
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probe. The number of observed binding events show an insignificant increase from 5.91% to 
7.56% (p > 0.05). 
 
 
Figure 6.4.5. Measurement of the physiologic implications of epinephrine-stimulated adhesion. 
(A) Foreground: Adhesion force histogram (n = 6 cells x 1024 force curves) obtained in 10 nM 
epinephrine between a LAMA5 tip and a wild-type RBC reveals a distribution of adhesion forces 
with a maximum value at 45 ± 8 pN, comparable to the baseline value. The frequency of 
adhesion events increased from 10.42% to 14.86% (p > 0.05) as compared to baseline 
measurements of wild-type RBCs. Background: Adhesion force histogram (n = 6 cells x 1024 
force curves) obtained between a LAMA5 tip and a SCT RBC. The frequency of adhesion 
events increased significantly from 16.89% to 35.04% (p < 0.01) as compared to baseline 
measurements of SCT RBCs. The distribution reveals a maximum value at 48 ± 10 pN, 
comparable to the baseline SCT value. (B) Foreground: Adhesion force histogram (n = 6 cells x 
1024 force curves) obtained in 10 nM epinephrine between an integrin αvβ3 tip and a wild-type 
RBC reveals a distribution of adhesion forces with a maximum value at 48 ± 9 pN, comparable 
to the baseline value. The frequency of adhesion events increased insignificantly from 5.91% to 
8.99% (p > 0.05) as compared to baseline measurements of wild-type RBCs. Background: 
Adhesion force histogram (n = 6 cells x 1024 force curves) obtained between a integrin αvβ3 tip 
and a SCT RBC. The frequency of adhesion events increased from 7.56% to 19.89% (p < 0.05) 
as compared to baseline measurements of SCT RBCs. The distribution reveals a maximum 
value at 45 ± 11 pN, comparable to the baseline value. 
 
Epinephrine-stimulated SCT RBC adhesion to laminin and integrin αvβ3 
To test the hypothesis that an increase in epinephrine levels results in an increase in the 
frequency of adhesive interactions, we employed a similar approach. Treatment of wild-type 
RBCs with 10 nM epinephrine, a physiologically relevant level, induced an insignificant increase 
from 10.42% to 14.86% (p > 0.05) in the frequency of BCAM/Lu-laminin binding events (n = 6, 
Figure 6.4.5A), and an insignificant increase from 5.91% to 8.99% (p > 0.05) in the frequency of 
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ICAM-4-αvβ3 binding events (n = 6, Figure 6.4.5B). There was no notable increase in the bond 
strength of either pair with epinephrine stimulation. The specificity of the BCAM/Lu-laminin 
interaction was validated via blocking experiments (Figure 6.4.6). By recording force-distance 
curves between a LAMA5 tip and wild-type RBCs in Alsever’s solution, the number of curves 
showing adhesion events dramatically reduces to 0.52% from 10.42% (p < 0.001). 
 
 
 
Figure 6.4.6. Validation of the specificity of the BCAM/Lu-laminin interaction on wild-type RBCs. 
(A) Adhesion force histogram obtained from 6,144 force curves (n = 6 cells x 1024 force curves) 
measured between a LAMA5 tip and a wild-type RBC. The distribution of adhesion forces 
reveals a maximum value at 46 ± 6 pN, as determined by a Gaussian fit. (B) Adhesion force 
histogram (n = 6 cells x 1024 force curves) obtained after injection of free laminin (250 μg/mL) 
into solution. Force-distance curves were measured in a LAMA5 tip and a wild-type RBC. The 
dramatic reduction of adhesion frequency to 0.52% from 10.42% on the wild-type in (A) (p < 
0.001) demonstrates the specificity of the BCAM/Lu-laminin interaction. 
 
Treatment of sickle cell trait RBCs (n = 6) with epinephrine induced an increase in the frequency 
of BCAM/Lu-laminin binding events from 16.89% to 35.04% (p < 0.01) (Figure 6.4.5A). The 
distribution of the wild-type RBCs with epinephrine has been overlaid on the distribution of the 
SCT RBCs with epinephrine in Figure 6.4.5A to demonstrate the broadened variability of the 
Lu/BCAM-laminin adhesion force on the treated SCT erythrocytes. Treatment of sickle trait 
RBCs (n = 6) with epinephrine induced an increase in the frequency of ICAM-4-αvβ3 binding 
events from 7.56% to 19.89% (p < 0.05) (Figure 6.4.5B). The distribution of the wild-type RBCs 
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with epinephrine has been overlaid on the distribution of the SCT RBCs with epinephrine in 
Figure 6.4.5D to demonstrate the broadened variability of the ICAM-4-αvβ3 adhesion force on 
the treated SCT erythrocytes. 
 
 
Figure 6.4.7. Distribution of BCAM/Lu and ICAM-4 on the surface of wild-type RBCs and sickle 
cell trait RBCs using different probes and cell preparations. (A,B) Adhesion force maps (color 
scale as shown) recorded with LAMA5 functionalized probes over wild-type RBCs (A) and sickle 
cell trait RBCs (B). (C,D) Adhesion force maps recorded with LAMA5 tips over wild-type RBCs 
(C) and sickle cell trait RBCs (D) in 10 nM epinephrine. (E,F) Adhesion force maps recorded 
with integrin αvβ3 probes over wild-type RBCs (E) and sickle cell trait RBCs (F). (G,H) Adhesion 
force maps recorded with integrin αvβ3 tips over wild-type RBCs (G) and sickle cell trait RBCs 
(H) in 10 nM epinephrine. Scale bars, 250 nm. 
 
Notably, 1 µm x 1 µm spatially-resolved adhesion maps revealed that the BCAM/Lu-mediated 
laminin binding activity is not homogeneously distributed over the SCT RBC surface, but 
concentrated on nanodomains. These nanodomains, often attributed to membrane rafts, are 
only observed on SCT RBCs (n = 6) in the presence of epinephrine (Figure 6.4.7D).  In contrast, 
wild-type RBCs (n = 6) stimulated with epinephrine (Figure 6.4.7C) demonstrate a nearly 
homogeneous distribution of BCAM/Lu receptors. Furthermore, ICAM-4 receptor nanodomains 
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are also observed, to a lesser degree, on the SCT RBC (n = 6) surface in the presence of 
epinephrine (Figure 6.4.7H), with a heterogeneous receptor distribution on the wild-type RBC (n 
= 6) stimulated with epinephrine (Figure 6.4.7G). In the non-stimulated environment, both wild-
type (Figure 6.4.7A, 6.4.7E) and sickle cell trait (Figure 6.4.7B, 6.4.7F) RBCs maintain a 
homogenous distribution of BCAM/Lu and ICAM-4 receptors. 
 
6.5. Discussion 
Although it is known that the BCAM/Lu-laminin and ICAM-4-αvβ3 binding complexes contribute 
to SCD vaso-occlusion, the quantitative characteristics of these adhesion interactions has not 
been explored in SCD or SCT erythrocytes. In wild-type RBCs and sickle cell trait RBCs, the 
magnitude of the BCAM/Lu-laminin binding complex (46 ± 6 pN and 46 ± 10 pN, respectively) is 
equal to the average rupture force of 50 ± 11 pN recorded between a functionalized laminin 
probe and a BCAM/Lu-coated gold substrate. In wild-type RBCs and sickle cell trait RBCs, the 
magnitude of the ICAM-4-αvβ3 binding complex (46 ± 10 pN and 47 ± 10 pN, respectively) is 
nearly the same as the average rupture force of 47 ± 15 pN recorded between a functionalized 
integrin αvβ3 probe and a ICAM-4-coated gold substrate. 
 
Interactions of receptor molecule cytoplasmic domains with the cytoskeleton can play critical 
roles in adjusting receptor function. It has been determined that BCAM/Lu has a high degree of 
connectivity to the erythrocyte membrane cytoskeleton via erythroid spectrin [253-254]. 
Importantly, disruption of the BCAM/Lu-spectrin linkage is accompanied by enhanced cell 
adhesion to laminin [254]. A major finding of the current study is that BCAM/Lu adhesion events 
in SCT erythrocytes increased (p < 0.05) as compared to the wild-type. It is known that Hb 
interacts with the spectrin network via band 3 [40, 151] and the introduction of HbS has recently 
been found to have an effect on the mechanical properties of SCT erythrocytes [93]. We 
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conjecture that HbS partially disrupts the spectrin network via its interaction with band 3, 
indirectly disrupting the BCAM/Lu-spectrin linkage. This results in increased diffusion and 
aggregation and thus significantly enhanced sickle trait RBC adhesion to ECM laminin. 
 
Epinephrine, acting through the β2-adrenergic receptor, increases Lu-laminin α5 sickle 
mediated red cell binding via a cAMP and PKA-dependent signaling pathway [72]. Further, the 
Lu cytoplasmic tail is phosphorylated in epinephrine-stimulated sickle cells, which may be a 
critical factor in sickle RBC’s enhanced adhesion to laminin [83]. The BCAM cytoplasmic tail, 
which lacks the last 40 amino acids of the sequence, does not undergo phosphorylation. It has 
been demonstrated that PKA-mediated phosphorylation of the Lu glycoprotein at serine 621 
positively regulates the adhesion function of Lu under flow conditions. While the molecular basis 
for the resulting increased adhesion is not yet understood, it has been hypothesized that 
phosphorylation of the Lu cytoplasmic tail weakens its interaction with spectrin, enabling the 
freely-floating transmembrane Lu molecules to cluster and thereby generate a larger adhesive 
force [83]. A major finding of our current study is the mapping of Lu nanodomains on 
epinephrine-stimulated SCT erythrocytes, accompanied by an increase in the frequency of 
binding events (p < 0.01) from the baseline SCT erythrocytes. The significant broadening of the 
bond magnitude distribution agrees with the aggregation of receptors into nanodomains 
detected in Figure 6.4.7D. While the frequency of adhesive interactions increases on the wild-
type RBC in the stress-induced epinephrine environment, this increase (from 10.42% to 
14.86%) is not significant and receptor clustering is not observed (see Figure 6.4.7C). This 
observation strengthens our conjecture that HbS disrupts the spectrin network resulting in 
aggregation of BCAM/Lu receptors in SCT RBCs. It is noted that, receptor aggregation is not 
detected in the case of SCT RBCs without epinephrine (see Figure 6.4.7B).  
 
ICAM-4 mediated binding to endothelial cells and leukocytes is also activated by epinephrine via 
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stimulation of the β2-adrenergic receptor which triggers a cAMP and PKA-dependent signaling 
pathway [255]. In addition, ICAM-4 on epinephrine-stimulated sickle cells undergo a significant 
increase in serine phosphorylation, which may be a critical factor in sickle RBC’s enhanced 
adhesion to endothelial integrin αvβ3 [249]. It has been hypothesized that phosphorylation-
induced changes in the ICAM-4 cytoplasmic domain cause a conformational change in its 
extracellular domain, thus generating a larger adhesive force. We observed an increase in the 
frequency of binding events (p < 0.05) from the baseline SCT erythrocytes (see Figure 6.4.5D) 
on epinephrine-stimulated SCT erythrocytes. Another important finding of the present data is the 
quantification of the insignificant increase (p > 0.05) of ICAM-4-αvβ3 adhesion events on the 
wild-type RBCs in the stress-induced epinephrine environment (see Figure 6.4.5B). This is 
consistent with the known fact that there is minimal ICAM-4 phosphorylation in wild-type RBCs, 
due to an age-related reduction in the cell’s ability to produce cAMP and thereby enhance PKA 
activity in response to stimulation [72, 256-257]. While the current study tests the effect of 
epinephrine on single molecule adhesion interactions thought to contribute to vascular blockage 
in sickle cell vaso-occlusion, epinephrine has also been found to work via increasing RBC 
trapping in the spleen and liver [255, 258]. 
 
6.6. Conclusions 
The observed increases in adhesion frequency along with the detected receptor aggregation 
into nanodomains is significant evidence of the contribution of epinephrine to enhancing 
BCAM/Lu-laminin and ICAM-4-αvβ3 bond interactions. These findings suggest a mechano-
adhesive role for epinephrine in the pathophysiology of vaso-occlusive incidents related to 
sudden death in SCT individuals during strenuous exercise. 
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Chapter 7. Establishing the Sensitivity of Force Nanoscopy in the Detection of 
Native SK Channels in Living Neurons 
 
7.1. Abstract 
The spatial distribution of ion channels is an important determinant of neuronal excitability. 
However, there are currently no quantitative techniques to map endogenous ion channels with 
single-channel resolution in living cells. Here, we demonstrate that integration of pharmacology 
with single molecule atomic force microscopy (AFM) allows for the high-resolution mapping of 
native potassium channels in living neurons. We focus on calcium-activated small conductance 
(SK) potassium channels, which play a critical role in brain physiology. By linking apamin, a 
toxin that specifically binds to SK channels, to the tip of an AFM cantilever, we are able to detect 
binding events between the apamin and SK channels. We find that native SK channels from rat 
hippocampal neurons reside primarily in dendrites as single entities and in pairs. Importantly, we 
establish the sensitivity of force nanoscopy and show that SK channel dendritic distribution is 
dynamic and under the control of protein kinase A. Our study demonstrates that integration of 
toxin pharmacology with single molecule AFM can be used to quantitatively map individual 
native ion channels in living cells, and thus provides a new tool for the study of ion channels in 
cellular physiology. 
 
7.2. Introduction 
A major challenge in cellular biology is to determine the subcellular distribution of ion channels 
resident in neurons and other cells in living tissue. In neurons, the differential localization of ion 
channels specifies the intrinsic excitability and computational properties of the subcellular 
neuronal compartments (dendrites, soma, axon). The distribution of ion channels is typically 
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determined using antibodies raised against ion channel subunits together with light, confocal, 
total internal reflection fluorescence (TIRF) microscopy or electron microscopy (EM). These 
studies have revealed that ion channels can be polarized within cells and can concentrate in 
high and low density areas within the plasma membrane [259-260]. 
 
Unlike confocal or TIRF microscopy that have an in-plane spatial resolution of ~250 nm, 
immunogold-EM has a spatial resolution of 20-30 nm making it the highest resolution method to 
determine the subcellular distribution of ion channels [261-262]. However, it is limited by its 
inability to map ion channels in living cells. Lately, several advances in super-resolution 
fluorescence microscopy have made it possible to image proteins in either living or fixed tissue 
at high spatial resolutions (30-70 nm) [261]. Still, these approaches are generally limited by 
antibody specificity and/or the use of fluorescent labels that require overexpression of tagged 
channels in cells.     
 
Recently, single molecule atomic force microscopy (AFM) has been used to localize native 
proteins in living cells at high resolution (~10 nm) [263]. The technique involves detection of 
binding events occurring between a cell surface protein and a protein attached to the tip of the 
AFM cantilever [90]. However, single molecule AFM inherently relies on the specificity and 
affinity of the protein-protein interactions, which are often unknown. Given the wealth of 
knowledge available regarding the binding of natural toxins to specific ion channels, we 
hypothesized that combination of AFM with toxin pharmacology could reveal the localization of 
endogenous ion channels in neurons with single-channel resolution. 
 
Following neuronal activity, calcium can activate apamin-sensitive SK channels with relatively 
high affinity [264-266]. Such activation can regulate synaptic plasticity and dendritic neuronal 
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excitability [267]. SK channels are enriched in dendrites and post-synaptic densities, although 
other evidence indicates an approximately uniform neuronal distribution [268-272]. Moreover, 
the spatial organization of these channels within a neuronal compartment is unclear. At least 
one SK channel isoform (SK2-L) is prone to clustering in heterologous cells [273], raising the 
possibility that SK channels might not be uniformly distributed on neuronal surfaces, even within 
a neuronal compartment. To determine SK channel subcellular distribution, we speculated that 
by attaching apamin molecules to the tip of an AFM cantilever we could detect binding forces 
between apamin and single SK channels on neuronal surfaces of living cells. Apamin is a bee 
venom toxin that specifically binds to SK channels at their extracellular region with high affinity 
and with 1:1 stoichiometry [274].  
 
7.3. Materials and Methods 
Experiments were carried out according to the guidelines of the University of Connecticut 
Institutional Animal Care and Use Committee. 
 
Preparation of functionalized cantilever probes 
Silicon nitride AFM cantilevers were rinsed with ethanol and 18MΩ water before being treated 
with 30μL APTES and 10µL triethylamine for 1h. Cantilevers were then added to the PEG-linker 
solution containing: 0.5mL methylene chloride, 7µL triethylamine, and 7.5µL PEG-linker (Quanta 
Biodesign) at 4°C for 1h. Probes were rinsed with methylene chloride, ethanol, and 18MΩ 
water. 50μL of 100 nM apamin was added in contact with the probes for 2h. Cantilevers were 
rinsed in PBS buffer and stored in PBS at 4°C. 
 
Atomic force microscopy measurements 
Binding force maps and force-distance curves were obtained using a MFP-3D-BIO (Asylum 
89 
 
Research) AFM. HEK293T cell measurements were performed in culture media at 25°C. 
Neuronal cell measurements were performed in neurobasal media stabilized with 30µL of 20 
mM HEPES buffer at 25°C. Cells were located via differential interference contrast microscopy 
and a scan area of 1µm2 was chosen with a lateral resolution of 31.25nm. 
 
Unless otherwise specified, measurements were recorded with a loading rate of 24000 pN/s, 
calculated by multiplying the tip retraction velocity (nm/s) by the cantilever spring constant 
(pN/nm). The nominal spring constant    of the employed cantilever was 30 pN/nm, as provided 
by the manufacturer. Exact values for the cantilever spring constants were obtained via a 
thermal noise based method implemented by the manufacturer and used in all calculations. This 
cantilever stiffness was chosen because it is known that when     10 pN/nm, the soft linkage 
of the protein-protein interaction dominates the behavior of the cantilever-protein effective spring 
system [104]. Probes had nominal tip radii of 20 nm and nominal angle of 20°. 
 
Electrophysiology 
HEK293T cells were transfected with recombinant DNA (0.1 - 3µg) using Lipofectamine 2000 
(Invitrogen) and recorded 24-hr post-transfection. SK2 currents were recorded with conventional 
whole-cell patch-clamp recordings. The recording electrodes were filled with solution containing 
(in mM): 110 K-gluconate, 10 KCl, 20 KOH, 4 Mg·ATP, 8.73 CaCl2, 20 HEPES, 10 EGTA·KOH 
(pH 7.2). Based on the Ca-Mg-ATP-EGTA Calculator v1.0 using constants from NIST database 
#46 v8 the free Ca2+ concentration was 1.1µM. The electrode resistances were 4–5MΩ. The 
extracellular solution contained (in mM): 144 NaCl, 2.5 KCl, 2.5 CaCl2, 1.2 MgCl2, 10 HEPES, 
and 22 D-Glucose (pH 7.2). A voltage ramp was applied from a holding potential of -100mV to 
+20mV (13mV/s). The data were low-pass filtered at 2kHz and sampled at 10kHz. For all 
recordings, we used a Multiclamp 700B amplifier interfaced to a computer through a Digidata 
1440A digitizer (Molecular Devices). Data were acquired with Clampex v10.2 (Molecular 
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Devices).  
 
Primary hippocampal cultures 
Dissociated hippocampal cultures were prepared from Sprague-Dawley pups of either sex as 
described previously [275]. 
 
Molecular biology 
SK2-S subcloned into a pEGFP-N1 vector (Clontech) was a gift of Dr. Chul-Seung Park 
(Gwangju Institute of Science and Technology, Gwangju, Korea) while SK2-L was a gift from 
John P. Adelman (Vollum Institute, OHSU) 
 
Data Analysis 
To detect the distribution of SK2 channels on the cell surface, spatially-resolved binding force 
maps were recorded using an apamin functionalized probe over 1µm2 areas. Binding forces 
were extracted from each of the 1024 force curves acquired from each test. A MATLAB 
(MathWorks) program was used to create visual binding force maps. 
 
7.4. Results 
To test our approach, we functionalized the tip of an AFM cantilever with apamin through a 
PEG-linker (Figure 7.4.1A) and transiently transfected HEK293T cells with the most commonly 
used SK2 channel isoform, SK2-S. Force-distance curves were recorded between the apamin-
functionalized tips and SK2-S channels. Binding forces are defined as the maximum rupture 
force associated with the force-distance curves (Figure 7.4.1B). We expected that binding 
forces would be higher in areas where the apamin-functionalized cantilever made contact with 
underlying SK channels compared to areas without SK channels, as the attraction between  
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Figure 7.4.1. Detection of SK2 channels on living cells using Atomic Force Microscopy (AFM). 
(A) AFM cantilever probe is functionalized with apamin, a toxin that specifically binds to SK 
channels. (B) When apamin attached to the AFM probe adheres to an SK2 channel on the cell 
surface, the force-displacement curve exhibits an abrupt shift to zero value as shown in the red 
curve. The shift corresponds to the rupture force. If there is no SK2 channel at the detection 
point and consequently no binding interaction, the retraction curve is smooth similar to the black 
curve. The arrow pointing from right-to-left shows the movement of the AFM probe approaching 
and making contact with the cell surface, while the arrow pointing downward and to the right 
demonstrates the movement of the AFM probe retracting from the cell surface. (C) Binding force 
map of a HEK293T cell transfected with SK2-S channels in the absence (i) and presence of 100 
nM ambient apamin (ii) to mask SK2 channels apamin binding sites. (iii) Binding force map of an 
untransfected HEK293T cell probed with an apamin functionalized probe shows minimal 
attraction. Each pixel corresponds to a rupture force according to the color scale shown. (D) 
Frequency graph of untransfected and SK2-S transfected cells in the absence or presence of 
ambient apamin. Star indicates statistical significance of p<0.01 (ANOVA Tukey post-hoc test). 
(F) Expression of SK2-S channels in HEK293T lead to apamin sensitive currents. Scale bars, 
250 nm. Color scale as shown. 
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apamin and the channels would require a higher rupture force compared to apamin interactions 
with the plasma membrane. Binding forces were measured over a 1µm2 area of HEK293T 
plasma membrane in cells transfected with SK2-S. For each recording, 1024 force-distance 
curves were obtained with a lateral resolution of 31.25nm. Potassium channel width has been 
reported to be ~10nm [276]. Figure 7.4.1Ci shows an example of a SK2-S binding force map 
with rupture forces detected between 21.0 to 56.4 pN for events above baseline. Such events 
were detected in 4.56 ± 0.75% of sampled sites (n=6). We also investigated the dynamics of the 
apamin SK2-S interaction by recording the force-distance curves at different cantilever 
retraction rates (2400 pN/s, 32 ± 7 pN; 24000 pN/s, 33 ± 10 pN; 240000 pN/s, 34 ± 10 pN; n=3). 
The mean binding force did not depend on the retraction rate suggesting that the observed 
interactions between apamin and SK2-S were at thermodynamic equilibrium [104]. 
 
To determine the specificity of the measured binding forces, we repeated experiments in SK2-S 
transfected cells pre-incubated with apamin as well as untransfected HEK293T cells. As shown 
in Figure 7.4.1C and 7.4.1D, we found that the frequency of binding force events was not 
significantly different between SK2-S transfected cells pre-incubated with apamin (Figure 
7.4.1Cii) and untransfected cells (Figure 7.4.1Ciii). Events with significant binding forces most 
likely reflected SK2-S channels that were not bound by bath-applied apamin. Lastly, we 
measured SK2-S current using patch clamp electrophysiological recordings to verify that the 
expressed channels were functional and apamin-sensitive (Figure 7.4.1E). 
 
Do the detected events indicate the presence of a single SK channel? To answer this question, 
we transfected varying concentrations of two SK channel isoforms, SK2-S and SK2-L in 
HEK293T cells. Previously it has been shown that the SK2-L isoform tends to form clusters 
possibly due to its cysteine rich N-terminus [273], unlike the SK2-S isoform. We found that 
increasing the concentration of transfected SK2-S plasmid (0.5 to 3.0 µg) did not substantially 
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change the mean binding force of detected events (0.5 µg, 27 ± 7 pN; 1.5µg, 32 ± 8 pN; 3.0 µg, 
31 ± 10 pN) (Figure 7.4.2A). By plotting a histogram of binding forces, a unimodal Gaussian 
distribution was obtained for each concentration. The unimodal distribution together with the 
unchanged mean binding force suggested that we primarily detected a single population of SK2-
S channels with no more than one SK2-S channel per 31.25nm.  
 
A different situation was encountered with the SK2-L isoform. Increasing the concentration of 
transfected SK2-L plasmid from 0.1µg to 3.0µg substantially increased the mean binding force 
(0.1µg, 27 ± 6 pN; 1.5µg, 44 ± 10 pN; 3.0µg, 43 ± 11 pN) (Figure 7.4.2B). Cells transfected with 
0.1µg of SK2-L resulted in force distributions similar to experiments on cells transfected with the 
SK2-S isoform, suggesting that at this very low concentration single SK2-L channels can be 
identified. At the higher concentrations of 1.5 and 3.0µg, the mean binding forces for SK2-L 
were approximately twice as large as the mean force obtained with 0.1µg SK2-L or the non-
clustering SK2-S. 
 
Considering that both isoforms share the same apamin binding site sequence [273], the higher 
mean binding force most likely reflected the presence of two SK2-L channels per recorded site. 
If this was the case, cells pre-incubated with 20pM apamin should have a similar mean binding 
force to the value obtained for single SK2-L channels. This is because the dissociation constant 
(KD) for apamin binding to SK2 channels is ~10pM [274]. Thus, in the presence of 20pM apamin 
at least one of the two SK2-L channels in a cluster should be occupied by apamin thereby 
becoming unavailable for detection by the AFM probe. Indeed, in cells transfected with 3µg 
SK2-L and in the presence of ambient 20pM apamin, the binding force histogram became 
bimodal (Figure 7.4.2C) with a major peak at 27 ± 5 pN (n=5), a value similar to that obtained 
with low plasmid concentrations (27 pN; Figure 7.4.2D). A minor second peak was also 
recorded (39 ± 9 pN, n=5) likely reflecting remaining clustered channels not bound by the pre-
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applied apamin. In summary, our data suggest that the apamin-dependent binding forces 
measured by AFM are specific and can be used to quantitatively map SK channels on living cell 
surfaces. 
 
Figure 7.4.2. Counting SK2 channels in living cells. Binding force map and corresponding 
frequency histograms of HEK293T cells transfected with (A) 3.0 µg SK2-S (n=6), 1.5 µg SK2-S 
(n=6), and 0.5 µg SK2-S (n=6), (B) 0.1 µg SK2-L (n=6), 1.5 µg SK2-L (n=6), and 3.0 µg SK2-L 
(n=6). (C) Binding force frequency histograms of HEK293T cells transfected with 3.0 µg SK2-L 
(n=5) in cells pre-incubated with 20 pM apamin. (D) Summary graph showing the relationship 
between binding force and increased levels of SK2-L transfection.  Scale bars, 250 nm. Color 
scale as shown. 
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After establishing the technique in HEK293T cells, we next employed AFM using apamin-
functionalized tips to map the subcellular distribution of native SK channels in cultured 
hippocampal pyramidal neurons. Although SK channels play a critical role in hippocampal 
neurons, there is no consensus about their subcellular localization with some studies indicating 
a somatic localization of SK channels [272] whereas others a more dendritic localization of SK 
channels [268-269]. We probed different 1µm2 cell surface regions, focusing on the soma and 
dendrites (Figure 7.4.3). Based on our recordings, SK channel distribution in neurons was 
polarized with the highest binding event frequency found on dendritic regions furthest from the 
soma (>30 µm) (6.2 ± 1.1%, n = 11), and the lowest frequency at the soma itself (0.29 ± 0.1%, n 
= 5), a 20-fold difference (Figure 7.4.3A-C; p<0.001 Student’s t-test). The frequency of binding 
events at dendritic areas proximal to the soma (~10-20µm) was 0.70 ± 0.2% (n=7). Interestingly, 
the binding force distribution at more distal dendritic regions (>30µm) did not follow a unimodal 
distribution, but instead was best fitted as a mixture of two Gaussians with peaks at 22 ± 6 pN 
and 41 ± 14 pN (Figure 7.4.3A). These values are similar to those we obtained for single and 
clustered channels in HEK293T cells (Figure 7.4.2), suggesting that native SK channels are 
distributed as single channels or as groups of two channels in distal dendritic regions of 
hippocampal pyramidal neurons. Therefore, the density of SK channels on dendritic surfaces is 
~60-90 channels/µm2, assuming a 6.2% event detection frequency over the 1024 samples in the 
1µm2 area (Figure 7.4.3). 
 
The absence of apamin-sensitive SK channels at the soma was intriguing given that they had 
been detected in the soma of cultured pyramidal neurons in prior studies [264]. However, this 
work focused on the localization of transfected SK2-S channels rather than endogenous 
channels and may have resulted in artificially high levels of SK2 channels throughout the cell. 
To determine whether overexpression changed the distribution of channels, we overexpressed 
SK2-S channels in cultured hippocampal pyramidal neurons and repeated measurements with 
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the apamin functionalized AFM probe. In this situation, binding forces were readily detectable at 
the soma from SK2-S transfected neurons (Figure 7.4.3D). The binding force histogram could 
be fitted as a mixture of two Gaussians, with peaks of 40 ± 11 pN and 67 ± 14 pN (Figure 
7.4.3D), values approximately two- and three-fold greater than the mean binding force for a 
single SK channel. This confirms that overexpressed SK2 channels are localized to the soma 
and suggests that they cluster in groups of two to three channels. However, the absence of 
significant binding events in the soma of untransfected neurons indicates that native SK 
channels are minimally expressed in this subcellular compartment. 
 
 
 
Figure 7.4.3. SK channels are polarized in pyramidal neurons. (A) Binding force maps and 
corresponding histogram showing detected SK2 channels on the distal region of the dendrite 
(n=11). (B) Binding force maps and corresponding histogram showing detected SK2 channels 
on the proximal region of the dendrite (n=7). (C) Binding force maps and corresponding 
histogram showing the detection of SK2 channels on the soma (n=7). (D) Binding force maps 
and corresponding histogram showing the detection of SK2 channels on the soma after 
transfection with SK2 channels (n=6). Scale bars, 250 nm. Color scale as shown. 
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Finally, we used the quantitative nature of this technique to determine how the dendritic SK 
channel distribution changes in response to neuromodulation. SK channel activity is affected by 
multiple neuromodulators, often through generation of cAMP and subsequent activation of 
protein kinase A (PKA). Studies in neurons and heterologous cells have shown that application 
of forskolin, a strong PKA activator, causes the internalization of SK2 channels from cell 
surfaces [277-278]. Therefore, we measured binding events in neurons that had received either 
15µM or 30µM forskolin for 15 minutes. Compared to untreated neurons, the more distal 
dendrites (>30µm from the soma) of forskolin-treated neurons exhibited fewer apamin-
dependent binding events (Figure 7.4.4). Interestingly, the mean binding force histograms are 
different in all three conditions (Figure 7.4.4C): 1) in untreated neurons there is a bimodal 
histogram with relatively equal peaks at 22 and 44 pN; 2) the histogram for neurons treated with 
15 µM FSK is bimodal with a larger peak at 31 pN and a smaller peak at 42 pN; and 3) the 
apamin binding force histogram follows a unimodal distribution after 30 µM forskolin treatment 
centered on 27 pN. The peak in the presence of 30 µM forskolin is centered at 27 pN a value in 
between the two peaks in the untreated neurons, thus making it difficult to conclude whether 
clusters were preferentially lost. Future studies are needed to explore the effect of FSK on the 
SK channels subcellular distribution. 
 
7.5. Discussion 
In this work we show that integration of single molecule AFM with toxin pharmacology allowed 
us to map the spatial organization and density of endogenous SK channels in living neurons. By 
taking advantage of the nanometer resolution of single molecule AFM, we demonstrate that SK 
channels are highly concentrated on neuronal dendrites. Importantly, we show that SK channels 
are organized on neuronal membranes as either groups of two or single entities. This differential 
clustering might represent the distribution of the two SK2 channel isoforms, plasma membrane 
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diffusional barriers, or areas of exocytosis. Currently, we cannot distinguish between these 
alternatives.  
 
 
Figure 7.4.4. SK channel maps in pyramidal neurons are dynamic. (A) Binding force maps 
showing detected SK2 channels without FSK on the soma, proximal dendrite, and outward 
dendrite. (B) Binding force maps showing a significant decrease in detected SK2 channels after 
administration of 30 µM FSK for 15 minutes. (C) Binding force histograms showing the 
distribution of rupture forces in the native state (tan, background) and after 15 µM (green; n=4) 
and 30 µM FSK administration (red, foreground; n=6). Scale bars, 250 nm. Color scale as 
shown. 
 
The high density of SK channels in dendrites is also consistent with electrophysiological and 
imaging work showing that SK channels are critical in regulating dendritic integration [279], 
controlling the kinetics of excitatory postsynaptic potentials, and induction of long-term 
potentiation, and learning and memory [267]. But is there a particular advantage for the high SK 
channel concentration in dendrites? We suggest that high SK channel concentration might 
increase the gain and reliability of SK channel activation. This might be necessary as SK 
channels are found in calcium microdomains. That is, SK channels and calcium channels are 
found within 100-150nm distances from each other, unlike BK channels that are in calcium 
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nanodomains (10-30nm) [280]. As the calcium concentration decays very rapidly following 
calcium channel closure, the likelihood of activating SK channels would also decrease quickly. 
SK channels partly counteract this effect by having high calcium affinity (Km: ~500-700nM) 
[280]. However, SK channel activation might also be boosted though their high dendritic density. 
This will further increase their prospect of activation, as more SK channels will be available to 
capture calcium. Future studies and modeling are required to test this possibility and to examine 
whether high SK channels density could lead to buffered diffusion of calcium within the SK 
channel clusters [281]. Calcium buffered diffusion will further increase the probability of SK 
channel activation. 
 
In conclusion, by using naturally derived toxins that bind with high affinity to ion channels, we 
can map the subcellular distribution of native ion channels at the cell surface. Over the years, 
toxins have emerged as an invaluable tool to study ion channels physiology as well as the 
relationship between their structure and function [282]. Other studies have also used toxins for 
ion channel localization however, these studies relied on non-living tissue and the use of either 
radioactive labeled toxins or toxins conjugated with fluorescence probes. Although conjugating 
toxins with fluorescent dyes would allow for the determination of ion channel density in living 
neurons, it would be difficult to visualize ion channels on the single channel level without 
appropriate computational tools. Integration of toxin pharmacology with single molecule AFM 
bypasses these issues, as it only requires knowledge of the forces between the toxin and the 
ion channel of interest. We expect our approach to have a significant impact to the study of ion 
channels and other surface proteins for which high affinity toxins exist. 
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Chapter  8. AKAP-Dependent Modulation of BCAM/Lu Adhesion on Normal and 
Sickle Cell Disease RBCs Revealed by Force Nanoscopy 
 
8.1. Abstract 
Human normal and sickle red blood cells (RBCs) adhere with high affinity to laminin via the 
basal cell adhesion molecule/Lutheran (BCAM/Lu) receptor which is implicated in vasoocclusive 
episodes (VOEs) in sickle cell disease (SCD) and activated through the cyclic adenosine 
monophosphate (cAMP) signaling pathway. However, the effect of the cAMP pathway on the 
expression of active BCAM/Lu receptors at the single-molecule level is unknown. We 
established an in vitro technique, based on atomic force microscopy, which enables detection of 
single BCAM/Lu proteins on the RBC surface and measures the unbinding force between 
BCAM/Lu and laminin. We showed that the expression of active BCAM/Lu receptors is higher in 
homozygous sickle RBCs (SS-RBCs) than normal RBCs and that it is critically dependent on 
the cAMP signaling pathway on both normal and SS-RBCs. Importantly, we illustrated that A-
kinase anchoring proteins (AKAPs) are crucial for BCAM/Lu receptor activation. Furthermore, 
we found that SS-RBCs from hydroxyurea-treated patients show a lower expression of active 
BCAM/Lu receptors, a lower unbinding force to laminin, and insignificant stimulation by 
epinephrine as compared to SS-RBCs from untreated patients. These findings may lead to 
novel anti-adhesive targets for VOEs in SCD. 
 
8.2. Introduction 
Red blood cells (RBCs) express several surface adhesion receptors known to modulate cellular 
physiology [62, 122]. In sickle cell disease (SCD) [28-29], cytoadherence of RBCs to endothelial 
laminin via the basal cell adhesion molecule/Lutheran (BCAM/Lu) receptor is thought to be a 
major contributor to and possibly the primary cause of vasoocclusive episodes (VOEs) [64, 71]. 
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On normal and homozygous sickle RBCs (SS-RBCs), the activation of adhesion receptors can 
be modulated by hormones such as epinephrine [30, 72], pharmaceutical drugs such as 
hydroxyurea [73, 78], and other biochemical stimuli [283]. Because SCD patients have 
extensive endothelial damage [80] and elevated plasma levels of laminin [81], RBC adhesion 
studies have focused on the specific interaction between BCAM/Lu and the α5 chain on laminin 
(LAMA5), a component of the subendothelial matrix [82-83, 284]. Although it is known that this 
interaction is mediated by cyclic adenosine monophosphate (cAMP) [72], the effects of the 
cAMP signaling pathway on the expression of BCAM/Lu receptors and on the interaction 
between BCAM/Lu and LAMA5 at the single-molecule level are unknown. Further, it is unknown 
if scaffold or anchoring proteins, such as A-kinase anchoring proteins (AKAPs) [88], play a role 
in BCAM/Lu receptor activation. It is also unknown, at the single-molecule level, if treatment with 
hydroxyurea (HU) modulates BCAM/Lu receptor expression or modifies the strength of the bond 
between BCAM/Lu and LAMA5. 
 
In this paper, we employed single-molecule atomic force microscopy (AFM) [30, 96, 285] to 
quantitatively study the modulation of BCAM/Lu expression on the membrane of normal and 
SS-RBCs. Single-molecule AFM measures the unbinding force between a specific ligand and its 
corresponding receptor on a single cell with piconewton sensitivity [89, 91-92, 132]. We 
detected the unbinding force between BCAM/Lu and LAMA5, which is interpreted as adhesive 
force. The generated data are used to calculate the expression of active BCAM/Lu receptors on 
the RBC surface and their spatial distribution on the membrane at high resolution (~30 nm) [30, 
91, 286]. 
 
Previous experimental approaches utilizing flow adhesion assays [72] have shown that in SS-
RBCs, the interaction between BCAM/Lu and LAMA5 is strongly mediated by cAMP-dependent 
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protein kinase A (PKA) [72, 83]. Stimulation of the β2-adrenergic receptor (β2-AR) [85-86] 
activates the G-protein coupled receptor Gαs, which stimulates adenylyl cyclase (AC) [87]. AC 
then catalyzes the conversion of adenosine triphosphate (ATP) to cAMP, resulting in PKA 
activation and ensuing BCAM/Lu-laminin adhesion. Normal RBCs, however, adhere minimally 
to the vascular endothelium [122] and their response to stimulation by epinephrine or forskolin 
has not been detected by flow adhesion experiments [72]. Here, by using a single-molecule 
assay, we clearly detected variability in the expression of BCAM/Lu on normal and SS-RBCs as 
it is modulated by the cAMP signaling pathway. 
 
It is currently unknown if the scaffold protein AKAPs [88] play a role in BCAM/Lu receptor 
activation by localizing PKA activity to specific subcellular domains within RBCs. In other cell 
types, it has been found that PKA activity is localized within the cell by attachment of the PKA 
molecule to an AKAP. Specifically, a PKA tetrameric holoenzyme [79], consisting of two 
catalytic and two regulatory subunits, binds to an AKAP via its regulatory subunits. The resultant 
PKA/AKAP complex is localized to a unique subcellular domain due to the AKAP-specific 
targeting domain [85, 287]. In this work, we showed that AKAPs mediate the activation of 
BCAM/Lu by PKA in RBCs, signifying that cAMP activates PKA locally, close to the cell 
membrane.  
 
Hillery et al. [78] first demonstrated that SS-RBCs from patients receiving hydroxyurea undergo 
a decrease in adhesion to LAMA5. This finding was contrasted by another result [288] showing 
that the expression of BCAM/Lu receptors on SS-RBCs from HU-treated patients increased. A 
resolution to this conflicting evidence was offered by a recent work which demonstrated that the 
reduced adhesion of SS-RBCs to LAMA5 is likely due to inhibition of BCAM/Lu phosphorylation 
by HU [73]. However, it is still unclear if the lower adhesion is only due to the reduced 
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expression of active BCAM/Lu receptors as a result of inhibition of BCAM/Lu phosphorylation, or 
if HU also affects the unbinding force between BCAM/Lu and LAMA5. In our experiments, we 
measured the expression and unbinding force to LAMA5 of active BCAM/Lu receptors on SS-
RBCs from untreated and HU-treated patients. We found that both the expression and adhesive 
force of active BCAM/Lu molecules is decreased in HU-treated patients. These data 
demonstrate a very beneficial effect of HU in reducing the propensity of SS-RBCs to adhere to 
LAMA5.  
 
In summary, we employed single-molecule AFM to investigate interactions between RBCs and 
the endothelium, and their regulation via cAMP. We quantified cAMP-dependent modulation of 
active BCAM/Lu receptor expression in normal and SS-RBCs. We are first to demonstrate that 
AKAPs are crucial for the activation of BCAM/Lu receptors. Lastly, we showed that HU 
treatment results in decreased erythrocyte adhesion to the endothelium due to lower expression 
of BCAM/Lu receptors and lower binding forces between BCAM/Lu and LAMA5.  
 
8.3. Methods 
Patients and blood samples 
Homozygous SCD patients (SS) at steady-state, and age-/race-matched healthy volunteers at 
least 18 years old were eligible to participate in this study which was approved by the 
Institutional Review Boards of the UCONN Health Center and UCONN-Storrs. Individuals with 
SCD were eligible to participate if they had not been transfused in ≥ three months and were not 
having an acute VOE, suggesting a phenotype of milder severity. A complete blood count test 
was obtained for each patient. The untreated patients average HbF concentrations of 9.6±4.0% 
(range: 0%–18.2%), while HU-treated patients average 34.1% (range: 18.1%-56.1%). 
Reticulocyte percentages average 10.8±2.0% (range: 4.2%-15.7%) for untreated patients and 
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4.1±0.9% (range: 2.3%-6.7%) for HU-treated patients. Healthy volunteers were eligible to 
participate if they did not have a blood disorder or hemoglobinopathy, which was confirmed by 
screening blood samples via hemoglobin electrophoresis. Experiments were performed using 
fresh-drawn, heparin-anticoagulated venous blood. 
 
Red blood cell preparation 
Whole blood was centrifuged at 500g for 10min at 4°C to isolate RBCs. The buffy coat was 
aspirated and discarded. RBCs were washed 3x with Alsever’s solution. RBCs were 
immobilized by incubation on a poly-l-lysine coated glass petri dish for 10min at 37°C and 
unattached RBCs were removed by rinsing. 
 
Reagents 
Human laminin subunit alpha-5 (LAMA5) was obtained from MyBioSource (San Diego, CA), St-
Ht31 inhibitor peptide and St-Ht31P control peptide (reconstituted in Alsever’s solution) were 
obtained from Promega (Madison, WI). Alsever’s solution, forskolin (Coleus forskohli) 
(reconstituted in DMSO), Rp-Adenosine 3’,5’-cyclic monophosphorothioate triethylammonium 
salt (Rp-cAMPS; reconstituted in DMSO), KT-5720 (reconstituted in methanol), epinephrine 
(reconstituted in Alsever’s solution), bovine serum albumin (BSA; reconstituted in PBS) were 
purchased from Sigma Aldrich (St. Louis, MO). 
 
Preparation of LAMA5 probes 
Silicon nitride cantilevers (Bruker Probes, Camarillo, CA) were silanized with 2% v/v 3-
aminopropyltriethoxysilane in acetone (10min), then rinsed with deionized (DI) water and 
immersed in glutaraldehyde (0.5%, 30min). Cantilevers were rinsed with DI water, incubated in 
LAMA5 solution (100μg/mL, 30min), rinsed again, and incubated in BSA (100μg/mL, 5min) to 
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block remaining aldehyde groups. Cantilevers were stored at 4°C and utilized within 48 hours. 
 
Atomic force microscopy assays 
Force-distance curves were recorded between laminin-functionalized probes and BCAM/Lu 
receptors on the RBC surface (Figure 8.3.1A) using the MFP-3D-BIO AFM (Asylum Research, 
Santa Barbara, CA). An unbinding force is defined as the maximum rupture force associated 
with the force-distance curve. A representative curve highlighting regions of the approach and 
retraction cycle is shown in Figure 8.3.1B. On surface regions void of BCAM/Lu receptors, we 
expected the unbinding force to be approximately zero, while unbinding forces are significantly 
higher in regions where the laminin-functionalized cantilever made contact with active BCAM/Lu 
receptors. Unbinding forces were measured on 1μm x 1μm areas of the RBC membrane with a 
lateral resolution of 31.25nm (1024 sampled sites per experiment). To determine the spatial 
distribution of BCAM/Lu receptors on the RBC surface, unbinding forces were plotted as a force 
map (Figure 8.3.1D) using MATLAB (Mathworks) in which the color of each square indicates the 
magnitude of the corresponding unbinding force obtained from an individual curve [30]. 
 
An inverted microscope (Zeiss Axiovert A1) was used to position the AFM cantilever in contact 
with a chosen RBC (Figure 8.3.1C). Chosen RBCs were less than 10µm in diameter and 
exhibited a distinct biconcave shape, suggesting RBC maturity. Experiments were performed in 
Alsever’s solution at 37°C, and biochemical modulators were added at least 30min prior to 
experiments. For each assay, 3 RBCs were tested from each subject’s blood. Values reporting 
“N = ” denote the number of unique donors per condition and “n = ” denote the total number of 
tested cells. Measurements were recorded with a loading rate of 24000pN/s [30]. The nominal 
spring constant of the employed cantilever was 30pN/nm and the exact spring constant value 
was obtained via a thermal noise-based method and used in all calculations [289]. 
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Figure 8.3.1. Measurement of the frequency of active BCAM/Lu surface receptors and the 
unbinding force with LAMA5 on RBCs using AFM. (A) AFM cantilever probe functionalized with 
LAMA5. Illustration corresponds to the force curve shown in (B). (B) Force curve obtained from 
experiments highlighting regions of the approach and withdrawal of the cantilever from the 
sample. When LAMA5 attached to the AFM probe adheres to a BCAM/Lu receptor on the cell, 
the force-displacement curve exhibits an abrupt shift to zero which corresponds to the rupture 
force (red curve). If there is no BCAM/Lu receptor at the detection point and consequently no 
adhesive interaction, then the retraction curve is similar to the black curve. Specific regions are 
as follows: (i) No interaction between the tip and cell; (ii) Functionalized cantilever deflects 
downward towards the cell as a result of van der Waals forces; (iii) Positive deflection of the 
cantilever due to repulsive forces; (iv) Negative deflection of the cantilever tip as a result of 
adhesion forces between the tip and the cell. (C) Representative optical microscopy image 
showing a human RBC and an AFM cantilever probe. (D) Unbinding force maps of single 
normal RBCs (i) in the absence and (ii) presence of bath laminin to mask BCAM/Lu binding 
sites. (iii) Unbinding force maps of single normal RBCs in epinephrine (1μM) show an increase 
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in active BCAM/Lu receptors. Scale bars, 250nm. Color scale as shown. (E) Frequency 
distributions of measured unbinding forces fit with the Gaussian model to obtain the average 
unbinding force and (F) box-whisker plot of the collective frequency of detected BCAM/Lu 
receptors on normal RBCs per experimental condition. Data are presented as median with max 
and min whiskers and the average denoted as (+).The ‘n’ on the x-axis indicates the total 
number of mature RBCs analyzed in each group, obtained from the following numbers of human 
subjects: – Bath laminin: 4 subjects; + Bath laminin, + Epinephrine: 3 subjects. Significance 
relative to – bath laminin is denoted as * such that p<0.05 and ** such that p<0.005 (two-tailed t-
test). 
 
Statistical methods 
Values for the unbinding force between BCAM/Lu and LAMA5 are reported as average ± 
standard deviation (SD) as determined by a frequency distribution fit with the Gaussian model 
(GraphPad Prism). In the frequency (%) distribution, each bin contains the number of unbinding 
forces with values within the bin’s range divided by the total number of sampled sites. We note 
that the frequency of zero force points is not shown since it is much larger than the frequency of 
non-zero force points and would obscure the graphs. Collective frequency (%), denoted CF, is 
defined as the total number of all non-zero force points, without respect to specific unbinding 
forces, divided by the total number of sampled sites for each experimental condition. It is 
reported as average ± standard error of the mean (SEM) and is illustrated by box-whisker plots. 
The collective frequency of active receptors was compared between groups using a one-way 
ANOVA with the Tukey post hoc test, and between two conditions using a two-tailed t-test. 
Results were considered significant if p<0.05. 
 
8.4. Experimental Validation 
Immunofluorescence following probe functionalization 
Immunofluorescence was used to validate cantilever functionalization with LAMA5. Freshly 
prepared cantilevers were incubated (1 hour at 25°C) with anti-LAMA5 antibody (200 μg/mL) 
conjugated to AlexaFluor®488 (EMD Millipore). Fluorescent images were obtained using a 
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Leica TCS SP2 Confocal Microscope (Figure 8.4.1.). Negative controls were produced using the 
specific anti- LAMA5 antibody with non-functionalized probes and with probes functionalized 
with the toxin apamin. 
 
Figure 8.4.1. Immunofluorescence following probe functionalization. 
 
Scan area determination 
To determine the ideal scan area for the detection of active BCAM/Lu receptors, we recorded 
unbinding force maps on 2 μm x 2 μm areas of the RBC membrane with a lateral resolution of 
31.25nm (4096 sampled sites per experiment). Multiple cells (n=10) were scanned from one 
healthy subject. Using a MATLAB script, each 2μm x 2μm binding force map was then divided 
into areas of the following sizes: 1 μm x 1 μm, 500 nm x 500 nm, and 250 nm x 250 nm. 
 
First, the frequency of detected receptors was calculated for each unbinding force map. For 
each cell, the total number of force maps is as follows: 2 μm x 2 μm, n = 1; 1 μm x 1 μm, n = 4; 
500 nm x 500 nm, n = 16; 250 nm x 250 nm, n = 64. The results are illustrated using a box-
whisker plot of the collective frequency of detected BCAM/Lu receptors for each scan size 
(Figure 8.4.2). The ‘n’ on the x-axis indicates the total number of scan areas analyzed in each 
group, obtained from n=10 RBCs from one healthy subject. Using a one-way ANOVA with the 
Tukey post hoc test and Bartlett’s test, we find that differences among the standard deviations 
are statistically significant (p < 0.0001). As expected, there is no difference among the means. 
Analysis was also performed on individual cells, yielding the same result. To validate this result, 
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the D’Agostino-Pearson omnibus test was employed to determine if the collective frequency 
values exhibit normality. It was determined that 500 nm x 500 nm and 250 nm x 250 nm 
unbinding force maps do not exhibit normality (p<0.0001). To make experimental testing more 
efficient, we performed all atomic force microscopy tests on 1μm x 1μm areas of the RBC 
membrane. 
 
Figure 8.4.2. Scan area size determination. Box-whisker plot of the collective frequency of 
detected BCAM/Lu receptors for each scan size. Data are presented as median with max and 
min whiskers. The ‘n’ on the x-axis indicates the total number of scan areas analyzed in each 
group, obtained from n=10 RBCs from one healthy subject. 
 
Specificity of experimental assay 
To determine the specificity of the measured unbinding forces, we performed experiments on 
normal RBCs at baseline and on normal RBCs pre-incubated with laminin.  As shown in Figure 
8.4.3, we found that the frequency of binding force events significantly decreased on RBCs pre-
incubated with laminin (p < 0.01, from 4.23 ± 1.27% to 0.868 ± 0.197%). Furthermore, the 
unbinding force decreased in the presence of bath laminin (from 43.45 ± 9.64 pN to 35.42 ± 
6.72 pN) Events with significant binding forces most likely reflected BCAM/Lu receptors that 
were not bound by bath-applied laminin.  
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Figure 8.4.3. Specificity of unbinding forces. 
 
8.5. Results 
Single-molecule measurement of active BCAM/Lu receptors on normal RBCs 
We first performed experiments on normal RBCs in Alsever’s solution to determine the baseline 
frequency (- bath laminin) of active BCAM/Lu receptors and the unbinding force of BCAM/Lu to 
LAMA5. Figure 8.3.1D(i) shows representative BCAM/Lu-LAMA5 force maps with forces 
detected between 21.66 and 65.39pN. The frequency of non-zero unbinding forces detected on 
normal RBCs is shown in Figure 8.3.1E. By accumulating all of the non-zero unbinding forces 
per cell we obtained the collective frequency, as explained in the methods. The results, 
illustrated using a box-whisker plot, show that unbinding forces were detected in 3.31±0.67% of 
sampled sites (Figure 8.3.1F).     
 
To determine the specificity of measured unbinding forces, we repeated experiments on normal 
samples preincubated with laminin. As shown in Figures 8.3.1D(ii),F, the CF of events detecting 
unbinding forces on RBCs preincubated with laminin (+ bath laminin) was 0.89±0.21%, which is 
significantly lower (p<0.01) than the baseline frequency (- bath laminin, CF: 3.31±0.67%). 
Recorded unbinding forces likely reflected BCAM/Lu receptors that were not bound by bath 
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laminin. To establish that the assay can detect variations in the number of active BCAM/Lu 
receptors, we preincubated RBCs with epinephrine (1μM), a β-AR agonist known to increase 
BCAM/Lu binding to LAMA5, and found that events were detected in 10.27±2.02% of sampled 
sites, a significant increase (p<0.001) in the CF from baseline (Figure 8.3.1D(iii),F). Frequency 
distributions (Figure 8.3.1E) show that while the average unbinding force between BCAM/Lu 
and LAMA5 did not change in these experimental conditions, the frequency of detected events 
changed significantly. Further, the data in Figure 8.3.1F illustrate that the AFM-based assay can 
detect differences in the collective frequency of active BCAM/Lu receptors on normal RBCs at 
baseline and preincubated with laminin or epinephrine. 
 
BCAM/Lu adhesion of normal RBCs to endothelial laminin is PKA-dependent 
Taking advantage of the high-resolution and high-sensitivity of single-molecule AFM, we 
investigated changes in the frequency of active BCAM/Lu receptors on normal and SS-RBCs 
via pharmacologic modulation of the cAMP-PKA pathway. First, we treated normal RBCs with 
forskolin (30μM, FSK), a strong AC activator that stimulates cAMP production, subsequently 
activating PKA. Compared to untreated RBCs, forskolin-treated RBCs exhibited significantly 
more unbinding events as shown by the frequency distribution and box-whisker plots (Figure 
8.5.1A,C; CF: 18.19±4.68%; p<0.001). Previous evidence suggests that the interaction between 
BCAM/Lu and LAMA5 is stimulated significantly by FSK in SS-RBCs but insignificantly in normal 
RBCs [72]. These studies used a FSK concentration (80μM) much higher than that currently 
used (30μM). To understand the discrepancy between ours and previous results, we  
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Figure 8.5.1. Distribution of BCAM/Lu on normal RBCs and unbinding force of BCAM/Lu to 
LAMA5. (A) Unbinding force maps and corresponding unbinding force frequency histograms of 
normal RBCs measured at baseline and after treatment with 30μM FSK, and (B) measured in 
the presence of the PKA inhibitors Rp-cAMPS and KT-5720. (C) Box-whisker plot showing the 
collective frequency of detected BCAM/Lu receptors on normal RBCs for the biochemical 
modulators indicated on the x-axis, presented as in Figure 8.3.1. The ‘n’ on the x-axis indicates 
the total number of mature RBCs analyzed in each group, obtained from the following numbers 
of human subjects: Baseline: 4 subjects; FSK (30μM), Rp-cAMPS, KT-5720: 3 subjects. 
Significance relative to baseline is denoted as * such that p<0.001 (ANOVA, Tukey post hoc 
test).  
 
 
113 
 
used the higher concentration of FSK employed in the previous study [72]. In this case, we 
found that the interaction between BCAM/Lu and LAMA5 was stimulated (data not shown; CF: 
10.10±1.89%, N=3, n=9) significantly more than normal RBCs at baseline (p<0.05), albeit not 
significantly more than those treated with 30μm FSK. It is possible that flow adhesion assays, 
which measure the average adhesion of a large number of erythrocytes to a functionalized-
substrate under flow-induced shear stress, are not sensitive enough to detect increases in the 
overall low adhesion of normal RBCs. 
 
To quantify the effect of PKA inhibition on the frequency of active BCAM/Lu receptors, we 
treated RBCs with Rp-cAMPS (100μM), a strong inhibitor of PKA activation by cAMP. RBCs 
pretreated with Rp-cAMPS exhibited fewer unbinding events (Figure 8.5.1B-C; CF: 1.17±0.47%) 
than normal RBCs at baseline. An apparent decrease in the unbinding force following 
preincubation with Rp-cAMPS compared to baseline results is statistically insignificant. Next, we 
directly inhibited PKA using KT-5720 (1μM) and recorded a decrease in the unbinding event 
frequency (Figure 8.5.1B-C; CF: 2.16±0.41%), albeit not as large as with Rp-cAMPS. Figure 
8.5.1C shows a box-whisker plot summarizing changes in the collective frequency of active 
BCAM/Lu receptors on normal RBCs in response to cAMP-dependent pathway modulation. It is 
clear that there is a significant increase in the collective frequency of active BCAM/Lu receptors 
resulting from 30μM forskolin, demonstrating that our system can detect changes in the 
adhesive properties of human RBCs in response to increases in intracellular cAMP. 
 
SS-RBCs demonstrate greater PKA-dependence of BCAM/Lu adhesion to endothelial 
laminin than normal RBCs 
After establishing our single-molecule AFM technique on normal RBCs and confirming that we 
can detect differences in the frequency of active BCAM/Lu in response to cAMP-dependent  
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Figure 8.5.2. Distribution of BCAM/Lu on SS-RBCs and unbinding force of BCAM/Lu to LAMA5. 
(A) SS-RBCs show a significantly greater number of BCAM/Lu surface receptors than normal 
RBCs at baseline. Measurement after treatment with (B) 30μM FSK, (C) 100μM Rp-cAMPS, 
and (D) 1μM KT-5720 indicate that SS-RBCs behave similar to normal RBCs upon cAMP-PKA 
pathway modulation. (E) Box-whisker plot of the collective frequency of detected BCAM/Lu 
receptors on SS-RBCs for the biochemical modulators indicated on the x-axis. The ‘n’ on the x-
axis indicates the total number of mature RBCs analyzed in each group, obtained from the 
following numbers of human subjects: Baseline: 5 subjects; FSK (30μM), Rp-cAMPS, KT-5720: 
4 subjects. Significance relative to baseline is denoted as * such that p<0.05 and ** such that 
p<0.01 (ANOVA, Tukey post hoc test). 
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pathway modulators, we applied the same experimental approach to SS-RBCs. In agreement 
with previous reports [72, 122], we measured a significant increase in the frequency of 
BCAM/Lu receptors on SS-RBCs (Figure 8.5.2A,E; CF: 8.89±2.05%) as compared to normal 
RBCs (p<0.01). Next, we quantified changes in the frequency of active BCAM/Lu receptors on 
SS-RBCs in response to cAMP-dependent pathway modulation. Following preincubation with 
FSK (30μM), we observed an increase in the CF to 20.56±3.63% on SS-RBCs, which was 
significantly greater than that measured at baseline (Figure 8.5.2E; p<0.01) and similar to that 
observed on normal RBCs (Figure 8.5.2B). Importantly, when treated with Rp-cAMPS, the 
adhesion level of SS-RBCs reduced to that of normal RBCs treated with Rp-cAMPS. However, 
preincubation with KT-5720 (Figure 8.5.2D) did not decrease the BCAM/Lu receptor frequency 
on SS-RBCs to the adhesion level of normal RBCs, but still significantly decreased below the 
baseline measurement to 2.66±1.02% (Figure 8.5.2E; p<0.05). Frequency distributions illustrate 
that the response to modulation of BCAM/Lu on SS-RBCs was analogous to that on normal 
RBCs (Figure 8.5.2B-D). Further, the collective frequency of detected BCAM/Lu receptors was 
highly sensitive to cAMP-dependent pathway modulators (Figure 8.5.2E).  
 
A-kinase anchoring proteins regulate BCAM/Lu adhesion  
After establishing that our assay can detect cAMP-dependent modulation of active BCAM/Lu 
receptors on normal and SS-RBCs, we investigated the possibility of localized BCAM/Lu 
activation via AKAPs [85, 287]. To detect the presence of AKAPs on normal and SS-RBCs, cells 
were treated with St-Ht31 peptide (5μM), which inhibits binding of PKA to AKAPs. Our 
experiments revealed that following pretreatment with St-Ht31, the CF of active BCAM/Lu 
receptors decreased significantly in normal RBCs (Figure 8.5.3A-B; CF: 5.71±1.23% to 
3.15±1.09%; p<0.05) and in SS-RBCs (Figure 8.5.3C-D; CF: 7.19±1.42% to 2.02±0.37%; 
p<0.005). As a negative control, RBCs were pretreated with St-Ht31P control peptide (5μM),  
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Figure 8.5.3. Modulation of BCAM/Lu via AKAPs on the RBC membrane. (A) Measurements in 
5μM St-Ht31 inhibitor peptide demonstrate the presence of AKAPs on normal RBC membranes 
as revealed by the reduction of the frequency of active BCAM/Lu receptors. (B) Box-whisker plot 
of the collective frequency of detected BCAM/Lu receptors on normal RBCs for the biochemical 
modulators indicated on the x-axis, presented as in Figure 8.3.1. The ‘n’ on the x-axis indicates 
the total number of mature RBCs analyzed in each group, obtained from the following numbers 
of human subjects: Baseline, St-Ht31: 5 subjects; St-Ht31P: 4 subjects; St-Ht31 + FSK (30μM): 
3 subjects. Significance relative to baseline is denoted as * such that p<0.05 and ** such that 
p<0.005 (ANOVA, Tukey post hoc test). (C) Measurements in 5μM St-Ht31 inhibitor peptide 
demonstrates the presence of AKAPs on SS-RBC membranes as revealed by the reduction of 
active BCAM/Lu receptors. (D) Box-whisker plot of the collective frequency of detected 
BCAM/Lu receptors on SS-RBCs for the biochemical modulators indicated on the x-axis, 
presented as in Figure 8.3.1. The ‘n’ on the x-axis indicates the total number of mature RBCs 
analyzed in each group, obtained from the following numbers of human subjects: Baseline, St-
Ht31, St-Ht31P, St-Ht31 + FSK (30μM): 4 subjects. Significance denoted as in (B). 
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which did not alter the collective frequency of active BCAM/Lu receptors in normal RBCs (Figure 
8.5.3B; CF: 5.92±1.09%) or in SS-RBCs (Figure 8.5.3D; CF: 6.49±1.27%) as compared to 
baseline measurements. To ensure that AKAP inhibition would block BCAM/Lu receptor 
activation, RBCs were treated with St-Ht31 (5μM) and subsequently with FSK (30μM). On 
normal RBCs, the CF of active BCAM/Lu receptors was measured to be 5.83±1.65% versus 
18.19±4.68% following only FSK stimulation (Figure 8.5.3B; p<0.005). Similarly, on SS-RBCs 
the CF of active BCAM/Lu receptors was measured to be 6.57±1.60% in this case versus 
19.63±3.44% following only FSK stimulation (Figure 8.5.3D; p<0.005). This indicates the 
presence of AKAPs in the RBC membrane and suggests their importance in the mediation of 
RBC cytoadherence to the endothelium in both normal and SS-RBCs. 
 
Hydroxyurea decreases the frequency and the strength of BCAM/Lu-dependent adhesion 
events on SS-RBCs 
Hydroxyurea is currently the only pharmacologic treatment to reduce the frequency of VOEs in 
SCD, yet only two-thirds of patients respond favorably to the drug [74]. The drug has specifically 
been found to inhibit phosphorylation of BCAM/Lu receptors and consequently to decrease SS-
RBC adhesion to laminin [73, 78]. Here, we investigated the quantitative effect of HU treatment 
on the frequency of active BCAM/Lu receptors and on the magnitude of the unbinding force 
between BCAM/Lu and LAMA5, which could be another reason for the reduced adhesion of SS-
RBCs to laminin. Our experiments showed that SS-RBCs from HU-treated patients have a 
significantly lower frequency of active BCAM/Lu receptors than SS-RBCs from untreated 
patients (Figure 8.5.4A; CF: 8.89±2.05% to 2.43±0.51%; p<0.001). Importantly, we also 
detected that the unbinding force between BCAM/Lu and LAMA5 was lower on SS-RBCs from 
HU-treated patients (Figure 8.5.4B; CF: 35.14±7.18pN versus 40.00±8.12pN; p<0.0001). Next, 
the physiologic implication of epinephrine-stimulated adhesion of HU-treated SS-RBCs was 
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studied. We treated SS-RBCs with epinephrine and found that for SS-RBCs from patients 
undergoing HU-treatment, the frequency of BCAM/Lu did not increase significantly. Figure 
8.5.4C shows that while the CF of BCAM/Lu receptors increased significantly following 
treatment with epinephrine on both normal RBCs and untreated SS-RBCs, there was no 
significant increase in hydroxyurea-treated SS-RBCs.  
 
 
Figure 8.5.4. Modulation of the collective frequency of BCAM/Lu receptors on SS-RBCs from 
HU-treated patients. (A) SS-RBCs from HU-treated patients (N=4, n=12) have a significantly 
lower frequency of BCAM/Lu receptors than SS-RBCs from untreated patients (N=5, n=15) and 
healthy subjects (N=4, n=12). (B) Normalized cumulative distribution clearly shows significant 
shift in the unbinding force of BCAM/Lu and laminin on SS-RBCs from HU-treated patients 
(p<0.0001). (C) Preincubation with epinephrine causes a significant increase in the collective 
frequency of BCAM/Lu receptors on both normal RBCs (N=3, n=9) and SS-RBCs from 
untreated patients (N=5, n=15) but not on SS-RBCs from HU-treated patients (N=4, n=12). 
Significance is denoted as * such that p<0.05 and ** such that p<0.005 as computed using the t-
test. 
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8.6. Discussion 
In this work, we established a technique, based on AFM, which enables the detection of single 
BCAM/Lu molecules on the RBC surface and measures the unbinding force between BCAM/Lu 
and LAMA5. The technique is used to study the effect of the cAMP signaling pathway on the 
activation of BCAM/Lu receptors at the single-molecule level. Importantly, we demonstrate that 
AKAPs are essential for BCAM/Lu receptor activation, and that the collective frequency of 
BCAM/Lu receptors, present on both the normal and SS-RBC membrane, is critically dependent 
on the cAMP pathway. Lastly, we found that SS-RBCs from hydroxyurea-treated patients have 
a lower frequency of active BCAM/Lu receptors than SS-RBCs from untreated patients, and 
undergo insignificant stimulation by epinephrine. We also demonstrated that the unbinding force 
between BCAM/Lu and LAMA5 in hydroxyurea-treated patients is lower than in untreated 
patients. 
 
cAMP-dependent modulation of BCAM/Lu on normal RBCs 
We first determined how the frequency of active BCAM/Lu receptors changes in response to 
cAMP signaling. Forskolin activates AC which raises levels of cAMP and subsequently activates 
the cAMP-dependent pathway. Normal RBCs treated with FSK (30μM) showed an increase in 
the frequency of active BCAM/Lu receptors significantly above baseline, in accordance with 
established cAMP-dependent pathway modulation. However, previous studies based on flow 
adhesion assays showed that adhesion of normal RBCs via BCAM/Lu is not mediated 
significantly by forskolin, likely due to low levels of intracellular cAMP [72]. In contrast, our 
results indicate that normal RBC adhesion to LAMA5 via the BCAM/Lu receptor is significantly 
modulated by the cAMP-dependent pathway. This difference is due to two reasons. First, 
previous studies used a forskolin concentration of 80μM, which is more than 2x greater than the 
concentration we initially employed (30μM). When normal RBCs were treated with 80μM FSK, 
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the frequency of active BCAM/Lu receptors did not increase as significantly above the baseline 
as in the case of 30μM FSK. This suggests that high concentrations of FSK may desensitize 
BCAM/Lu to cAMP-dependent pathway signaling, as shown for the ICAM-4 receptor on RBCs 
and signaling receptors on other cell types [249, 290-291]. Second, because the adhesiveness 
of normal RBCs is low, the high-sensitivity of AFM allows for a more precise detection of active 
adhesion receptors than traditional flow adhesion assays. We also note that flow adhesion 
assays did not detect adhesion of non-stimulated normal RBCs to laminin [72-73]. 
 
cAMP-dependent modulation of BCAM/Lu on SS-RBCs 
While the pathway by which cAMP mediates BCAM/Lu receptor activation is well-established, 
the possibility that AKAPs are involved in the localization of cAMP close to the RBC membrane 
has not been investigated. In the current work, we used specific biochemical modulators to 
investigate the subcellular targeting of the cAMP-dependent PKA [79]. PKA activity can be 
mediated by AKAPs, which sequester PKA to specific subcellular sites through binding to its 
regulatory subunits [85, 287, 292]. Each AKAP contains two classes of binding sites: an 
anchoring motif, which binds to the regulatory subunit of PKA, and a targeting domain, which 
directs the subcellular localization of the PKA-AKAP complex through association with structural 
proteins, membranes, or other cell elements [287]. BCAM/Lu-mediated SS-RBC adhesion to 
LAMA5 is activated by the phosphorylation of serine 621 in the BCAM/Lu cytoplasmic domain, 
but this phosphorylation does not occur as readily in normal RBCs [83]. We conjecture that this 
is due to the presence of more PKA-AKAP complexes in SS-RBCs, and resultant AKAP 
assistance in the phosphorylation of BCAM/Lu on RBCs. Also, because protein activation is 
highly selective despite the high cAMP diffusion constant of 270-280 μm2/s, it is likely that the 
cAMP is compartmentalized [293-294] and has a basal effect on normal RBCs which only 
requires increases in cAMP near the membrane. This may explain why we detected modulation 
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of BCAM/Lu via the cAMP-dependent pathway despite low levels of cAMP in normal RBCs [72]. 
 
Hydroxyurea reduces the adhesion of SS-RBCs via the BCAM/Lu receptor 
Hydroxyurea, a pharmacologic treatment for SCD VOEs, is known to stimulate an increase in 
HbF [75-76] synthesis, and may also alter RBC signaling [73, 77-78]. The drug has been found 
to decrease SS-RBC adhesion to laminin [73, 78], although it increases BCAM/Lu surface 
expression [73, 288]. Hillery et al. [78] first demonstrated that RBCs from SCD patients 
receiving HU undergo a decrease in adhesion to laminin. Recently it was shown that although 
BCAM/Lu receptor expression is increased on SS-RBCs from HU-treated patients, SS-RBC 
adhesion to laminin is decreased because of inhibition of cAMP phosphorylation [73, 288]. In 
our experiments, we measured a lower frequency of active BCAM/Lu receptors on SS-RBCs 
from HU-treated patients versus SS-RBCs from untreated patients. In addition, AFM 
measurements revealed a lower unbinding force between BCAM/Lu on SS-RBCs from HU-
treated patients with LAMA5 as compared to untreated patients. The lower unbinding force 
between BCAM/Lu and LAMA5 in conjunction with the lower frequency of active BCAM/Lu 
receptors on SS-RBCs from HU-treated patients demonstrate the beneficial effect of HU in 
reducing SS-RBC adherence to LAMA5, a mechanism thought to be critical to VOE genesis. 
 
To determine the physiological implications of cAMP-stimulated adhesion of HU-treated RBCs, 
we preincubated SS-RBCs from untreated and HU-treated patients with epinephrine, a hormone 
released during stress and known to stimulate the β2-AR [30, 72]. Our results indicate that 
epinephrine does not significantly increase the frequency of active BCAM/Lu receptors on the 
surface of SS-RBCs from HU-treated patients. Further, because we did not detect a difference 
in the unbinding force or the receptor frequency, we conjecture that HU modifies the β2-AR 
pathway thereby reducing the ability for epinephrine-stimulation. Consistent with previous 
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studies related to the phenotypic variability of SCD [72], we also found that the patient response 
to epinephrine was variable.  
 
A determinant of clinical phenotype in SCD is the adhesive property of RBCs, defined by the 
subcellular density and distribution of adhesion receptors, and the unbinding force associated 
with specific ligands. In this work, single-molecule AFM was employed to quantify the response 
to cAMP-dependent pathway modulation via measurement of specific ligand-receptor unbinding 
forces and the CF of active adhesion receptors on the RBC. Importantly, we detected the 
presence of AKAPs on the membrane of both normal and SS-RBCs, and revealed that these 
proteins play a significant role in the modulation of BCAM/Lu via the cAMP pathway. Lastly, we 
demonstrated that HU-treatment reduces the ability for stimulation by epinephrine suggesting 
that HU modifies the β2-pathway. The study shows new, important implications for AFM 
cytoadhesion assays in evaluating the pharmacologic response of adhesion receptors on RBCs.  
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Chapter 9. Single-Cell Force Spectroscopy as a Technique to Quantify Human 
Red Blood Cell Adhesion to Subendothelial Laminin 
 
9.1. Abstract 
Single-cell force spectroscopy (SCFS), an atomic force microscopy (AFM)-based assay, 
enables quantitative study of cell adhesion while maintaining the native state of surface 
receptors in physiological conditions. Human healthy and pathological red blood cells (RBCs) 
express a large number of surface proteins which mediate cell-cell interactions, or cell adhesion 
to the extracellular matrix. In particular, RBCs adhere with high affinity to subendothelial matrix 
laminin via the basal cell adhesion molecule and Lutheran protein (BCAM/Lu). Here, we 
established SCFS as an in vitro technique to study human RBC adhesion at baseline and 
following biochemical treatment. Using blood obtained from healthy human subjects, we 
recorded adhesion forces from single RBCs attached to AFM cantilevers as the cell was pulled-
off of substrates coated with laminin protein. We found that an increase of the overall cell 
adhesion measured via SCFS is correlated with an increase in the resultant total force 
measured on 1 µm2 areas of the RBC membrane. Further, we showed that SCFS can detect 
significant changes in the adhesive response of RBCs to modulation of the cyclic adenosine 
monophosphate (cAMP) and protein kinase A (PKA) pathway. Lastly, we identified variability in 
the RBC adhesion force to laminin amongst the human subjects, suggesting that RBCs maintain 
diverse levels of active BCAM/Lu adhesion receptors.  By using single-cell measurements, we 
established a powerful new method for the quantitative measurement of the adhesion of single 
RBCs with specific receptor-mediated binding. 
 
9.2. Introduction 
Although red blood cells (RBCs) are generally considered to be relatively inactive due to their 
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lack of a nucleus and other organelles, they express several surface adhesion receptors which 
modulate cellular function [62]. Many of these receptors mediate cell-cell interactions, or 
adhesion, on both healthy and pathological RBCs. Knowledge of cytoadhesion is necessary to 
understand normal physiology, the pathophysiology of disease, and the cellular-level effects of 
pharmacotherapies. Atomic force microscopy (AFM) [89] has introduced a wide range of novel 
approaches for imaging and manipulating biological systems in their native environment [132, 
144, 157, 286, 295-296]. AFM allows for measurements of native biological samples under 
physiological conditions [30, 92] while avoiding complex sample preparation procedures and the 
artifacts accompanying them. In this paper, we present single-cell force spectroscopy (SCFS) 
as a new tool [130, 134-135] which enables the quantitative study of RBC adhesion while 
maintaining surface receptors in their native state. The technique is performed by measuring the 
adhesion between a single RBC attached to an AFM cantilever and a surface coated with either 
purified proteins or other cells. 
 
In the past, RBC adhesion was traditionally investigated via large-scale flow adhesion assays 
[122-125], which measure the average adherence of a large number of RBCs to a 
functionalized-substrate under flow-induced shear stress [126-127]. These measurements 
provide only estimates of the adhesion force to which cells are subjected because the shear 
force exerted on cells depends on parameters such as cell size and shape, as well as the 
viscoelastic and elastic properties of the cells [128-130]. For example, it is known that RBCs 
from sickle cell disease (SCD) patients show variability in their viscoelastic and elastic 
properties [100, 119], and these properties can change after biochemical or pharmacologic 
treatment [87]. Further, flow adhesion assays are unable to provide information regarding 
receptor activity, including detachment forces, receptor localization, and changes in the number 
of active receptors upon biochemical stimulation. To obtain more controlled and quantitative 
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measurements of RBC adhesion, single-molecule and single-cell methods must be employed. 
 
AFM studies of RBC adhesion have been utilized to provide quantitative evidence of changes in 
surface receptor distribution and values for the unbinding forces with specific ligands [30]. A 
technique known as single-molecule force spectroscopy (SMFS) utilizes cantilever tips 
functionalized with specific ligands to probe the cell surface. SMFS measures the unbinding, or 
detachment force, between a specific ligand on the AFM tip and its corresponding receptor on 
the membrane of a single cell with piconewton sensitivity [30, 91-92, 131-132]. Because SMFS 
is broadly used in conjunction with optical microscopy, the user has the ability to choose a RBC 
of interest for measurements. SMFS operates by collecting a set of force-distance curves of the 
approach-retract cycle of the functionalized tip from the cell surface. Specifically, the retraction 
curve, obtained when the functionalized probe pulls away from the RBC surface, gives the 
detachment force. Individual approach/retract curves can be obtained at many points on a RBC 
surface to create a two-dimensional map of detected surface adhesion receptors [30, 297]. 
Forces probed by SMFS reflect interactions between molecules [91]. Specifically, this technique 
allows for (i) quantifying the detachment force of specific receptor-ligand bonds, (ii) mapping the 
distribution of active receptors on cellular surfaces with high resolution, and (iii) calculating the 
density of active receptors on the cell surface [94, 96-98]. While SMFS is a very powerful 
technique to study RBC adhesion at the single-molecule level, it cannot provide the overall 
adhesion of a living cell to a substrate or to another living cell. Further, it is currently unknown 
how SMFS measurements compare to whole cell measurements. 
 
To overcome these limitations, SCFS assays which use a living cell as a probe were developed 
[130, 134-138]. This AFM-based method is highly versatile because of its ability to measure a 
wide range of forces, from ~5 pN to ~100 nN [130]. In SCFS, a RBC attached to an AFM 
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cantilever is positioned above a functionalized substrate or another living cell. Similar to SMFS 
measurements, SCFS also records force-distance curves of an approach/retract cycle between 
the RBC probe and the functionalized substrate or cell. The RBC is lowered onto the substrate 
until a preset contact force is reached, and then held stationary for a defined time. 
Subsequently, the cell is withdrawn from the substrate at a constant speed and bonds between 
the cell and substrate break until the two entities are completely separated. In this case, the 
maximum detachment force is characterized as the force required to fully disengage the RBC 
from the functionalized substrate.  
 
The adhesion of single RBCs is central to disease pathology. In this work, we established the 
technique of single-cell force spectroscopy as a method to probe RBC adhesion, specifically 
with subendothelial laminin proteins. Importantly, we found a significant correlation between 
SMFS measurements and SCFS measurements. To our knowledge, these two measurement 
techniques had not been directly compared until now. Finally, we showed that SCFS can detect 
significant changes in the adhesive response of RBCs to modulation of the cyclic adenosine 
monophosphate (cAMP) pathway. Based on these measurements, we identified variability in the 
RBC adhesion force to laminin amongst the human subjects, suggesting that RBCs maintain 
diverse intracellular levels of tonic protein kinase A (PKA). This is especially important in the 
case of blood pathologies in which specific blood cell adhesion receptors are targeted for anti-
adhesive therapies, suggesting that individual treatment remedies may be needed. 
 
9.3. Methods 
Human subjects, blood samples, and blood preparation 
Healthy volunteers at least 18 years old were eligible to participate in this study if they did not 
have a blood disorder or hemoglobinopathy, which was confirmed by screening blood samples 
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via complete blood count and hemoglobin electrophoresis. This study was approved by the 
Institutional Review Boards of the UCONN Health Center and UCONN-Storrs. Written informed 
consent was obtained from all subjects. Whole blood was centrifuged at 500g for 10min at 4°C 
to isolate the RBCs. The buffy coat and plasma were discarded and RBCs were washed 3x with 
Alsever’s solution. 
 
Reagents 
Alsever’s solution, laminin, glutaraldehyde, biotinamido-caproyl-labeled bovine serum albumin 
(biotin-BSA, reconstituted in PBS), streptavidin (reconstituted in PBS), biotinylated concanavalin 
A (ConA, reconstituted in PBS), 3-aminopropyltriethoxysilane (APTES, reconstituted in 
acetone), forskolin (Coleus forskohli, reconstituted in DMSO), KT-5720 (reconstituted in 
methanol), epinephrine (reconstituted in Alsever’s solution), bovine serum albumin 
(reconstituted in PBS), were purchased from Sigma Aldrich (St. Louis, MO). Anti-laminin-5 
antibody conjugated to AlexaFluor®488 was obtained from EMD Millipore (Billerica, MA). BCAM 
protein was obtained from Novus Biologicals (Littleton, CO). 
 
Surface coating with laminin 
Clean glass petri dishes (Ted Pella, Inc., Redding, CA) were divided using a hydrophobic PAP 
pen (Sigma Aldrich, St. Louis, MO) enabling us to separate RBCs from the laminin surface 
(Figure 9.3.1a). One half of the glass surface was silanized with 2% v/v 3-APTES for 10min, 
then rinsed with deionized (DI) water and treated with 0.5% glutaraldehyde for 30min. Surfaces 
were rinsed with DI water, incubated in laminin solution for 30min, rinsed again, and incubated 
in bovine serum albumin (100μg/mL) for 5min to block remaining aldehyde groups. Dishes were 
prepared on the same day of use.  
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Preparation of cantilevers 
Tipless silicon nitride AFM cantilevers (NanoWorld, Neuchâtel, Switzerland) were cleaned in 
ethanol and thoroughly rinsed with DI water. Cantilevers were then soaked in acetone for 5min, 
and UV irradiated for 15min. Next, cantilevers were incubated overnight in 0.5 mg/ml biotin-BSA 
at 37°C. After rinsing with PBS, cantilevers were fixed in 1% glutaraldehyde for 30s. Cantilevers 
were rinsed again, then incubated in 0.5 mg/ml streptavidin for 10min at 25°C, rinsed, and finally 
incubated in 0.5 mg/ml biotinylated Con A (in PBS) for 10min at room temperature. 
 
Silicon nitride cantilevers (Bruker Probes, Camarillo, CA) for single-molecule experiments were 
functionalized with BCAM protein as follows. Cantilevers were silanized with 2% v/v APTES for 
10min, then rinsed with DI water and immersed in 0.5% glutaraldehyde for 30min. Cantilevers 
were rinsed with DI water, incubated in BCAM solution (100μg/mL) for 30min, rinsed again, and 
incubated in bovine serum albumin (100μg/mL) for 5min to block remaining aldehyde groups. 
Cantilevers were stored at 4°C and utilized within 48 hours. 
 
Cell capture and experimental setup 
Cells were allowed to weakly bind to the non-functionalized region of the glass substrate via 
incubation at 37°C for 10min followed by rinsing with Alsever’s solution. This gentle 
immobilization on the glass substrate allowed for engagement of the tipless cantilever on a 
chosen RBC. Single cells were captured by positioning the ConA-functionalized cantilever 
above the center of a cell (Figure 9.3.1a) and gently lowering it onto the cell for ~30 s with a 
contact force of 1nN. Cells were precisely attached at the very end of the tipless cantilevers 
(Figure 9.3.1c) to prevent the cantilever surface (incubated with ConA) from interacting with the 
laminin substrate. The cell was lifted from the surface and allowed to establish firm adhesion on 
the cantilever for 1min before being moved to the laminin-functionalized area of the glass dish. 
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Figure 9.3.1. Measurement of red blood cell adhesion to subendothelial matrix laminin using 
single-cell force spectroscopy. (a) The apex of a tipless ConA-functionalized AFM cantilever is 
positioned above a RBC. It is then gently pushed (~1 nN) for 30 s onto the cell. The cantilever-
bound RBC is separated from the substrate and allowed to establish firm adhesion to the 
cantilever for 1 min. The cantilever is then slowly moved to the functionalized segment of the 
petri dish to perform adhesion measurements. (b) Representative force-distance curves 
obtained from experiments for an RBC probing a laminin substrate. The measured detachment 
forces are 0.64 nN in the first curve which shows a single rupture and 1.06 nN in the second 
curve which shows multiple rupture events. (c) Optical microscopy image showing a human 
RBC attached to the apex of a ConA-functionalized cantilever. 
 
AFM setup for SCFS 
SCFS experiments were conducted using the MFP-3D-BIO AFM (Asylum Research, Santa 
Barbara, CA) mounted on an inverted optical microscope (Zeiss Axiovert A1). The nominal 
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spring constant of the employed cantilever was 80 mN/m and the effective spring constant was 
obtained via a thermal noise-based method prior to cell capture and used in all calculations 
[289]. The effective cantilever stiffness was lower than then nominal spring constant for each 
functionalized cantilever, as expected [298-299]. All experiments were performed in Alsever’s 
solution at 37°C, and biochemical modulators were added 30min prior to experiments. For each 
assay, 5 RBCs were tested from each subject’s blood. Values reporting “N = ” denote the 
number of unique donors per condition and “n = ” denote the total number of tested cells. 
 
Each measuring session involved testing a single RBC probe attached to a previously calibrated 
cantilever for 100 approach/retraction cycles on a laminin-functionalized glass substrate. As 
monitored by optical microscopy, the captured cells rarely detached from the cantilever during 
pulling. Tests were performed with a preset trigger force of 500 pN. After the approach and a 
contact time of 0.1 s (unless otherwise noted), the cantilever was retracted at 800 nm/s until the 
RBC completely detached from the laminin substrate. Recorded force-distance curves were 
used to determine the detachment force of the RBC from the laminin substrate. A detachment 
force is defined as the maximum rupture force associated with the force-distance curve. Two 
representative curves are shown in Figure 9.3.1b. A relatively high number of curves exhibited 
single rupture events, as shown in the first curve. The experiments also resulted in curves 
compatible with multiple rupture events as shown in the second curve.  
 
Statistical methods 
Values for the detachment forces are reported as average ± standard deviation (SD) as 
determined by a frequency (%) distribution fit with the Gaussian function (GraphPad Prism). In 
the frequency (%) distribution, each bin contains the number of detachment forces with values 
within the bin’s range divided by the total number of approach/retraction cycles. For SMFS, 
131 
 
frequency (%) is defined as the total number of all non-zero force points divided by the total 
number of sampled sites for each experimental condition. It is reported as average ± standard 
error of the mean (SEM). 
 
9.4. Results and Discussion 
Surface density of laminin for functionalized substrates 
To obtain the experimental parameters used in our SCFS assay, we first needed to determine 
the appropriate solution concentration of laminin to be used for functionalization of the glass 
substrate. SMFS experiments were performed using a BCAM-functionalized probe against a 
laminin substrate. Substrates were prepared with various solution concentrations of laminin (1 
µg/ml, 5 µg/ml, 10 µg/ml, 25 µg/ml, 50 µg/ml, and 100 µg/ml) and three 1 µm x 1 µm areas of 
each substrate were scanned with a lateral resolution of 31.25 nm yielding a total of 3072 
measurements for each laminin solution concentration.  
 
The average detachment force of BCAM with laminin was nearly constant across all solution 
concentrations, measuring 105 ± 11 pN (Figure 9.4.1a,b). Interestingly, this detachment force 
was approximately double what our lab had previously measured for the inverse interaction 
between BCAM on the RBC and laminin on the AFM probe using SMFS [30, 300]. In this case, 
we conjectured that more BCAM proteins attached to the AFM tip make contact with multiple 
laminin proteins on the substrate. BCAM proteins are approximately 6nm [301-302], whereas 
laminin is a cruciform structure with four arms of lengths ranging between 40 nm and 80 nm 
[303], therefore it is possible for multiple BCAM proteins to attach to multiple laminin binding 
sites. Upon functionalizing a substrate with BCAM and measuring the detachment force using a 
laminin-functionalized probe, we confirmed that the bond force is 43 ± 13 pN, in agreement with 
our previous measurements (Figure 9.4.1a).  
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For laminin-functionalized substrates, the percentage of sampled sites where a detachment 
force was detected increased with higher laminin concentrations (Figure 9.4.1c; 1 µg/ml: 35.22 ± 
6.28%; 5 µg/ml: 60.19 ± 5.47%; 10 µg/ml: 51.66 ± 6.45%; 25 µg/ml: 73.21 ± 7.63%; 50 µg/ml: 
63.93 ± 7.09%; 100 µg/ml: 71.13 ± 2.53%; p < 0.01, one-way ANOVA with Tukey post hoc). 
Variability reflects different substrate and probe preparations. To determine background noise, 
measurements were recorded on a substrate in which the laminin functionalization step was 
omitted (0 µg/ml). For the 0 µg/ml laminin substrate, interactions were detected in 4.1 ± 0.65% 
of sampled sites. The substrate density appeared to reach a plateau at 25 µg/ml, suggesting 
that 25 µg/ml, 50 µg/ml, or 100 µg/ml were suitable for our assay. 
 
We next determined the effect of different laminin solution concentrations on the adherence of 
RBC probes to the laminin substrate. RBCs were attached to ConA-functionalized tipless AFM 
cantilevers (Figure 9.3.1a,c). Five cells from each healthy human subject were used as a probe 
and pressed onto laminin substrates with a contact time of 0.1 s and the cantilever was 
subsequently retracted until the cell was completely detached from the laminin substrate. 
Background noise was quantified by using a RBC to probe a substrate in which the laminin step 
was omitted from the functionalization procedure. Small forces of 73 ± 23 pN were detected in 
25.70 ± 7.43% of sampled curves. The specificity of the interaction is demonstrated by 
performing experiments in a bath solution of 100 μg/mL laminin, thus blocking the BCAM/Lu 
receptors prior to interaction with the laminin functionalized substrate. By recording 
approach/retraction cycles between RBC probes and a substrate functionalized with 50 µg/ml 
laminin, the number of curves showing detachment forces dramatically reduced from 88% to 8% 
(p < 0.0001, Figure 9.4.1d). Further, detachment forces recorded in bath laminin decreased five-
fold, from 511 ± 216 pN to 106 ± 23 pN (p < 0.0001) reflecting bath laminin bound to many 
BCAM/Lu receptors and thereby significantly reducing the propensity for binding of the RBC 
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probe to the laminin substrate. 
 
 
Figure 9.4.1. Determination of laminin solution concentration to be employed in SCFS assay. 
(a) Frequency distributions obtained from SMFS experiments of measured detachment forces 
between (i) a substrate coated with laminin (50 µg/ml) and a BCAM/Lu probe, and (ii) a 
substrate coated with BCAM (50 µg/ml) and a laminin probe. (b) Plot of the average detachment 
force measured at each tested laminin solution concentration shows the values are nearly 
consistent (1 µg/ml: 111 ± 33 pN; 5 µg/ml: 116 ± 41 pN; 10 µg/ml: 114 ± 46 pN; 25 µg/ml: 129 ± 
93; 50 µg/ml: 78 ± 34 pN; 100 µg/ml: 100 ± 38). (c) Plot of the substrate density measured at 
each tested laminin concentration shows that the density appears to reach a plateau at 25 µg/ml 
(1 µg/ml: 35.22 ± 6.28%; 5 µg/ml: 60.19 ± 5.47%; 10 µg/ml: 51.66 ± 6.45%; 25 µg/ml: 73.21 ± 
7.63%; 50 µg/ml: 63.93 ± 7.09%; 100 µg/ml: 71.13 ± 2.53%; p < 0.01, one-way ANOVA with 
Tukey post hoc). (d) Frequency distributions obtained from SCFS experiments of detachment 
forces between a RBC probe and laminin substrate (50 µg/ml) measured in the (i) absence and 
(ii) presence of bath laminin. The significant reduction in the number of curves showing 
detachment forces, from 99% to 8% (p < 0.0001) demonstrates the specificity of the 
measurements. (e) Plot of mean detachment force for human RBC probes (N=2, n=10) at each 
laminin solution concentration. Detachment forces were found to increase with higher laminin 
concentrations (1 µg/ml: 97 ± 49 pN; 5 µg/ml: 100 ± 49 pN; 10 µg/ml: 205 ± 79 pN; 25 µg/ml: 
245 ± 142 pN; 50 µg/ml: 511 ± 216 pN; 100 µg/ml: 479 ± 118 pN; p < 0.0001), appearing to 
plateau at the 50 µg/ml concentration. (f) Plot of RBC binding frequency shows an increase in 
binding as laminin substrate concentration increases (1 µg/ml: 51.16 ± 13.31%; 5 µg/ml: 66.01 ± 
5.43%; 10 µg/ml: 96.04 ± 2.97%; 25 µg/ml: 65.02 ± 10.91%; 50 µg/ml: 87.46 ± 1.78%; 100 
µg/ml: 72.11 ± 10.90%; p < 0.0001). 
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After confirming the specificity of the measured interaction, RBC probes were used to record 
forces against each laminin substrate. Detachment forces were found to increase with higher 
laminin solution concentrations (1 µg/ml: 97 ± 49 pN; 5 µg/ml: 100 ± 49 pN; 10 µg/ml: 205 ± 79 
pN; 25 µg/ml: 245 ± 142 pN; 50 µg/ml: 511 ± 216 pN; 100 µg/ml: 479 ± 118 pN; p < 0.0001), 
appearing to stabilize around the 50 µg/ml concentration (Figure 9.4.1e). For the 50 µg/ml 
concentration, we obtained force curves characterized by maximal detachment forces up to 3.4 
nN. In contrast, the 1, 5, 10, and 25 µg/ml concentrations resulted in maximal detachment 
forces of less than 2.2 nN reflecting the need for a denser laminin concentration on the 
substrate to maximize BCAM/Lu receptor binding. These detachment force values are 
comparable to those observed for RBCs in other experiments [136]. Moreover, the frequency of 
RBC binding to the laminin substrate, or the percentage of approach/retract cycles which 
recorded detachment forces, also increased with higher laminin concentrations (Figure 9.4.1f) 
confirming the need for a higher density of laminin (1 µg/ml: 51.16 ± 13.31%; 5 µg/ml: 66.01 ± 
5.43%; 10 µg/ml: 96.04 ± 2.97%; 25 µg/ml: 65.02 ± 10.91%; 50 µg/ml: 87.46 ± 1.78%; 100 
µg/ml: 72.11 ± 10.90%; p < 0.0001).  
 
From the experiments employed to determine the appropriate solution concentration of laminin 
to be used for substrate functionalization, and the effect of different concentrations on RBC 
detachment forces, we found that detachment forces appear to reach a plateau at the 50 µg/ml 
laminin concentration (Figure 9.4.1e), whereas the surface density detected via SMFS appears 
to reach a plateau at the 25 µg/ml laminin concentration (Figure 9.4.1c). Tethered polymer 
layers are comprised of polymer molecules attached to a surface, with a density high enough 
that the chains must stretch away from the surface [304-305]. By maximizing the brush height, 
the free-energy cost per chain is minimized, thus minimizing the strength of repulsion between 
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chains. This situation may have a large effect on the binding of tested cells and molecules to 
proteins attached to a surface. The surface distribution of a tethered polymer layer can be 
characterized by the distance between attachment points,  . As   approaches the radius of 
gyration,   , of the polymer chain, the molecules interact and the polymer layer structure 
gradually passes from the single-chain (mushroom) regime to the brush regime. In the 
'mushroom' regime the reduced tethered density,       
 , where        , is Σ < 1, the 
'mushroom-to-brush' transition regime occurs for 1 < Σ < 5, and the transition to 'brush' regime 
occurs at Σ = 5. The value Σ = 1 corresponds to           [306]. For the case of laminin, 
where          [307-308], the 'mushroom' regime appears for           and the 
transition to 'brush' regime occurs at                  [306]. Because the lateral step 
size was 31.25 nm during our SMFS experiments, after we reach the first transition point, from 
'mushroom' to 'mushroom-to-brush' regime, it is difficult to distinguish between different surface 
densities. Based on Figure 9.4.1c, we conjecture that the transition point was reached at 
approximately 25 µg/ml laminin solution concentration. This conclusion is reinforced by the fact 
that the binding frequency for SCFS experiments plateau at the same laminin concentration (25 
µg/ml), meaning that at this concentration, most of the substrate is covered with laminin chains 
in the 'mushroom' form. We found however, that the detachment force reaches a plateau at 
approximately 50 μg/ml solution concentration, meaning that the binding between all active RBC 
adhesion receptors and laminin molecules reaches equilibrium at this concentration. We 
conjecture that this is the second transition point, from 'mushroom-to-brush' to 'brush' regime, 
and determined the corresponding concentration of 50 μg/ml to be most suitable for SCFS 
assays of human RBCs.  
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Figure 9.4.2. Human RBC adhesion to laminin substrates (50 µg/ml) at increasing contact times 
(N=2, n=10). (a) Frequency distributions show that the mean detachment force for RBCs from 
laminin substrates are the same for 0.1 s and 5 s contact times, however the range of measured 
detachment forces increases. (b) Plot shows that the mean detachment force does not 
significantly change with increasing contact time, however the deviation increases (0.1 s: 0.70 ± 
0.28 nN; 1 s: 0.68 ± 0.28 nN; 2.5 s: 0.65 ± 0.35 nN; 5 s: 0.70 ± 0.49 nN; 10 s: 0.74 ± 0.43 nN). 
 
Dependence of BCAM/Lu-mediated RBC adhesion on contact time 
To investigate the time dependence of cell adhesion formation in more detail, we varied the 
contact time of RBCs with 50 µg/ml laminin substrates between 0.1 and 10 s and determined 
the respective detachment forces. It should be noted that the maximal contact time that can be 
achieved with our AFM system is 10 s. For each contact time interval, 5 cells were analyzed and 
100 approach/retraction cycles were recorded per cell at each interval. For the 0.1 s contact 
time, RBCs required forces of several hundred piconewtons for laminin detachment (Figure 
9.4.2a). As the contact time increased to 10 s, we recorded a minor increase in the mean 
detachment forces (Figure 9.4.2b), however the range of forces increased significantly, with a 
maximal detachment force of 3.3 nN at 0.1 s and 13.7 nN at 10 s. Because the result is similar 
across the different time scales, we opted to use the 0.1 s contact time for experimental 
convenience. At higher time scales, the RBC had a greater probability to detach from the probe 
prior to the completion of 100 approach/retraction cycles leading to experimental failure. 
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Increases in SCFS detachment forces correlates with increases in total forces recorded 
by SMFS on 1 µm2 membrane regions 
To determine the relationship between single-molecule measurements and single-cell 
measurements, we performed both assays using 5 cells from healthy human subjects (N = 3). In 
contrast to SMFS experiments, which probe specific receptor-ligand adhesion events on a small 
area on the cell membrane with high resolution, SCFS obtains the detachment force of cell 
probes from a functionalized substrate, or another cell. The method of SCFS is more readily 
comparable to flow adhesion assays, which measure the average adhesion of a large number of 
RBCs to a functionalized-substrate under flow-induced shear stress. Further, the measurements 
of SCFS are able to specifically quantify the detachment of cells from endothelial proteins found 
in capillaries and blood vessels, giving substantial insight into cytoadhesion events in the body. 
 
SMFS experiments probed 1 µm x 1 µm areas of the RBC surface with a lateral resolution of 
31.25 nm, enabling us to measure single-rupture events. The details of the technique along with 
the protocols we follow and the calibration tests are explained elsewhere [30, 300]. For the 
SCFS assay, RBCs probed a laminin-functionalized substrate (50 µg/ml laminin solution 
concentration) with a contact time of 0.1 s. For comparison of SMFS to SCFS, the resultant total 
force associated with each 1 µm x 1 µm membrane area was calculated as the product of the 
frequency of detected events and the mean detachment force. For example, an area with a 
mean detachment force of 39.51 pN detected in 2.83% of sampled sites yields a total force of 
1.15 nN, while an area with a mean detachment force of 46.98 pN detected in 3.52% of 
sampled sites yields a total force of 1.69 nN. Resultant total forces measured on 1 µm x 1 µm 
areas of the RBC ranged from 0.77 nN to 3.92 nN (Figure 9.4.3a). In contrast, detachment 
forces obtained between single RBCs with a laminin substrate were lower, averaging 0.61 ± 
0.27 nN and ranging from 0.24 nN to 1.38 nN (Figure 9.4.3a). The mean detachment force for 
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an entire RBC corresponds to the simultaneous formation of approximately 15-20 active bonds 
between BCAM/Lu molecules expressed on the RBC surface and laminin added to the 
substrate. This was calculated by dividing the average single cell detachment force by the 
average single-molecule detachment force, where the detachment force of one BCAM/Lu 
receptor from laminin is taken to be 40.24 pN, as determined by fitting the Gaussian model to a 
frequency (%) distribution of all SMFS measured detachment forces. 
 
Since multiple cells (n = 5) were tested from each subject (N = 3), detachment forces could be 
compared between subjects. The Pearson correlation test was used to determine the strength 
of relationship between single-molecule and single-cell force spectroscopy assays (Figure 
9.4.3b). We found that SMFS total force (1 µm x 1 µm area) correlated strongly with the whole 
cell force obtained via SCFS (Pearson correlation test; r = 0.96, R2 = 0.93). Due to the fact that 
SCFS measurements reflect the percentage of bonds that are currently active, as well as innate 
cellular features, they can be used as an innovative tool to study RBC adhesion. However, it is 
important to note that detachment of the cell from the substrate is a complicated process, and 
the detachment force obtained is a result not only of receptor-ligand binding strength and spatial 
distribution of receptors on the cell membrane but also of other factors such as membrane 
fluctuations, cellular elasticity, and cell shape [130, 309-310]. 
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Increases in RBC compliance may allow the cell to spread, leading to an increased number of 
ligand-receptor interactions and in effect, greater detachment forces measured via SCFS [138]. 
Because our experiments were conducted using RBCs from healthy subjects (N = 3, n = 5), the 
samples had a similar Young’s modulus and we found that there was not a significant 
correlation between the mean effective Young’s modulus of tested samples [30, 100] and the 
mean detachment force of RBCs (Pearson correlation test; r = -0.62, R2 = 0.39). 
 
cAMP-dependent modulation of red blood cell adhesion to laminin via BCAM/Lu 
To establish the sensitivity of the assay in the detection of variations in the adhesion of 
BCAM/Lu to laminin based primarily on the number of active receptors, we investigated 
changes in the detachment force between single RBCs and the laminin substrate via 
 
Figure 9.4.3. Correlation of single-cell measurements with traditional SMFS measurements. (a) 
Plot of the mean detachment forces from SMFS and SCFS assays. Experiments were 
performed on 5 cells from each human sample (N=3). SCFS experiments used single RBCs to 
probe a laminin functionalized substrate (50 µg/ml) with a contact time of 0.1 s. SMFS 
experiments probed BCAM/Lu receptors on 1 µm x 1 µm areas of the RBC surface with a 
laminin-functionalized probe. The resultant total force for each area was calculated as the 
product of the frequency of detected events and the mean detachment force. Error bars 
represent SEM. (b) Correlation of the resultant total force on 1 µm x 1 µm areas of the RBC 
surface obtained via SMFS with the mean detachment force obtained via SCFS measurements 
(Pearson correlation test; r = 0.96, R2 = 0.93). Each plotted point represents 5 tested cells from 
one healthy subject. 
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pharmacologic modulation of the cAMP signaling pathway. Quantitative understanding of RBC 
cytoadherence mediated by the second messenger cAMP is necessary to fully elucidate the 
mechanism of RBC adhesion. Previous experimental approaches utilizing flow adhesion assays 
have shown that the interaction between BCAM/Lu and laminin is mediated by cAMP-
dependent PKA [30, 83]. Stimulation of the β2-adrenergic receptor (β2-AR) [85-86] activates the 
G-protein coupled receptor Gαs, which stimulates adenylyl cyclase (AC) [87]. AC then catalyzes 
the conversion of adenosine triphosphate (ATP) to cAMP, resulting in PKA activation and 
ensuing BCAM/Lu-laminin adhesion. In human RBCs, basal intracellular cAMP levels are 
controlled through the activity of phosphodiesterases [224, 293], which limit not only the 
signaling lifespan of cAMP but also the distance it can diffuse from its site of production [311]. 
 
First, we treated RBCs with forskolin (30μM, FSK), a strong AC activator that stimulates cAMP 
production, subsequently activating PKA. Compared to untreated RBCs, forskolin-treated RBCs 
exhibited significantly higher detachment forces shown by the shift in the frequency distribution 
and bar graph (Figure 9.4.4a,b,e; p < 0.0001, one-way ANOVA with Tukey post hoc). To 
quantify the effect of direct PKA inhibition on the detachment force of the RBC with laminin, 
RBCs were treated with KT-5720 (1μM), a PKA inhibitor, which resulted in a significant 
decrease in the detachment force from baseline measurements (Figure 9.4.4c; p < 0.01). PKA 
is a key regulator of BCAM/Lu receptor activation on human RBCs. Based on the results 
obtained in the presence of KT-5720 and FSK, PKA inhibitor and activator respectively, we 
conjecture that RBCs maintain varying intracellular levels of tonic PKA [311-312]. We further 
speculate that this tonic PKA is modulated by cAMP levels and must be raised for activation of 
BCAM/Lu receptors to occur, resulting in elevated adhesion to subendothelial laminin. Indeed, 
inhibition of PKA activity with KT-5720 was sufficient to reduce the number of active BCAM/Lu 
receptors on the RBC surface, reflected by the significant decrease in detachment forces. This 
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is suggestive of a tonic drive because even in the absence of PKA inhibitors and activators, 
PKA exerts a sustained, steady-state activation of BCAM/Lu receptors. Finally, the physiologic 
implication of cAMP-stimulated adhesion was studied by treating RBCs with epinephrine (1μM), 
a hormone released during stress and strenuous exercise which is known to stimulate the β2-
AR. Treatment with epinephrine resulted in a significant increase in the detachment force as 
compared to baseline (Figure 9.4.4d; p < 0.0005). These data demonstrate that the single-cell 
AFM assay can detect differences in the detachment of whole RBCs from a laminin substrate in 
response to pharmacologic modulation (Figure 9.4.4e). Because a single-cell technique was 
used to measure 5 cells each from several human subjects (N=3), we also showed the 
individual results of detachment forces for each subject. Figure 9.4.4f shows the mean 
detachment force for each subject measured in each condition. Interpatient variations in 
baseline measurements showed that the sustained steady-state activation of BCAM/Lu 
receptors by PKA is not identical among human subjects.   
 
It should be noted that previous experiments using flow adhesion assays did not detect 
adhesion of non-stimulated normal RBCs to laminin [72-73] nor an increase in adhesion upon 
FSK stimulation [72]. It is highly possible that flow adhesion assays, which measure the average 
adhesion of a large number of erythrocytes to a functionalized-substrate under flow-induced 
shear stress, are not sensitive enough to detect increases in the overall low adhesion of normal 
RBCs.  
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Figure 9.4.4. Single-cell force spectroscopy can clearly detect significant changes in RBC 
adhesion to laminin substrates (50 µg/ml) following treatment with biochemical agents 
modulating the cAMP-dependent pathway. (a) Frequency distribution of the mean detachment 
force associated with healthy RBCs at baseline (N=3, n=15) shows a mean force of 0.61 ± 0.27 
nN. (b) Measurement in FSK (30 µM) indicates a significant increase in the mean detachment 
force to 1.15 ± 0.46 nN (p < 0.0001, one-way ANOVA with Tukey post hoc). Dotted distribution 
represents frequency distribution of the mean detachment force measured at baseline. (c) 
Measurement in KT-5720 (1 µM) indicates a significant decrease in the mean detachment force 
to 0.37 ± 0.23 nN (p < 0.01). (d) The physiologic implication of cAMP-stimulated adhesion was 
studied. Measurement in epinephrine (1 µM) indicates a significant increase in the mean 
detachment force to 0.76 ± 0.35 nN (p < 0.0005). (e) Summary of mean detachment forces 
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obtained for healthy RBCs from laminin substrates in the presence and absence of biochemical 
agents known to modulate cAMP-dependent adhesion. (f) Variability in mean detachment force 
amongst patient samples under different conditions. 
  
9.5. Conclusion 
In this work, SCFS was established as a method to quantify the strength and modulation of 
adhesion of human RBCs to functionalized substrates. We first determined the appropriate 
solution concentration of laminin to utilize for substrate functionalization via SMFS to determine 
the density of protein adsorption to the substrate. Subsequently, single-cell experiments were 
performed to measure variation in the detachment force associated with different laminin 
concentrations. From these tests, we determined the 50 µg/ml solution concentration of laminin 
to be most effective for our assay. Next, we probed laminin substrates with RBCs using various 
contact times, with a minimum contact time 0.1 s, and a maximum contact time of 10 s. While 
the mean detachment forces did not increase significantly, we observed an increase in the 
range of measured detachment forces. At 10 s, there was an increased probability of 
experimental failure resulting when the RBC would detach from the probe prior to the 
completion of 100 approach/retract cycles. Therefore, we chose 0.1 s for experimental 
convenience and for comparison between single-molecule and single-cell detachment forces. 
We found a significant correlation between results from SMFS measurements probing BCAM/Lu 
with a laminin-functionalized probe and SCFS measurements probing a laminin substrate with 
an RBC probe. Finally, we established that SCFS can detect variations in the detachment force 
of RBCs to laminin based primarily on the number of active BCAM/Lu receptors, which was 
modulated via biochemicals affecting the cAMP-PKA pathway. This study shows new, important 
implications for AFM-based SCFS measurements in understanding and evaluating the 
pharmacologic response of adhesion receptors on RBCs. Further, this method can easily be 
employed to measure the adhesive interactions of various cell types with functionalized 
substrates or other cells.  
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Chapter 10. Epilogue 
 
The pathogenesis of vasculopathy in sickle cell disease is a multi-faceted biological process 
resulting from red cell sickling, inflammation and adhesion biology, coagulation activation, 
stasis, deficient bioavailability and excessive consumption of NO, excessive oxidation, and 
reperfusion injury physiology [2]. VOEs account for much of the morbidity and mortality in SCD 
and also with exercise-induced collapse and sudden death in SCT. The biomechanical 
properties of increased erythrocyte stiffness and abnormal cytoadherence to endothelial 
components were investigated to gain insight into the cascade of events involved in the 
pathogenesis of complications in SCD and SCT. AFM is appropriate for measuring the 
biomechanical and adhesive properties of living cells due to its high force sensitivity and ability 
to measure local and overall properties of individual cells in physiological conditions. In 
particular, the effective Young’s modulus was quantified for RBCs from healthy, SCT, and SCD 
subjects, as well as RBC adhesive properties, defined by 1) the subcellular density and 
distribution of adhesion receptors, and 2) the unbinding force associated with specific ligands. 
 
Three-dimensional topographic images were recorded for human RBCs from healthy subjects, 
SCT subjects, and SCD subjects using AFM. The characteristic biconcave shape was observed 
for normal erythrocytes while SCT erythrocytes deviated from this morphology by means of a 
decrease in the diameter and height, likely due to increased membrane stiffness and 
dehydration. In contrast to normal and SCT RBCs, erythrocytes from patients with SCD 
substantially deviated from the characteristic biconcave shape and possessed highly irregular 
morphologies characterized by protrusions, elongation, bumps, and enlargement associated 
with aggregation of HbS fibers. 
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The biomechanical properties of human RBCs from healthy subjects, SCT subjects, and SCD 
subjects were investigated. A systematic force-displacement curve analysis based on the Hertz 
model was established to quantify the effective Young’s modulus of RBCs from human subjects 
via AFM microindentation measurements. Consistent with the Hertz model, no adhesion was 
observed between the indenter and the tested cell. It was determined that sickle RBCs possess 
Young’s modulus values between 1-60 kPa depending on their degree of oxygenation and, we 
conjecture, the percentage of HbS present in the RBCs. Both oxygenated and deoxygenated 
samples of RBCs from patients with SCD maintained a bimodal distribution with peaks 
representative of normal RBCs (   = 1.0 kPa ± 1.1 kPa) and SCT RBCs (   = 3.0 ± 2.7 kPa). 
Significantly higher Young’s modulus values resulting in peaks at   = 15 kPa for oxygenated 
sickle RBCs and   = 40 kPa for deoxygenated sickle RBCs were likely a result of the presence 
of polymerized HbS. This significant increase in the Young’s modulus upon full deoxygenation 
can present major problems in SCD vasculopathy because rigid RBCs have a greater 
propensity to occlude the microvasculature, resulting in severe VOEs. Small Young’s modulus 
values for both oxygenated and deoxygenated SCD erythrocytes are likely due to treatment with 
the drug hydroxyurea, a variable in the obtained clinical samples. Hydroxyurea is the only 
approved medication for the treatment of VOEs in SCD for adults which works by stimulating the 
production of HbF and inhibits sickling by preventing effective contact between HbS molecules.  
 
The AFM technique used to measure the stiffness of normal and pathological RBCs was then 
employed in the study of RBCs from mice with SCD. In an effort to rectify the increased stiffness 
of sickle RBCs, mice were fed a diet supplemented with DHA, an omega-3 fatty acid. To date, 
studies of omega-3 fatty acids in human SCD showed a decrease in acute painful VOEs, but 
have not carefully assessed the effect of DHA on sickle RBC structural and functional 
characteristics. Although individuals with SCD are known to have increased daily pain and 
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allodynia, effects of omega-3 fatty acid supplementation on chronic or neuropathic pain in SCD 
have not been reported. Our findings indicate that DHA supplementation improves RBC 
membrane flexibility measured via AFM and reduces irreversibly sickled cells in mice with SCD. 
The increased RBC flexibility and decrease in irreversibly sickled RBCs found in this study at 
steady state suggest that the RBCs in SCD DHA mice may be more resistant to acute sickling 
events and resultant tissue injury, such as can be induced using hypoxia-reoxygenation in SCD 
mice. Therefore, dietary supplementation with omega-3 fatty acids may provide a safe and 
effective way to ameliorate pathologies associated with VOEs in human and murine SCD. 
 
As previously mentioned, the abnormal cytoadherence of RBCs to the endothelium is thought to 
be a chief contributor to the complicated biological processes causing the pathogenesis of 
vasculopathy in SCD and SCT. It is known that the BCAM/Lu-laminin and ICAM-4-αvβ3 binding 
complexes contribute to VOEs, yet the single-molecule characteristics of these adhesive 
interactions were previously unknown for SCT and SCD erythrocytes. To establish the single-
molecule force spectroscopy technique which measures adhesive interactions, experiments 
were performed using a functionalized laminin probe and a BCAM/Lu-coated gold substrate. In 
wild-type and SCT RBCs, the magnitude of the BCAM/Lu-laminin binding complex (46 ± 6 pN 
and 46 ± 10 pN, respectively) was found to be equal to the average rupture force of 50 ± 11 pN 
recorded between a functionalized laminin probe and a BCAM/Lu-coated gold substrate. 
Similarly, in wild-type RBCs and sickle cell trait RBCs, the magnitude of the ICAM-4-αvβ3 
binding complex (46 ± 10 pN and 47 ± 10 pN, respectively) is nearly the same as the average 
rupture force of 47 ± 15 pN recorded between a functionalized integrin αvβ3 probe and a ICAM-
4-coated gold substrate. Further, the observed increase in adhesive frequency, in conjunction 
with the detected receptor aggregation into nanodomains, is significant evidence of the 
contribution of epinephrine to enhancing BCAM/Lu-laminin and ICAM-4-αvβ3 adhesive 
interactions. These findings suggest a mechano-adhesive role for epinephrine in the 
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pathophysiology of VOEs related to collapse and sudden death in SCT individuals during 
strenuous exercise. 
 
The sensitivity of the SMFS system was validated in a neuronal system to quantitatively map SK 
channels. Because the activation of adhesion receptors on RBCs and other cells can be 
modulated by various biochemical stimuli, it was important to assure that the technique could 
detect changes in the population of membrane components such as adhesion receptors or ion 
channels. We showed that integration of single-molecule force spectroscopy with toxin 
pharmacology allowed us to map the spatial organization and density of endogenous SK 
channels in living neurons. By taking advantage of the nanometer resolution of single-molecule 
AFM, we demonstrated that SK channels are highly concentrated on neuronal dendrites and are 
organized on neuronal membranes as either groups of two or single entities. To establish the 
technique’s sensitivity, forskolin was used to show that SK channel dendritic distribution is 
dynamic and under the control of PKA.  
 
SMFS was employed to investigate the effects of subcellular cAMP pathway targeting on the 
activation of BCAM/Lu receptors at the single-molecule level on normal and SCD RBCs. In 
SCD, cytoadherence of RBCs to endothelial and subendothelial matrix components is thought 
to be a major contributor to and possibly the primary cause of VOEs. A determinant of clinical 
phenotype in SCD is the adhesive properties of RBCs, defined by the subcellular density and 
distribution of adhesion receptors, and the unbinding force associated with specific ligands. 
Importantly, we demonstrate that AKAPs are essential for BCAM/Lu receptor activation, and 
that the collective frequency of BCAM/Lu receptors, present on both the normal and SS-RBC 
membrane, is critically dependent on the cAMP pathway. HU-treatment was also found to 
reduce the ability for BCAM/Lu receptor stimulation by epinephrine suggesting that HU modifies 
β2-AR signaling. We also measured that the unbinding force between BCAM/Lu and laminin in 
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hydroxyurea-treated patients is lower than in untreated patients. The study shows new, 
important implications for AFM cytoadhesion assays in evaluating the pharmacologic response 
of adhesion receptors on RBCs. 
 
To examine the relevance of results based on SMFS in the cytoadhesion of entire RBCs, SCFS 
was established to measure the adhesion of whole cells with a functionalized substrate. We first 
determined the appropriate solution concentration of laminin to utilize for substrate 
functionalization by employing both SMFS and SCFS experiments. It was determined that the 
50 µg/ml solution concentration of laminin is most effective for this assay. Laminin substrates 
were then probed with RBCs using various contact times, ranging from 0.1 s to 10 s. While the 
mean detachment forces did not increase significantly, we observed an increase in the range of 
measured detachment forces with increased contact time. It was determined that elevated 
overall cell adhesion measured via SCFS coincided with a rise in the resultant force measured 
on 1µm2 areas of the RBC membrane via SMFS. To establish the sensitivity of the technique, 
RBCs were treated with biochemicals affecting the cAMP-PKA pathway and we indeed found 
that SCFS can detect variations in the detachment force of RBCs to laminin based primarily on 
the number of active BCAM/Lu receptors. This study shows new, important implication for AFM-
based SCFS measurements in understanding and evaluating the pharmacologic response of 
adhesion receptors on RBCs.  
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